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BOTANICAL TERMS 
 
Andromonoecious Hermaphrodite and male flowers on same plant. 
Axillary Situated in or arising from an axil. 
Calyx The sepals of a flower collectively forming the outher floral envelope or 
layer of the periants enclosing a developing bud; usually green. 
Corolla The petals of a flower collectively forming an inner floral envelope or 
layer of the perianth. 
Disk of flower The enlarged part of the flower to which sepals, petals and other flower 
organs are attached. 
Filiform sepals Threadlike sepals. 
Glandular hair A trichoma with enlarged unicellular or multicellular secretory hairs at 
the terminus. 
Hermaphroditic flower Flowers with both male and female reproductive organs. 
Indumentum Covering of fine hairs/scales on leaf. 
Inflorescence The flowering part of a plant or arrangement of flowers on a stalk. 
Lamina The blade of a leaf; the broad, expanded portion of a petal/sepal. 
Monoecious Unisexual reproductive units of both sexes appearing on the same plant. 
Ovary The organ (part of pistil) that bears the ovules (seeds) of a flower. 
Develops to a fruit in most flowering plants. 
Panicle A branched inflorescence. 
Pedicle A stalk which supports one flower/fruit. 
Pericarp The fruit wall. 
Petals Part of the perianth that is usually brightly colored (syn. flower petal). 
Petiole Stalk, petiolate leaf; having a stalk or petiole. 
Pistil The female ovule-bearing part of a flower composed of ovary and style 
and stigma (syn. gynoecium). 
Raceme Type of inflorescence that is unbranched and indeterminate and bears 
pedicellate flowers along the axis. 
Receptacle The apex of the flower stalk, from which the organs of the flower grow. 
Scale In subgenus Combretum: stalked multicellular scales on leaves. Can be 
used for species identification. 
Sepals One of the green parts that forms the calyx of the flower. 
Sessile Resting directly upon the main stem or branch, without a petiole or 
footstalk; a sessile leaf or blossom. 
Short shoots Shoots having very short internodia thus nodes situated very near each 
other. In Terminalia spp. 
Spike An indeterminate inflorescence bearing sessile flowers on an unbranched 
axis. 
Stamen The male reproductive organ of the flower. 
Stigma The apical end of the style where pollen is deposited. 
Stipe Supporting stalk or stemlike structure especially of a pistil. 
Stipitate Supported by a stipe. 
Subulate sepals Very narrow and tapering gradually to a fine point from a broadish base. 
Zygomorphic flower A bilateral flower consisting of two symmetrical halves. 
 
Definitions from Webster`s dictionary and http://www.wikipedia.org . 
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ABSTRACT 
 
In Africa various species of Combretum, Terminalia and Pteleopsis are used in traditional 
medicine. About 24 different species of Combretum are well known in traditional medicine and 
used for various ailments and diseases ranging from heart and worm remedies to wound 
dressings, treatment of the mentally ill, and scorpion stings. Many species of Terminalia are used 
for infections, diarrhea, venereal diseases and fever. Species of Pteleopsis are known to be 
effective for gastric ulcers, infertility, venereal diseases and dysentery. Some species of 
Combretum, Terminalia and Pteleopsis have already been documented for their antimicrobial as 
well as cytotoxic effects, and in some cases the active compounds have been isolated. 
Antimicrobial hydrolysable tannins, flavonoids, lignans, stilbenes, phenanthrenes and pentacyclic 
triterpenoids are known from some species of the three genera. Combretastatins, a group of 
stilbenes with cytotoxic, antiangiogenic and antivascular effects have been isolated from 
Combretum caffrum as well as from some other species of Combretum. Hydrolysable tannins 
from species of Terminalia have been shown to possess antimutagenic effects as well as being 
growth inhibitory against various cancer cell lines. 
 
The aim of this work has been to document the ethnomedicinal uses of several species of 
Combretum and Terminalia in seven villages of the Mbeya region, south-western Tanzania, and 
to use this information for finding species with good antimicrobial and cytotoxic potential. The 
ethnomedical information I obtained from traditional healers was important, and facilitated the 
finding of Combretum and Terminalia species with excellent antimicrobial and cytotoxic effects. 
 
I initiated this work with a five weeks expedition to Tanzania in spring 1999 (Study I). Sixteen 
different species of Combretum and Terminalia, as well as Pteleopsis myrtifolia were collected 
from various locations in the districts of Mbeya, Iringa and Dar-es-Salaam. During the expedition 
traditional healers in seven villages in the Mbeya region were interviewed in Swahili and 
Nyakyusa on the medicinal uses of the collected species of Combretum and Terminalia with the 
aid of a questionnaire. Interestingly, the results of the interviews correlated well between the 
different villages, the same species being used in similar ways in different villages. Of the ten 
species of Combretum and Terminalia I showed the traditional healers, six were frequently used 
as medicinal plants. Combretum molle was used in six villages out of the seven for treatment of 
bacterial infections, skin diseases, diarrhea, oedema and wounds. Combretum zeyheri was also a 
popular medicinal plant in the villages in Mbeya, as well as C. fragrans, C. psidioides, 
Terminalia sericea and T. kaiserana. Most of the species mentioned are used for the treatment of 
bacterial infections, such as gonorrhea, syphilis and influenza, as well as for skin diseases, 
diarrhea and wounds. Roots and leaves were the most commonly used organs, although stem bark 
was reported to be used by one of the traditional healers I interviewed. Fruits and flowers from 
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Combretum and Terminalia were never used as medicine, and some of the healers reported that 
the seeds are poisonous. The most common way to prepare medicines from the plants was to 
make hot water decoctions from dried plant material. Other ways were to mix dried, powdered 
plant material with maize porridge, Ugali for oral use or with sheep fat for ointments. Infusions 
made from either dried of fresh plant material were also common. The extract of the leaves of C. 
molle was reported to be used for baths treating patients with bacterial infections. The process of 
preparation of the plants to medicine was never shown to us, since many traditional healers think 
that the phytomedicine looses its medicinal properties and power of healing in this way. In many 
cases different species of Combretum as well as Terminalia were mixed together, and generally it 
is thought that the medicinal properties of mixtures of plants are more effective than preparations 
made of one plant. I have screened twenty-one extracts of six Combretum species and four 
Terminalia species, collected from Tanzania, for their antibacterial effects against two gram-
negative and five gram-positive bacteria, as well as the yeast, Candida albicans, using an agar 
diffusion method (Study I). Most of the screened plants showed substantial antimicrobial activity. 
The most potent extract was a methanolic root extract Terminalia sambesiaca which gave a MIC 
value of 0.9 mg/ml against Enterobacter aerogenes. Also root extracts of Terminalia sericea and 
T. kaiserana gave excellent antibacterial effects. Notably, a hot water decoction of T. sericea, the 
way in which this plant is prepared for traditional medicine in Mbeya, gave as good antibacterial 
effects as extracts of this species made in MeOH or EtOH. This indicates that some of the 
antimicrobial compounds in T. sericea might be polar. A leaf extract of T. kaiserana was the only 
extract used in this study to inhibit the growth of the gram-negative E. coli, and the effect was 
found to be bactericidal. Combretum fragrans and C. padoides gave the best antibacterial results 
of all the investigated Combretum species, and this is in accordance with the use of C. fragrans 
for diarrhea in Tanzanian traditional medicine. 
 
In study II I have screened thirty-five crude extracts of five species of Terminalia, ten of 
Combretum and Pteleopsis myrtifolia for their antifungal effects against five species of yeast 
(Candida spp.) and Cryptococcus neoformans, using an agar-diffusion method. There were 
substantial differences between the species of Combretum and Terminalia in their antifungal 
effects, some being highly effective and others showing no effects. Interestingly, the most 
effective plant extracts gave antifungal effects comparable to the standard antibiotics itraconazol 
and amphotericin B, used in this investigation. The Terminalia species gave in general stronger 
antifungal effects than the species of Combretum, and the best effects were obtained with 
methanolic root extracts of T. sambesiaca, T. sericea and T. kaiserana, although also root 
extracts of C. padoides, C. molle and C. fragrans gave good antifungal results. Candida glabrata, 
C. krusei and Cryptococcus neoformans proved to be the most sensitive fungal species, whereas 
C. alba, C. tropicalis and C. parapsilosis were more resistant to the plant extracts. My 
investigation indicates that decoctions of Terminalia sambesiaca, T. sericea and T. kaiserana 
might be used for the treatment of fungal infections related to HIV. 
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Six antifungally and antibacterially active fractions were isolated from the roots of Terminalia 
sambesiaca with the aid of reversed-phase medium-pressure liquid chromatography (RP-MPLC) 
(Study II). The most polar fractions showed the strongest antifungal and antibacterial effects, 
although some less polar fractions also gave good growth inhibitory effects. This shows that T. 
sambesiaca roots contain antimicrobial compounds with a wide range of polarities. 
 
In study III I have evaluated the cytotoxic effects of twenty-seven plant extracts of eight species 
of Combretum, five species of Terminalia and Pteleopsis myrtifolia collected in Tanzania against 
three human cancer cell lines (HeLa, cervical carcinoma; MCF 7, breast carcinoma; T 24 bladder 
carcinoma) and one endothelial cell line (BBCE, bovine brain capillary endothelial cells). The 
cytotoxic and antiproliferative effects were evaluated with the Alamar Blue and the Coulter count 
methods. The most outstanding effects were obtained with a leaf extract of Combretum fragrans, 
which nearly totally inhibited the proliferation of the T 24 and HeLa cells at a concentration of 25 
μg/ml and inhibited 60 % of the growth of the HeLa cells at a concentration of 4.3 µg/ml. C. 
fragrans might induce apoptosis in HeLa cells since cells treated with this extract showed 
fragmented nuclei, a sign of apoptosis. The species of Terminalia were less cytotoxically potent 
than the Combretum species, although T. sericea and T. sambesiaca gave good cytotoxic effects 
(< 30 % proliferation). To the best of my knowledge I am the first to report that Combretum 
fragrans and Terminalia sambesiaca possess strong cytotoxic effects. T. sambesiaca is reported 
to be used for treatment of cancer in Tanzanian medicine, which is thus in accordance with the 
good cytotoxic results I have obtained for this species. 
 
In summary the studies above indicate that many of the species of Combretum, Terminalia and 
Pteleopsis, used in Tanzanian traditional medicine, are powerful inhibitors of both microbial and 
cancer cell growth. In depth studies would now be needed to find the active compounds behind 
these biological activities. 
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1. INTRODUCTION 
 
It has been estimated that less than 1 – 10 % of the large diversity of 250.000 – 500.000 plant 
species on the Earth have been studied chemically and pharmacologically for their medicinal 
properties (Farnsworth, 1991; Verpoorte, 2000). This is especially true for the tropical flora, as at 
date only 1 % of the species in these habitats have been studied for their pharmaceutical potential 
(Gurib-Fakim, 2006). Tropical forests and many other tropical ecosystems are rich sources of a 
diversity of plant derived chemical compounds, both because of the high species diversity but 
also because of the “eternal summer” which forces the plant species to the constant production of 
chemical defense compounds against herbivores and pathogens as well as against other plant 
species. Plants in a tropical rainforest also have to compete for space and light and this forces 
species to develop more efficient means of using energy and nutrients as well as to allocating 
resources for secondary compound production. For these reasons a greater portion of the tropical 
plant species contains secondary compounds, potentially useful as models for/as medicines 
(Wood-Sheldon et al., 1997). Plant derived compounds have been, and are still, important as such 
or as models (lead compounds) for medicines: 50 % of the prescription products in various 
countries in Europe and the US are either natural products or natural product derivates (Cordell, 
2002; Newman et al., 2003). To date about 50 drugs have come from tropical plants (Gurib-
Fakim, 2006). Plants continue to be a potent source of lead compounds. Although combinatorial 
techniques have been used for the optimization of a number of recently approved agents, these 
methods have not been able to identify a de novo combinatorial compound (Newman et al., 
2003). Examples of successful medicines derived from natural product leads include most 
antibiotics, the acethylcholine esterase (ACE) inhibitors, many anticancer agents, the 
immunosuppressants, cyclosporine and rapamycin and the antiparasitic avermectins (Harvey & 
Waterman, 1998). 
 
People have used plants for millennia and vast information of the medicinal uses of plants has 
therefore accumulated especially in the tropical parts of the world. According to the World 
Health Organization (WHO), about 80 % of the people in developing countries rely primarily on 
medicinal plants for their primary health care (Wood-Sheldon et al., 1997). In many remote areas 
in African countries people consult the traditional healer of the village in case of illness. Western 
hospitals and medicines are often beyond the reach and Western medicines many times too 
expensive for the people to afford. Even in the big cities such as Dar-es-Salaam, with 2 500 000 
inhabitants (http://en.wikipedia.org/wiki/Dar_es_Salaam), a large proportion of the inhabitants 
use traditional medicine for their health care (Swantz, 1974). In Africa the ethnopharmacological 
and –botanical knowledge on the uses of medicinal plants is often orally passed down from 
generation to generation. This abundance of information is in danger of disappearing since it is 
often kept secret until the last minutes of death of the traditional healer when they eventually call 
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on somebody to inherit the information (Kokwaro, 1976). Although traditional medicine has been 
recognized as a part of primary health care programmes in many African countries (WHO, 1978), 
there is a need to evaluate scientifically the crude extracts of plants for their medicinal and 
pharmacodynamic properties, clinical usefulness and toxicological potential (Kyerematen & 
Ogunlana, 1987). 
 
Higher plants are still poorly explored as sources of new drugs (Hostettman & Terreaux, 2000). 
There are several ways in selecting plant materials when searching for new medicinal 
plants/active compounds. Ethnopharmacological information on medicinal plants is often of 
substantial importance for the finding of new potential medicinal plants/new ways of using an 
already known plant. It has been estimated that 74 % of the pharmacologically active, plant 
derived components were discovered after the ethnomedical uses of the plants started to be 
investigated (Farnsworth & Soejarto, 1991; Wood-Sheldon et al., 1997). Another important way 
of discovering new medicinal plants and lead compounds is the phylogenetic approach in which a 
number of closely related species of plants, assumed to contain related chemical compounds 
(chemotaxonomy), are screened for their biological effects (Cotton, 1996; Vuorela et al., 2004). 
Random sampling collecting plant samples from certain habitats with high species diversity (for 
example tropical rainforests) can be beneficial for finding novel chemical entities (NCEs), but is 
somewhat time-consuming and requires hard work (Vuorela et al., 2004). This kind of sampling 
is likely to be the industrial approach and most likely to be used for evaluating plants for 
bioactive compounds (Fabricant & Farnsworth, 2001). 
 
Serious infections caused by bacteria that have become resistant to commonly used antibiotics 
have become a major global healthcare problem in the 21st century. In the developing countries 
bacterial infections are still the main cause of deaths (Iwu et al., 1999). The need for new 
antibacterial drugs is constant, because of the continuous development of antibiotically resistant 
strains of pathogenous bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), 
penicillin-resistant Streptococcus pneumoniae (PRSP) and vancomycin-resistant enterococci 
(VRE). Recently, a simultaneous development of resistance to several antibiotic classes has 
created very dangerous multidrug-resistant (MDR) bacterial strains (Alanis et al., 2005). Over 75 
% of the antibacterials in clinical use are of natural origin and most of them are obtained from 
fungal sources (Newman et al., 2003). A renewed interest in plant based antimicrobials has arisen 
during the last twenty years, but still plant based antimicrobials are poorly explored. Screening of 
plant extracts for antimicrobial activity has shown that higher plants represent a potential source 
of new anti-infective compounds (Press, 1996). Plant derived antimicrobial compounds might 
inhibit bacteria through different mechanisms than conventionally used antibiotics, and could 
therefore be of clinical value in the treatment of infections caused by resistant microbes (Eloff et 
al., 1998b). Only a small fraction of the known plant species of the whole world have been 
evaluated for the presence of antimicrobial compounds, and thus it is necessary to increase the 
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efforts in collecting and screening plants for the development of novel and environmentally safe 
antimicrobial agents (Stein et al. 2005). 
 
Life-threatening fungal infections have increased dramatically in immunocompromised patients 
during the past decades (Rex et al., 1997). Although new antifungal agents are under evaluation, 
only a few have been licensed for the treatment of systemic fungal diseases. To date, only three 
classes of antifungal drugs are available for the treatment of systemic fungal infections: the 
polyenes, the azoles and flucytosine (Denning, 2003). Although many of these drugs have 
advanced the management of fungal infections, failure rates remain high. The prolonged use of 
antifungal drugs in the treatment of chronical infections have caused the emergence of 
amphotericin-B and azole resistant Candida species (Patel, 1998). There is a general consensus 
that new antifungal agents are needed (Selitrennikov, 2001). Recently two naturally derived 
antifungals, caspofungin acetate and micafungin sodium, have been approved for antifungal 
therapy. This is for the first time since the 1970s that two natural products are approved as 
antifungals. During the period 1981- 2002, most of the antifungals approved for clinical use have 
been synthetic (Newman et al., 2003). The Spanish Merck group have recently reviewed the 
importance of natural products in antifungal chemotherapy (Vicente et al., 2003), but the focus in 
this review is kept on micro-organisms as producers of new antifungals. Higher plants might 
contain valuable, not yet explored lead compounds for antifungal therapy. 
 
Mortality that results from cancer is still unacceptably high and is becoming a growing public 
problem in the 21st century. The estimated worldwide new incidence of cancer is about 6 million 
cases per year. In the developed countries cancer is the second major cause of death after 
cardiovascular diseases (Srivastava et al. 2005). Natural products have been the mainstay in 
cancer chemotherapy for the past 30 years. Over 60 % of the clinically used anticancer drugs are 
of natural origin and most of them are derived from higher plants (Newman et al., 2003). Many 
of the chemotherapeutic medicines in current use have been discovered with the aid of traditional 
medicinal uses. This is the case with the powerful anti-leukemial drugs vinblastin and vincristin 
isolated from the native Madagascar plant, Catharanthus roseus and the podophyllins isolated 
from the roots of the mayapple, Podophyllum peltatum. The search for new anticancer lead 
compounds with enhanced biological properties and fewer adverse side effects is still needed. 
Natural products are likely to provide many of the lead structures also in the future (Mann, 2002). 
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2. REVIEW OF THE LITERATURE  
2.1. Traditional Medicine in Africa  
 
African traditional medicine is the oldest and perhaps the most diverse of all medicine systems. 
Africa is considered to be the cradle of mankind with a rich biological and cultural diversity, and 
there are marked differences between different regions of this continent when it comes to healing 
practices (Gurib-Fakim, 2006). Medicinal and poisonous plants, including a diverse array of 
woody plants, have always played an important role in African life. The traditions of collecting 
plants as well as processing herbal remedies and applying them have been handed down from 
generation to generation (von Maydell, 1996). 
 
2.1.1. Documentation of African traditional medicine  
 
Most of the African cultures have a verbal tradition, and therefore written information on cultural 
features in the past are not so readily available from Africa as from many other parts of the world 
(Hedberg & Staugård, 1989). There exists, however some documents on African traditional 
medicine, and the oldest of them is written by the famous Arab doctor and polyhistor, Avicenna, 
who lived 980-1037 A.D. With the colonization of Africa, European botanists started to explore 
the flora of various parts of the continent. The ethnobotanical information on the uses of the 
plants were sometimes documented on herbarium labels, and in this way ethnobotanical 
information on a number of plants began to accumulate (Hedberg & Staugård, 1989). Systematic 
accounts in written form dealing with medicinal plants in Africa are of fairly recent date, reports 
dealing with ethnopharmacological aspects being even more recent. An extensive review on 
African traditional medicine and on the use of plants for medicine is written by Maurice Iwu, a 
Nigerian pharmacognosist and ethnopharmacologist (Iwu, 1993). A number of traditional 
national pharmacopeias have appeared, starting with Madagascar in 1957, and research in the 
field of ethnobotany and ethnopharmacology has developed rapidly in many African countries 
(Hedberg & Staugård, 1989). The African Pharmacopoeia, covering traditional medicine of 
many African countries, has been published by the Scientific Technical Research Commission of 
the Organization of African Unity, starting with volume 1 in 1985 (African Pharmacopoeia, Vol. 
1, 1985). 
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2.1.2. The importance of traditional medicine in different African countries 
 
Traditional medicine is an important part of the health-care system in most of the African 
countries. About 80 – 90 % of the populations in African countries are dependent on traditional 
medicine for their primary health care (Hostettman et al., 2000). For example in Sudan, 
traditional medicine plays an important role for health care, since access to hospitals and other 
medicinal facilities is limited and a high percentage of the population are nomads (Elegami et al., 
2002). In Tanzania, over 60 % of the health seeking population have a traditional healer as their 
first point of contact (Hedberg et al., 1982). In spite of an extensive programme to create health 
centers and to train Rural Medical Aids and Medical Assistants, the traditional healer is still the 
only medical practitioner available, within reasonable distance, to many Tanzanians living in the 
rural parts of the country (Hedberg et al., 1982). Traditional medicine is also important in the big 
cities of Tanzania, such as Dar-es-Salaam (Swantz, 1974). The number of registered traditional 
healers in Tanzania has been estimated to about 30.000 – 60.000, currently even 75.000 (Mhame, 
2000), in comparison with about 600 Western-trained doctors (Weenen, 1990; 
http://www.fao.org//docrep/X5327e/x5327e06.htm). In South Africa it is estimated that about 27 
million people depend on traditional herbal medicines for their primary health care (Meyer et al., 
1996; Mander, 1998). In Nigeria traditional medicine is well acknowledged and established as a 
viable profession (Kafaru, 1994), and almost all plants seem to have some kind of application in 
traditional medicine (Babayi et al., 2004). Traditional medicine seems to have certain advances 
over imported systems of medicine because it is an integral part of the people’s culture and is 
particularly effective in solving certain cultural health problems (von Maydell, 1996). The 
African Union and the O.A.U. Scientific Council for Africa work for the promotion of systematic 
research on traditional medicine in different African countries (Swantz, 1974). 
 
The rising cost of Western medicine means that the people in African countries are increasingly 
turning to traditional medicine as an affordable alternative. The current policy in many African 
countries has been to incorporate traditional medicine into the formal health care sectors (Tsey, 
1997). In some African countries it is thought that traditional medicine should be taught and 
practiced as part of formal health care sectors (Tamakloe, 1995). Gradually, traditional medicinal 
practitioners (TMP) are being officially accepted as part of African health services and their 
medical knowledge is finding its place in hospitals and clinics (Neuwinger, 2000). In South 
Africa, traditional medicinal practices have only recently been officially recognized as a 
legitimate form of health care and traditional medicine is now being integrated in the official 
health care system under the Reconstruction and Development Plan (RDP) (Pick, 1992). In many 
countries in Africa traditional methods are now being used for the treatment of HIV infection 
(Morris, 2002) and malaria (Njoroge & Bussman, 2006), including the use of medicinal plants 
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that help alleviate the symptoms of these diseases. These methods are sometimes claimed to give 
fewer side effects than conventional antiretroviral therapy (Morris, 2002). 
 
2.1.3. The practice of traditional medicine in the African community 
 
The holders of traditional medicinal knowledge differ in different indigenous groups. In some 
cases all members of the community may know how to treat a wide range of common diseases 
and only seek the advice of a traditional healer for the treatment of specific diseases when their 
own treatments have failed. For example in Tanzania, common plant treatments are known and 
used by the majority of rural people, as well as by many people in the cities, although these 
people are not recognized as “waganga” (medicine men) since they are not selling their services 
to others (Swantz, 1974). These day to day uses of medicinal plants are often included as a part of 
the diet. In many cases there are no clear indications of the extent to which medicinal plants 
grown in home gardens are used by households as opposed to being prescribed by traditional 
healers (http://www.UNEP.org/CBD/WG8J/3/INF/3). The TMP (traditional medicinal 
practitioners, medicine men) sell their services on a business basis (Swantz, 1974). In some 
indigenous groups TMP hold most of the medicinal knowledge, and in these cases the knowledge 
is often passed down through certain families/tribes from generation to generation under a system 
of apprenticeship (Swantz, 1974; Neuwinger, 2000). In Dar-es-Salaam, among the Zaramo, a 
considerable number of the traditional medicine men have learnt their “uganga” (medicinal 
practice) from other ethnic groups since their uganga is thought to be more powerful (Swantz, 
1974). Traditional healers collect medicinal plants from the wild and/or cultivate some of them 
for their medicinal practice in their homes (Swantz, 1974; Hedberg & Staugård, 1989). Among 
the Zaramo in Dar-es-Salaam almost every tree, shrub or grass is believed to have medicinal 
value (Swantz, 1974). Traditional healers may sell some of their medicinal plants on local 
markets, as could be observed in Dar-es-Salaam (Fyhrquist, unpublished). In some African 
countries medicinal plants are sold in Amayeza stores, “medicine shops” 
(http://www.UNEP.org/CBD/WG8J/3/INF/3). 
 
African traditional medicine involves both the body and the mind. Health in Africa is the 
condition of physical, psychological, social and economical well-being. The cornerstone of 
African traditional medicine is that illness is usually due to outside influences and the 
requirement is to know who or what could have caused it (Neuwinger, 2000). For example the 
Yoruba in Nigeria have three explanations for the cause of illness and misfortune; the natural 
(physical cause), the preternatural (witchcraft, sorcery as causes) and the supernatural (various 
spirits as causes) (Prince, 1964). These fore mentioned categories of causes for diseases are 
shared by many other people in Africa, such as the Zaramo in Dar-es-Salaam (Swantz, 1974). 
Thus, the natural physical cause of the disease is treated with herbs, the preternatural cause with 
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magical acts and the supernatural cause with ritual sacrifices, offerings or exorcism (Swantz, 
1974). The healer typically diagnoses and treats the psychological basis of the illness before 
prescribing medicines to treat the symptoms. Most healers believe that the body requires 
treatment with several different plants, and it is the combination of these which produces a 
healing effect, either through complementary benefits or synergy and potentiation (Neuwinger, 
2000). Many recipes consist of several plants, or different parts of the same plant, since different 
plant parts often cause different effects. The magical strength of a healing plant is often also 
introduced into the therapy. Often the healers use plants according to their analogy and 
morphological similarities to the ailment being treated, so that for example plants containing red 
juice are used for everything connected to blood, as menstruation problems and bleeding 
(Neuwinger, 2000). 
 
2.1.4. Information on the medicinal uses of plants in Africa is in danger of 
disappearing 
 
The abundance of information on the traditional medicinal uses of plants in Africa is in danger of 
disappearing since the knowledge of how to use medicinal plants is mostly passed down orally 
and even to date is poorly documented (Gurib-Fakim, 2006), although written information has 
been produced for some specific regions (see chapter 2.1.2). The large volume written by Iwu 
(1993) about medicinal plants and their uses in several African countries is extensive and covers 
much, but Africa is large and there is still large areas which have not been explored for their 
traditional medicine. 
 
It is rare to find healers with written documents, apart from minor memory aids as to plant 
characteristics, which help to find medicinal plants similar in appearance but different in healing 
effects. Oral transfer of knowledge is vulnerable to disruption and interference and may result in 
the loss and distortion of valuable ethnomedical information. In indigenous groups where 
traditional healers hold most of the knowledge this is likely to be even more a problem. This is 
further made more problematical by the wish of keeping information secret and a refusal to reveal 
information - an issue of particular relevance to medicinal plants (Hedberg & Staugård, 1989). 
Transfer of knowledge between the generations is also a problem since the younger generation 
understand traditional medicine as being a profession mainly conducted by members of an older 
generation. Still, young people are using traditional medicine for their health problems, and 
believe in it (Ntemi & Bracebridge). 
 
Sustainability of the use of medicinal plants is an actual and important issue. The demand for 
medicinal plants is increasing in Africa as the population grows and pressure on medicinal plant 
resources will become greater than ever. The interest in plant derived medicines has also 
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increased in the West, among the pharmaceutical companies, and thus extensive gathering of 
plants from tropical habitats are made in order to find NCE. Most medicinal plants are currently 
obtained from the wild, and there are already reports of some medicinal plant species becoming 
extremely rare, such as Warburgia salutaris (Canellaceae), Cassine transvaalensis (Celastraceae) 
and Erythrophleum lasianthum (Leguminosae) (Fennel et al, 2004). The major factor 
contributing to the depletion of natural resources is the loss of habitats due to anthropogenic 
activity (Iwu, 1995; Rukangira, 2001). Africa is estimated to have 216,634 ha of closed forest 
areas and with a calculated annual loss of about 1 % due to deforestation, one of the highest rates 
of deforestation in the world, many of the medicinal plants and other genetic materials become 
extinct before they are even documented. Habitat conversion threatens not only the loss of plant 
resources, but also traditional community life, cultural diversity, and the accompanying 
knowledge of the medicinal value of several endemic plant species (Iwu, 1995). A large 
proportion of the plants found in Africa are endemic to the continent, the republic of Madagascar 
having the highest rate of endemism (82 %) (Gurib-Fakim, 2006; 
http://www.UNEP.org/CBD/WG8J/3/INF/3). Different solutions for the sustainable use of 
medicinal plants have been presented: Medicinal plants can, for example be grown as crops 
through small-scale farming in their natural habitats (Iwu, 1995; Van Staden, 1999). On the other 
hand, there are traditional healers who believe that plants grown under agricultural conditions 
will not have the same medicinal properties as those harvested from the wild. Cultivated material 
is believed to lack the “power” of wild medicinal plants (Cunningham, 1993). 
 
2.2. Description, brief systematics and geographical extension of the 
Combretaceae family  
 
The widespread pantropical Combretaceae family comprises of about 600 species and 20 genera 
(Tan et al., 2002), of which 11 occur in tropical Africa (Heywood, 1978). The family includes 
forest trees, 50 m or more high, to dwarf shrubs with subterranean rhizomes and short aerial 
shoots. In forests the large trees and lianas predominate, while in grassland the shrublike growth 
form is more common. Plants belonging to Combretaceae have compartmented hairs, known as 
the “combretaceous hairs”, which apart from the Combretaceae occur only in Cistaceae and 
Myrtaceae (Wickens, 1973). The family has traditionally been placed in the order Myrtales since 
Robert Brown established it in 1810 (Dahlgren and Thorne, 1984), and this placement has 
recently been supported by molecular studies (Conti et al., 1996). Within the family, two 
subfamilies, Strephonematoideae and Combretoideae, have been recognized since Engler & Diels 
(1899). The subfamily Strephonematoideae contains a single genus comprising six species, 
distributed in West Africa. The subfamily Combretoideae contains 19 genera, including the 
mangrove species, and is characterized by a wholly inferior ovary and seeds with small, folded 
and spirally twisted cotyledons. Combretoideae is a taxonomically and phylogenetically complex 
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group. Species of this subfamily are not always easy to recognize on the basis of their 
morphological characters, because the variation is wide in flowers, fruits and vegetative shoot 
morphology (Stace, 1965). 
The most known genera, as medicinal plants, are Combretum and Terminalia. Some species of 
Pteleopsis are also used for traditional medicinal purposes. 
 
2.2.1. The genus Terminalia L. 
 
The second largest genus of Combretaceae, Terminalia, consists of 200 species, distributed in the 
tropics and subtropics (Wickens, 1973; Tan et al., 2002). About 30 species of Terminalia are 
found in Africa (Wickens, 1973). Species of Terminalia vary greatly in morphology, anatomy 
and karyotype evidence (Excell 1954; Stace, 1965; Ohri, 1996). The species of Terminalia are 
small to large trees depending on the growth habitat. In rainforests they can reach heights of up to 
50 m, and often grow as emergents, reaching above the upper tree stratum. In Africa Terminalia 
species growing in Miombo woodlands are smaller, and usually reach heights of 10-20 m. 
 
Morphology 
 
The African species of Terminalia are most often trees and rarely shrublike in growth form 
(Wickens, 1973). Terminalia trees show a very distinct, pagoda-like tree architecture, known as 
Aubréville`s Model: the main stem produces whorls of horizontal lateral branches and each 
lateral branch is made up of a succession of branchlet units, each with the tip turned up and a 
cluster of leaves at its apex (van Wyk & van Wyk, 1997). Species of Terminalia lack scales or 
microscopic glands. In contrast to the Asian species of Terminalia with fleshy, hard, resinous, 5-
winged (-ridged) fruits, the fruits of the African species are usually 2-winged, papery and quite 
thin and very variable in shape and size, usually 1-3 cm long and 0.5-1.8 cm wide. The leaves of 
Terminalia species are usually spirally arranged, often crowded at the ends of the branches, 
sometimes on short shoots, rarely opposite, petiolate or subsessile. Two glands are often present 
at the base of the lamina or on the petiole. There are usually both hermaphroditic and male 
flowers in the same inflorescence. Usually the flowers are borne on axillary spikes with male 
flowers towards the apex and hermaphroditic flowers towards the base. Male flowers are stalked, 
the stalk resembling pedicels but corresponding to the lower receptacle with abortion of the 
ovary. Hermaphroditic flowers are sessile. The receptacle is divided into a lower part (lower 
receptacle) and an upper part, often scarcely developed, expanding into a shallow cup terminating 
into sepals. Petals are absent. Stamens are usually 10. The ovary is completely inferior; style free, 
not expanded at the apex. The flowers of Terminalia are remarkably uniform throughout the 
genus and scarcely ever provide any taxonomically useful characters and great reliance must 
therefore be placed on leaf, bark and fruit characters for species identification. (Wickens, 1973). 
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Most of the African species of Terminalia are growing in various kinds of woodlands such as 
coastal woodlands and Miombo woodlands including Brachystegia woodlands, as well as 
wooded grasslands, and some are typical components in riverine forests and rain forests 
(Wickens, 1973). 
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Figure 1. A large Terminalia sambesiaca- tree (15 m) growing in the Kitonga gorge, Tanzania. 
Photo: Pia Fyhrquist 
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Figure 2. Fruits of Terminalia spinosa. Photo: Pia Fyhrquist. 
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Figure 3. Miombo woodland in Kitonga gorge, Tanzania. Terminalia sambesiaca along with 
other species of Terminalia and Combretum were collected from this forest. Photo: Pia Fyhrquist 
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2.2.2. The genus Combretum Loefl. 
 
The largest genus of the family Combretaceae is Combretum, comprising of about 250 species 
and distributed throughout the tropics and subtropics. Combretum is absent from Australia and 
the Pacific Islands. Three subgenera are recognized by Excell and Stace; they are Combretum, 
Cacoucia (Aubl.) Excell & Stace and the monotypic Asian subgenus, Apetalantum Excell & 
Stace. On the worldwide scale the subgenera Combretum and Cacoucia are separable with 
certainty only on the character of the presence of either scales (subgen. Combretum) or 
microscopic stalked glandular hairs (subgen. Cacoucia) (Wickens, 1973). 
 
Morphology 
 
The species of Combretum are trees, shrubs, shrublets or woody climbers, very rarely 
subherbaceous. Scales (subgen. Combretum) or microscopic (sometimes macroscopic) stalked 
glands (subgen. Cacoucia) are present. The subgenus Combretum is sometimes, in addition, 
divided into eleven sections, based on the floral, scale and fruit anatomy (Wickens, 1973). In the 
genus Combretum the leaves are opposite, verticillate or rarely alternate, usually petiolate, almost 
always with entire margins. The petiole is sometimes persistant, and especially in climbers it 
forms a hooked wooded spine when the leaf abscises. The flowers are hermaphroditic, regular or 
slightly zygomorphic, 4-5-merous and they are borne in elongated or subcapitate axillary or 
extra-axillary spikes or racemes or in terminal or terminal and axillary, often leafy panicles. The 
receptacle is usually clearly divided into a lower part (lower receptacle) surrounding and adnate 
to the ovary, and an upper receptacle which sometimes is differentiated into a lower part 
containing the disk and an often more expanded upper part. Sepals are 4-5 (rarely more), deltate 
to subulate or filiform, sometimes scarcely developed. Petals are 4-5, small and inconspicuous or 
showy (white, purple, red) and exceeding the sepals. Stamens are twice as many as the petals, 
inserted in 1 or 2 series inside the upper receptacle. The disk of the receptacle is glabrous or 
hairy, with or without a free margin, sometimes inconspicuous and absent. In East African 
species the style is free, the stigma is sometimes expanded and the ovary is completely inferior. 
The fruit is 4-5 winged and ridged or angled, sessile or stipitate, indehiscent or rarely dehiscent; 
the pericarp is usually thin and papery, sometimes leathery, more rarely fleshy. Even if the fruits 
are often used as a good species identification characters, species identification is not always easy 
at the fruiting stage (Wickens, 1973). 
The shrublike growth forms are predominantly found in savanna-like habitats such as grasslands 
and wooded grasslands, whereas the treelike often grow in Miombo woodland. Climbers can be 
found in riverine forests and thickets as well as on ruderal habitats. Some species can be found in 
coastal and even swamp forests. Many species grow in lowland rainforests (Wickens, 1973). 
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Figure 4. Flowers of Combretum constrictum. Photo: Pia Fyhrquist. 
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Figure 5. Fruits of Combretum hereoense. Photo: Pia Fyhrquist. 
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2.2.3. The genus Pteleopsis Loefl. 
 
There are probably about nine species of Pteleopsis in tropical Africa. The genus is intermediate 
in many characters between Combretum and Terminalia. The species of Pteleopsis are small to 
medium-sized trees or occasionally shrubs. They lack scales or stalked glands. The leaves are 
opposite to subopposite, petiolate, almost glabrous to hairy. The flowers are andromonoecious 
(hermaphrodite and male flowers in the same inflorescence) as in Terminalia, 4-(5)-merous, 
pedicellate, in terminal and/or axillary or extra-axillary subcapitate racemes. The upper receptacle 
is campanulate, joined to the lower part of the receptacle by a slender stalk-like region. The 
hermaphroditic flowers are usually at the apex of the flowers and they have deltate sepals and 
somewhat obovate white petals. Stamens are ten and 2-seriate in East African species of 
Pteleopsis. The style is not expanded at the apex. The male flowers are usually placed towards 
the base of the inflorescence, similar to the hermaphrodite flowers, but with the ovary not 
developing and with a slender stalk replacing the lower receptacle. The style is present or 
vestigial. The fruit is 2-5 winged, and the wings are often decurrent into the comparatively long 
slender stipe. (Wickens, 1973). 
Species of Pteleopsis can be found in dry evergreen and riverine forest, deciduous woodland, 
coastal bushland and wooded grassland (Wickens, 1973). 
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Figure 6. Pteleopsis myrtifolia. Branches with fruits. Photo: Pia Fyhrquist. 
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2.3. Conventional antibiotics and the problem of microbial resistance 
 
Major improvements in the early recognition and treatment of infectious diseases has been done 
in the last 60 years. This has resulted in a significant reduction in the morbidity and mortality 
associated with these diseases. Unfortunately, bacteria and fungi have developed resistance to all 
classes of different antibiotics discovered to date (Alanis, 2005). The use/misuse of antibiotics 
has led to an increasing prevalence of multiple-drug resistant (MDR) strains, and there is now an 
urgent need to develop new effective antibiotic agents (Cantrell et al., 2001). Serious systemic 
fungal and bacterial infections have become a major cause of morbidity and mortality among 
hospitalized patients around the world in the 21st century. The incidence of serious microbial 
infections is increasing also due to the increasing number of immunocompromised patients due to 
HIV/AIDS (Espinel-Ingroff et al., 1998). In tropical countries infectious diseases account for 
approximately one-half of all deaths (Iwu et al., 1999). Many bacterial diseases, which were 
thought to have been eradicated from Western countries might once again become a serious 
health problem. There is thus an urgent need for compounds that act on novel molecular targets 
that circumvent the established resistance mechanisms. 
 
2.3.1. Conventional antibiotics and their targets in bacterial cells 
 
At least 17 different classes of antibiotics, synthetic and of microbial origin, have been produced 
up to date (Alanis, 2005). These antibiotics act by a) inhibiting the synthesis of the bacterial cell 
wall, b) inhibition of protein synthesis, c) inhibition of DNA synthesis, d) inhibition of RNA 
synthesis, e) competitive inhibition of folic acid biosynthesis, e) disorganizing membranes and 
other mechanisms (Madigan et al., 2000). 
Penicillins and the cephalosporins, derived from the fungal species Penicillium chrysogenum and 
Cephalosporinum sp. inhibit the synthesis of the bacterial cell wall by binding to the 
transpeptidase enzyme thus inhibiting the formation of peptidoglycan. Gram-negative bacteria are 
in general more resistant than gram-positive bacteria to the actions of antibiotics since they 
contain an outer membrane with a lipopolysackaride layer which render them impermeable to 
certain antibiotics and bactericidal compounds (Nikaido, 1996). Thus the naturally derived 
penicillin G does not have the ability to penetrate the gram-negative outer membrane. In 
synthetically modified penicillins (semi-synthetic penicillins) the N-acyl side chain is modified 
and enables these compounds to penetrate the outer membrane of gram-negative bacteria, and 
thus semi-synthetic penicillins have a much broader spectrum of activity than penicillin G. The β-
lactam ring structure in the penicillines is susceptible to the actions β-lactamases, enzymes 
produced by penicillin-resistant bacteria. Some semi-synthetic penicillins, such as oxacillin and 
methicillin, are β-lactamase resistant. The cephalosporins are more resistant than the penicillins 
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to the β-lactamases and thus have a broader spectrum of antibacterial activity (Madigan et al., 
2000). 
 
The other three main classes of antibiotics, derived from bacterial sources, such as the 
aminoglycoside and macrolide antibiotics, as well as the tetracyclines inhibit protein synthesis by 
binding to either the 30S or the 50S subunits of the ribosome (Madigan et al., 2000). 
 
Purely synthetic antibiotics act for example as growth analogues, such as the sulfa drugs, which 
block the synthesis of folic acid, a precursor to nucleic acids. A variety of analogues are known to 
different vitamins, amino acids, purines, pyrimidins and other compounds. The quinolones act 
with bacterial DNA gyrase and prevent the gyrase from supercoiling bacterial DNA, which is 
required for packing DNA in the bacterial cell (Madigan et al., 2000). 
 
2.3.2. Antifungal agents and their targets in fungal cells 
 
Invasive fungal infections have emerged as major causes of morbidity and mortality. During the 
last decades, the frequency of life-threatening infections has increased dramatically along with 
the number of potentially invasive species (Abi-Said et al., 1997; Berrouane et al., 1999; 
Boschman et al., 1998; Nguyen et al., 1996; Pfaller et al., 1998). For many years the treatment of 
fungal infections was essentially limited to amphotericin B. Therapeutic options did not emerge 
until the late 1980s, when fluconazole and itraconazole were introduced. The azole derivates are 
the most widely used antifungals today, although resistance is emerging. During the 1990s there 
has been a major expansion in antifungal drug research (Groll et al., 1998). Current strategies for 
finding new antifungal drugs include screening of natural products, among them also higher 
plants. Although many new antifungal drugs have been developed, they belong to relatively few 
chemical classes. The antifungal drugs available can be classified into five major classes, based 
upon their molecular mechanism of action: 1) Inhibition of DNA or RNA synthesis (flucytosine), 
2) Impairment of membrane function (for example amphotericin B), 3) Inhibition of the synthesis 
of ergosterol (azole derivates, allylamines), 4) Inhibition of 1,3-β-D-glucan synthase 
(echinocandin derivates), 5) Inhibition of fungal mitosis, probably by preventing sliding of 
microtubules (griseofulvin). Antifungal agents aim on different genera of fungi, being active 
against certain but excluding others. For example, griseofulvin is active against dermatophytes, 
but not against Candida or Aspergillus species. However, the major impact of antifungal 
resistance is not in the context of genus-level resistance but on the intra-species level, such as 
when earlier sensitive species suddenly become resistant against the antifungal therapy (Bossche 
et al., 1994). 
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2.4. Plant derived antimicrobials 
 
The search for antimicrobial agents has mainly been concentrated on lower plants, fungi and 
bacteria as sources. Much less research has been conducted on antimicrobials from higher plants 
(Iwu et al., 1999). Since the advent of antibiotics, in the 1950s, the use of plant derivatives as 
antimicrobials has been virtually nonexistent. The interest in using plant extracts for treatment of 
microbial infections has increased in the late 1990s as conventional antibiotics become 
ineffective (Cowan, 1999). For example, none of the conventional antifungal drugs used to date 
seems to be ideal in efficacy, safety and antifungal spectrum (Di Domenico, 1998; Ablordeppey 
et al., 1999). In addition, many of the antimicrobial drugs in use have undesirable effects or are 
very toxic, produce recurrence, show drug-drug interactions or lead to the development of 
resistance (White et al., 1998). Although some new drugs have emerged for the treatment of 
obstinate fungal infections, such as allylamines and caspofungine (Vicente et al., 2003), and 
combination therapy is sometimes used to make the treatment more effective, there is a real need 
for a next generation of safer and more potent antifungal drugs (Bartoli et al., 1998). Also, it is 
increasingly difficult to deliver new antibacterial leads by modifying known antibacterial 
compounds. Therefore, the focus on much antibacterial research has moved to the identification 
of new chemical classes (Barker, 2005), and many smaller pharmaceutical companies have taken 
up this challenge (Boggs & Miller, 2004). Antimicrobial compounds from plants may inhibit 
bacteria/fungi through different mechanisms than conventional antibiotics, and could therefore be 
of clinical value in the treatment of resistant microbes (Eloff, 1998a). Phytomedicines derived 
from plants have shown great promise in the treatment of infectious diseases including 
opportunistic AIDS infections (Iwu et al., 1999). For example, plants containing protoberberines 
and related alkaloids, picralima-type indole alkaloids and Garcinia biflavanones used in African 
traditional medicine, have been found to be active against a wide variety of micro-organisms 
(Iwu et al., 1999). Investigations on plants used in traditional medicine for skin afflictions might 
provide new tropical antiseptics urgently needed in the Third World countries (Taylor et al., 
2001). Rapid extinction of some habitats and plant species due to deforestation, especially in the 
tropical parts of the world, lead to a loss of valuable antimicrobial chemicals (Lewis & Elwin-
Lewis, 1995). Thus, many pharmaceutical companies are now intensifying their screening 
programs on medicinal plants. 
 
2.4.1. Defense chemicals produced by plants 
 
Higher plants produce a great diversity of chemicals that have antimicrobial activity in vitro (Van 
Etten et al., 1994). Most of these defense molecules are secondary metabolites, of which at least 
12 000 have been isolated (Schultes, 1978). There are two broad categories of plant produced 
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antimicrobials. 1) Phytoalexins are low molecular compounds which are produced in response to 
either microbial, herbivorous or environmental stimuli (Van Etten et al., 1994). These compounds 
are synthesized de novo, and thus require activation of certain genes and enzymes required for 
their synthesis. Phytoalexins are chemically diverse and include simple phenylpropanoid 
derivates, flavonoids, isoflavonoids, terpenes and polyketides (Bailey & Mansfield, 1982; Dixon, 
1986; Greayer & Harborne, 1994). 2) Phytoanticipins are low molecular compounds which are 
present in plants before the challenge by microorganisms or are produced from pre-existing 
constituents after infection (Van Etten et al., 1994). These phytoanticipin toxins, e.g. phenolic 
and iridoid glycosides, glucosinolates and saponins are normally stored as less toxic glycosides in 
the vacuoles of plant cells. If the integrity of the cell is broken when penetrated by the microbe, 
the glycoside comes into contact with hydrolyzing enzymes present in other compartments of the 
cell, releasing the toxic aglycone (Osbourn, 1996). There is no sharp boundary between 
phytoalexins and phytoanticipins, and in one plant species a certain chemical can function as a 
phytoalexin, whereas it has the function of a phytoanticipin in another species (McMurchy & 
Higgins, 1984; Higgins & Smith, 1972). The rich diversity of secondary metabolites in plants has 
partly arisen because of selection for improved defense mechanisms against a broad array of 
microbes, insects and other plants. Related plant families often make use of similar secondary 
compounds for defense purposes (isoflavonoids in Leguminosae; sesquiterpenes in Solanaceae). 
Most antimicrobial secondary metabolites have relatively broad spectrum of activity. The 
specificity is determined to whether the pathogen has the enzymes necessary to detoxify a 
particular host product (Van Etten et al., 1994). 2.4.2. Plant derived individual compounds with 
antimicrobial effects 
 
2.4.1.1. Phenolic compounds 
 
Simple phenolics 
Simple phenolics, such as caffeic acid and cinnamic acid are known to possess antimicrobial 
effects (Brantner et al., 1996). Catechol and pyrogallol both are hydroxylated phenols shown to 
be toxic against microorganisms. Increased hydroxylation of the phenol group has been found to 
result in increased toxicity to microorganisms (Geissman, 1963). On the contrary, it has in some 
cases been found that highly oxidized phenols are more inhibitory (Scalbert, 1991). Phenolic 
compounds are thought to inhibit microbial enzymes possibly through reaction with sulfhydryl 
groups (the oxidized phenols) or through nonspecific interactions with the proteins (Mason & 
Wasserman, 1987). 
 
Quinones 
The potential range of quinone antimicrobial effects seems to be great. Probable targets for the 
quinones in the microbial cell are the surface –exposed adhesins, cell wall polypeptides and 
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enzymes bound to the membranes. Quinones are known to complex irreversibly with nucleophilic 
amino acids in proteins (Stern et al., 1996) thus leading to inactivation of the protein and loss of 
its function. It is also possible that quinones render substrates unavailable to the microorganism 
(Cowan, 1999). Anthraquinones, the largest group of quinones (Harborne et al., 1999), have been 
found to possess antibacterial effects by inhibiting nucleic acid synthesis, at least in Bacillus 
subtilis (Levin et al., 1988). 
 
Stilbenoids 
Stilbenoids are composed of two benzene rings separated with an ethane or ethene bridge, called 
bibenzyls and stilbenes, respectively. Phenanthrenes are biosynthetically derived from the 
bibenzyls and stilbenes. Stilbenes occur as aglycones or glycosides, and sometimes as polymers. 
Many higher plant families are known to produce stilbenes. Bibenzyls and their derivatives are 
rare in higher plants but occur in some families including Orchidaceae, Combretaceae and 
Dioscoreaceae, often alongside the corresponding phenanthrene or stilbene derivates. Many 
stilbenoids are known for their antifungal and antibacterial properties (Bruneton, 1999). Eloff et 
al. (2005) have found that leaves of the South African Combretum woodii contain high 
concentrations of the antimicrobially active bibenzyl, combretastatin B5. 
 
Flavonoids 
Flavonoids are constitutive compounds but are also synthesized by plants in response to 
microbial infection (Dixon et al., 1983). Nearly half of the 200 phytoalexins characterized up to 
now belong to the flavonoids (Harborne, 1988). Flavonoids have been found to show in vitro 
antimicrobial activity against a wide range of microorganisms, some showing potent activity 
against MRSA (Iinuma et al., 1994). Their activity has been attributed to their ability to complex 
with extracellular and soluble proteins and to complex with bacterial cell walls (Cowan, 1999). 
Lipophilic flavonoids may also disrupt microbial membranes (Tsuchiya et al., 1996). There are 
conflicting findings on the kind of molecular substitutions needed for a flavonoid in order to 
show antimicrobial activity. Some authors have found that flavonoids lacking hydroxyl groups on 
their β-rings are more active against microorganisms than flavonoids containing these groups and 
this finding supports the idea that their microbial target is the membrane (Chabot et al., 1992). 
Several authors have, however, also found the opposite effect; the more hydroxyl groups the 
greater antimicrobial activity (Sato et al., 1996). The low toxic potential of flavonoids makes 
them ideal as antimicrobial medicines (Cowan, 1999). 
 
Tannins 
Tannins are a large group of polyphenolic compounds which have received attention in recent 
years due to their claimed ability to cure a variety of diseases (Serafini et al., 1994). Tannins are 
subdivided into two groups: hydrolysable tannins and proantocyanidins (condensed tannins). 
Hydrolysable tannins are gallic acid and ellagic acid esters of core molecules that consist of 
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polyols such as sugars. Proantohocyanidins are polymers of flavan-3-ols (for example catechin) 
and flavan-3,4-diols linked through an interflavan bond that is not susceptible to hydrolysis 
(Haslam, 1989). A wide range of anti-infective actions have been assigned to tannins (Haslam, 
1996). Tannins have the ability to complex with proteins through nonspecific forces such as 
hydrogen bonding and hydrophobic effects and also through covalent binding (Stern et al., 1996). 
The antimicrobial mode of action for tannins may thus be related to their ability to inactivate 
microbial adhesins, enzymes, cell envelope transport proteins, etc. (Cowan, 1999). There is also 
evidence that tannins directly inactivate microorganisms, because already low concentrations of 
tannin (0.063 mg/ml) modify the morphology of germ tubes of Crinipellis perniciosa (Brownlee 
et al., 1998). Tannins have also been found to induce changes in the morphology of several 
species of ruminal bacteria (Jones et al., 1994). Due to their ability to bind to proteins and metals, 
tannins also inhibit the growth of microorganisms through substrate and metal ion deprivation 
(Scalbert, 1991). Hydrolysable and condensed tannins have been found to possess similar 
antifungal (filamentous fungi) and antibacterial potency, but the hydrolysable tannins were found 
to be more effective against yeasts (Cowan, 1999). Latté and Kolodziej (2000) found that a panel 
of different hydrolysable tannins had low antibacterial effects, but that they possessed fairly high 
anticryptococcal effects. 
Some research has been performed on the relationship between tannin structure and antimicrobial 
activity. The presence of a hexahydroxydiphenoyl moiety or its oxidatively modified entities was 
an important feature for the anticryptococcal activity of the ellagitannins corilagin, pelargoniin B 
and phyllanthusiin (Latté & Kolodziej, 2000). The pattern of B-ring hydroxylation of monomeric 
flavonols in condensed tannins has been shown to affect the level of growth inihibition of 
Streptococcus sobrinus and Streptococcus mutans (Sakanaka et al., 1989), Clostridium botulinum 
(Hara & Watanabe, 1989), Proteus vulgaris and Staphylococcus (Mori et al., 1987), and in all 
cases gallocatechins were more inhibitory than their catechin counterparts. The toxicity of tannins 
and lower molecular weight phenols has been discussed also in relation to their oxidation state; 
catechin was found to be devoid of any toxicity against methanogenic bacteria, whereas if 
oxidized it strongly reduced methane production (Field et al., 1989). The synthesis of red beet β-
glucan synthase was found to be strongly inhibited by various oxidized phenols, but the effect of 
oxidation was less marked for tannic acid (a hydrolysable tannin) than for smaller phenols 
(Mason et al., 1987). It has also been proposed that tannin toxicity would be related to molecular 
size (Mr), since the larger the molecule the more effectively it binds to proteins. This has been 
observed in many cases; dimeric ellagitannins have been found to be more adstringent than 
related monomers (McManus et al., 1985). On the other hand, in some cases the toxicity of 
tannins was found to be no higher than that of catechins (Siwaswamy et al., 1985), although 
catechins have very poor affinity to proteins. Kakiuchi et al. (1986) found that adding BSA to a 
glucosyl transferase solution before addition of gallotannins failed to remove the inhibition of the 
enzyme by the tannins and they concluded that inhibition of the enzyme is not necessarily due to 
the nonspecific binding of tannins to it. In their study of an array of different tannins and their 
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effects on ligand binding to various enzyme receptors, Zhu et al. (1997) found that some of the 
tannins inhibited ligand binding to specific receptors. Thus, this study shows that tannins have 
specific activity at the receptor level, and that these effects cannot solely be explained in terms of 
protein binding. 
 
2.4.1.2. Terpenes 
 
Terpenes are a large group of compounds responsible for the fragrance of plants and comprise the 
so called essential oil fraction. They are synthesized from isoprenoid units, and share origins with 
fatty acids. They differ from fatty acids in that they are branched and cyclized. Terpenes occur as 
monoterpenes, diterpenes, triterpenes, tetraterpenes, hemiterpenes and sesquiterpenes. When 
additional elements, such as oxygen, are added they are called terpenoids (Cowan, 1999). 
Terpenes and terpenoids have been found to possess antimicrobial activity (Amaral et al., 1998; 
Himejima et al., 1992; Mendoza et al., 1997). The mechanism of action of terpenes on microbes 
is not yet fully understood, but it is speculated to involve membrane disruption by the lipophilic 
compounds. Accordingly, Mendoza et al. (1997) found that addition of a methyl group on 
kaurene diterpenoids drastically reduced their antimicrobial activity. When different series of 
terpenoids were investigated for their antimicrobial effects it was found that the more lipophilic 
compounds were significantly more antibacterial than their more polar analogues (Cantrell et al., 
2001). 
 
2.4.2. Antimicrobial effects of plant extracts 
 
In traditional and alternative medicine it is common to use medicinal plants as such, without 
isolating the active ingredients from them. Using crude extracts might be a more important way 
to use medicinal plants than has been realized in Western medicine, since plants contain 
numerous secondary metabolites, and pathogens in nature interact with many chemicals 
simultaneously (Izhaki, 2002). Traditional plant remedies or phytomedicines, include crude 
vegetable drugs (herbs) as well as galenical preparations (extracts, fluids, tinctures, infusions) 
prepared from them. Although a number of studies of the antimicrobial effects of plant extracts 
have been performed, many plants used in different traditional medicinal systems have never 
been evaluated for their antimicrobial effects. For example, in Africa, over 5000 plants are known 
to be used for medicinal purposes, but only a small percentage have been described or studied 
scientifically, and different combinations of plant species used in traditional medicines have been 
studied even to a lesser extent (Taylor et al., 2001). The major problem in investigations on the 
biological activities of plant extracts and phytomedicines lies in the fact that a variety of plants 
may be used in a single traditional medicine preparation, and in the possibility of synergistic 
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effects resulting from the interactions of the compounds in the extract. This can even result in a 
loss of activity as the extract is purified (Couzinier & Mamatas, 1986). Eloff & McGaw (2006) 
point out that biologically active extracts can be extremely useful in their entirety, taking into 
account synergistic and other effects, and according to them an approval of standardized and 
formulated plant extracts as drugs might be the starting point in developing countries for a 
successful pharmaceutical industry to be able to compete with Western pharmaceutical 
companies. 
 
2.5. Antimicrobial effects and traditional medicinal uses of some 
species of Terminalia, Combretum and Pteleopsis reported in the 
literature 
2.5.1. Terminalia species  
 
A number of studies have been carried out on the ethnomedical uses of Terminalia species in 
Africa. Many Terminalia species have various applications in African traditional medicine, such 
as for the treatment of hypertension, diarrhea, bacterial and fungal infections and fever, just to 
mention some of them (Hedberg, 1982; Kokwaro, 1976; Chhabra, 1989; Fyhrquist et al. 2002) 
(Table 1). In Africa, all parts of the Terminalia species are used for medicinal purposes (Watt & 
Breyer-Brandwijk, 1962; Bouquet & Debray, 1974; Hedberg et al., 1982; Chhabra et al., 1989; 
Neuwinger, 2000), the fruits being reported to be used in only one case (Eldeen et al., 2005). In 
herbal remedies species of Terminalia are mostly used as hot water decoctions (woody plant 
parts) or infusions (leaves), but it is also common to mix dried, powdered plant parts with Ugali, 
maize porridge, and in some cases the fresh leaf sap is used. Sometimes decoctions of species of 
Terminalia are mixed with rice or maize porridge. Some of the species of Terminalia are used 
topically as well, mainly for the treatment of wounds, and are then applied as dressings or 
ointments. Sometimes the fumes of hot fomentations of the roots are inhaled for treatment of 
chest pains, presumably pneumonia or bronchitis. 
According to Hartwell (1982) at least seven different species of Terminalia are used for the 
treatment of cancer in systems of Asian traditional medicine. Especially the fruits of the Asian 
species are frequently used for medical applications such as fever, cough, diarrhea, dysentery and 
skin diseases (Valsaraj et al., 1997) and even for food (Barthakur et al., 1991) (Table 2). 
There are several investigations, most of them of quite recent date, on the antibacterial and 
antifungal effects of both African (Table 1), Asian (Table 2) and South American species of 
Terminalia. The antimicrobial effects have been evaluated with diverse methods, such as agar 
diffusion, agar dilution, direct bioautography and liquid serial dilution methods (microplates etc.) 
(Table 1 and 2). In most of the investigations crude extracts have been evaluated for their 
antimicrobial effects, but in some cases active fractions and compounds have been isolated and 
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even evaluated for their antimicrobial potential. Some of the results on the antimicrobial effects 
of Terminalia species support their use in traditional medicine for treatment of infectious 
diseases. The genus Terminalia seems to include species with potent antimicrobial effects and 
good effects have been obtained against both gram-positive and gram-negative bacteria as well as 
against yeasts (Candida spp.), the basidiomycet Cryptococcus neoformans and dermatophytes 
(Trichophyton spp., Epidermophyton spp. and Microsporum spp.). Terminalia species contain an 
array of different compounds with antimicrobial effects (Table 1 and 2) such as hydrolysable 
tannins (mostly ellagitannins) and their monomers gallic acid and ellagic acid, methylated ellagic 
acid derivatives, ethyl gallate, flavonoids, stilbenes, saponins, lignans, coumarins and 
triterpenoids. Antimicrobial compounds have been found from all plant parts of Terminalia 
species. 
Many of the investigations on the in vitro antimicrobial effects of compounds isolated from 
Terminalia spp. lack studies on the toxicity of the compounds, and these studies would be 
essential to predict the safety of use. Some organs of some species of Terminalia are reported to 
be poisonous, such as the roots of T. sericea (Watt & Breyer-Brandwijk, 1962) and thus care 
should be taken to prescribe the correct dosages. The use of extracts, and especially of 
unstandardized extracts made of plants from the wild is not free of risks since the composition of 
the secondary compounds may show great intraspecific variation. Therefore standardized extracts 
should be used if possible. 
 
2.5.1.1. African species of Terminalia 
 
Some African Terminalia species reported to have uses in traditional medicine/antimicrobial 
effects are briefly presented (Table 1). Emphasis is put on East African species which are used in 
my doctoral thesis, but some other species are presented briefly as well.  
 
Terminalia sericea 
Terminalia sericea Burch ex DC., Silver cluster-leaf (vernacular name in Swahili: 
Mhungweluwala, Mpululu; Nyakusa: Namatipo). This species occurs in tropical and South East 
and South West Africa and reaches its northern limits in Zaire and Tanzania. It occurs in 
Combretum-Terminalia, Brachystegia and Colophospermum woodland (Miombo woodland) as 
well as on wooded grassland on sandy soils, were it is frequently dominant or co-dominant, and 
forms dense stands. T. sericea is a small-medium sized deciduous tree (3-16 m) (Wickens, 1973). 
The crown is rounded to flattish, characteristically layered as in most species of Terminalia. The 
flowers are small, whitish on spikes, unpleasantly scented, and appear on the trees from July-
January (Drummond & Coates-Palgrave, 1973; van Wyk & van Wyk, 1997). The fruit is pinkish 
to purplish brown and surrounded by two wings. The leaves are clustered towards the tips of the 
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branches, narrowly obovate-elliptic and densely covered with silvery, silky hairs (van Wyk & van 
Wyk, 1997). The name sericea means silky (Drummond & Coates-Palgrave, 1973). 
T. sericea has a wide range of uses in traditional medicine (Table 1) and has recently been 
selected as one of the fifty most important medicinal plants in Africa by the Association for 
African Medicinal Plant Standards (http://www.aamps.net). The roots are the most frequently 
used part of Terminalia sericea in African traditional medicine and are prepared for herbal 
remedy in various ways. Hot water decoctions of the roots are used to stop diarrhea and to relieve 
colic pains (Neuwinger, 1996; Tshikalange et al., 2005; Moshi & Mbwambo, 2005), as well as 
for treatment of certain eye diseases (Drummond & Coates-Palgrave, 1973). Decoctions of the 
roots of this plant are also used against bilharzia (Kokwaro, 1976) and gonorrhea (Hedberg et al., 
1982). Sometimes root decoctions of T. sericea are mixed together with Carica papaya, Citrus 
limon and bark of Parinari excelsa, and infusions of the roots of T. sericea with Peltophorum 
africanum, Pterocarpus angolensis and Xymenia caffra for the treatment of venereal diseases 
(Neuwinger, 2000). Menstrual cramps are treated with enemas of root decoctions of T. sericea 
(Neuwinger, 2000). Roots steeped in water for one hour are used for the treatment of trachoma, a 
disease in the eyes (Neuwinger, 2000). The roots are made into tea for treatment of skin diseases 
and cough (Neuwinger, 2000). Powdered root is swallowed together with food to treat headache 
and to treat general body weakness (Neuwinger, 2000). The outer layers of the roots are boiled in 
water to provide a liquid which is used in hot fomentation (Drummond & Coates-Palgrave, 1973) 
or chest is exposed to the vapours of this liquid (Neuwinger, 1994) to treat pneumonia. The 
powdered root bark is taken with corn meal against diabetes (Watt & Breyer-Brandwijk, 1962). 
The roots of T. sericea are also reported to be emetic. The root is considered poisonous by many 
traditional healers (Watt & Breyer-Brandwijk, 1962), why caution must be taken while using this 
plant organ for medicine. Other plant parts than the roots are more rarely used in traditional 
medicine, but there are some reports of the uses of leaves and stem bark and even the fruits of T. 
sericea. Leaf infusions are used to treat “chest complaints” (pneumonia?) and diarrhea 
(Neuwinger, 2000). Wounds are treated with dressings of stem bark or leaves of T. sericea 
(Neuwinger, 2000). The stem bark of T. sericea is exported to Europe and possibly to Germany 
from Mozambique according to some reports (Rukangira, 2000). The dried fruits are used for 
treatment of tuberculosis (Eldeen et al., 2005). 
The uses of T. sericea for the treatment of infectious diseases in African traditional medicine are 
justified by several investigations which report that this species possesses great antimicrobial 
activity (Table 1). Aqueous (Tshikalange et al., 2005; Steenkamp et al. (2004) and methanol 
(Steenkamp et al., 2004) extracts of the roots of T. sericea have been found to inhibit the growth 
of gram-positive bacteria, but did not affect the growth of gram-negative bacteria up to 
concentrations of 4 mg/ml, whereas chloroform extracts were inactive against all the investigated 
bacterial species (Tshikalange et al., 2005). Moshi & Mbwambo (2005) found that in addition to 
being active against gram-positive bacteria, extracts of the roots T. sericea showed activity also 
against the gram-negative bacterium, Escherichia coli. Intermediate and polar extracts of the 
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roots of T. sericea have in general been found to possess the highest antimicrobial activity 
compared to more non-polar extracts (Moshi & Mbwambo, 2005; Tshikalange et al., 2005), and 
have also been found to be antifungal against Candida albicans and Aspergillus niger. In addition 
to the roots also the leaves of T. sericea have been found to be antimicrobial and activity was 
demonstrated both against gram-positive and gram-negative bacteria (Eloff, 1999). It is possible 
that the leaves contain different antimicrobial compounds as compared to the roots. Only one 
investigation has been done on the isolation of antimicrobially active compounds of T. sericea: 
Eldeen et al. (2005) have recently isolated Anolignan B from the roots of T. sericea and this 
compound showed activity both against gram-negative and gram-positive bacteria, and gave a 
MIC value of 3.8 μg/ml against Bacillus subtilis. In some previous investigations on the chemical 
constituents of T. sericea (Bombardelli et al., 1974 and 1986) the triterpenoids sericoside and 
arjunglucoside were isolated from the roots and stem bark of this plant, but no work on their 
biological effects was performed. On the other hand related terpenoids, such as arjungenin, 
sericic acid and arjunic acid, isolated from T. macroptera, have shown excellent antimicrobial 
effects (Conrad et al., 1998). Thus triterpenoids from Terminalia species seem to possess 
powerful antimicrobial effects. 
 
Terminalia kaiserana 
Terminalia kaiserana F. Hoffm. (vernacular name according to Makonde tribe: Mnyenze; 
Swahili: Mpululu; Nyakusa: Bena). This species of Terminalia grows to a small tree, up to 10 m, 
or is shrublike. The bark is fissured and the branchlets sericeous-tomentose to glabrous. The bark 
of the branches is purplish brown to purplish black, peeling off in strips to reveal a light brown, 
newly exposed surface. The leaves are spirally arranged and sparsely sericeous when young, but 
soon glabrescent. The inflorescences form axillary spikes, up to 11 cm long and flowers are 
creamy white. The fruit is purplish brown, broadly elliptic and surrounded by two wings. T. 
kaiserana occasionally forms hybrids with T. sericea These hybrids are characterized by more 
persistent hairs on the leaves, and they are longer and less sericeous than those of T. sericea. T. 
kaiserana occurs in Brachystegia woodland (Miombo woodland) and wooded grassland. 
(Wickens, 1973). 
Chhabra et al. (1989) report that the roots of Terminalia kaiserana are decocted and drunk for the 
treatment of headache and backache. According to Kokwaro (1976) and Haerdi (1964) the roots 
are used for gonorrhea, bilharzia and as diuretics. Root decoctions of T. kaiserana, together with 
Dalbergia (Dalbergiella?) nyassae and Bridelia cathartica are massaged on the painful region to 
treat kidney pains. The leaf sap and root decoction are drunk for the treatment of schistosomiasis, 
scabies, cough and cardiac problems. Bark and root decoctions are taken together with rice or 
cooked in a meal gruel and eaten as an aphrodisiac (Haerdi, 1964). Although T. kaiserana is 
popular in African traditional medicine there are no reports on antimicrobial or other biological 
activity or the chemicals of this plant. 
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Terminalia sambesiaca 
Terminalia sambesiaca (zambesiaca) Engl. & Diels., River cluster-leaf (vernacular name 
according to Pare tribe: Mnyara-ndeghe, Mpuku; according to Hehe-tribe: Msame-dume). T. 
sambesiaca grows into a tall tree, up to 39 m high. The bark is greyish, smooth to slightly rough 
and fissured. Young branchlets are tomentose, becoming glabrescent, with fibrous bark. The 
leaves are spirally arranged, petiolate; the lamina is elliptic to broadly elliptic or obovate-elliptic, 
the apex is rounded and distinctively acuminate, margin sometimes crenulate, base cuneate to 
obtuse or rounded, pubescent to pilose. The petiole is up to 4 cm long, tomentose. The 
inflorescences are axillary and occasionally terminal spikes, up to 15 cm long. The flowers are 
white, not sweetly scented. The fruits are reddish brown, elliptic and surrounded by two large 
wings. The apex of the fruits is subtruncate and sometimes emarginate; the base is narrowed into 
a stipe. T. sambesiaca has sometimes been confused with T. kilimandcharica, but can be readily 
distinguished from this species by the distinctively acuminate and sparsely haired leaves. In East 
Africa, T. sambesiaca extends up along river valleys into the range of T. kilimandsharica, and in 
some places it becomes difficult to differentiate from T. kilimandsharica without habit notes. 
(Wickens, 1973). 
Powdered root bark of T. sambesiaca is mixed with porridge and eaten for the treatment of 
bloody diarrhea, whereas the stem bark and leaves are decocted and drunk to treat cancer, 
stomach ulcers and appendicitis (Chhabra, 1989). Extracts of the stem bark of T. sambesiaca 
showed antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, 
Salmonella typhi and Shigella boydii (Chhabra et al., 1989), which justifies the traditional uses of 
this plant for the treatment of bloody diarrhea, stomach ulcers and appendicitis. Leaf extracts of 
T. sambesiaca have been found to possess antifungal effects against Candida albicans and 
Cryptococcus neoformans, with average MIC values ranging from 0.232 – 0.64 mg/ml (Masoko 
et al., 2005; Masoko & Eloff, 2005) and the antifungal activity was concentrated to nonpolar 
hexane and dichloromethane fractions. 
 
Terminalia spinosa 
Terminalia spinosa Engl.. (vernacular name according to Zaramo tribe: Mtaba) is a common 
species in East Africa. It grows to a tree, up to 20 m high. The bark is grey, longitudinally 
fissured and the branchlets are greyish or reddish brown. Long shoots zigzag with occasional 
spur shoots. 2 (-3) spines occur at the base of the spur shoots. The leaves are borne on the spur 
shoots, the lamina being broadly obovate. The inflorescences are up to 6 cm long spikes which 
are borne on the spur shoots. The flowers are white to purplish, shortly pedicellate and glabrous 
outside. The fruit is reddish purple, oblong-elliptic with no apical peg, 2-winged (Wickens, 
1973). T. spinosa occurs in Acacia, Commiphora and coastal bushland, and less often in 
Brachystegia woodland and wooded grassland. 
The fresh leaves of T. spinosa are pounded and the juice (fresh leaf sap) is drunk for the treatment 
of malaria. T. spinosa stem bark is chewed or added to tea to reduce fevers (Heine & Brenzinger, 
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1988). T. spinosa is believed to have magical properties: the wind makes a mournful wailing 
noise like a mad person when it blows through the thorns (Kokwaro, 1976). 
Fabry et al. (1996) found good antibacterial activity of extracts of young branches of T. spinosa 
against Staphylococcus aureus and Enterococci, but no activity against Mycobacterium 
tuberculosis. T. spinosa has been found to contain coumarins and tannins (Okemo, 1996; 
Omulokoli, 1997) but these compounds have not been evaluated for their antimicrobial effects. 
 
Terminalia avicennoides 
Terminalia avicennoides Guill. & Perr. is a tree that is common in the savanna region in West 
Africa (Abdullahi et al., 2001). This plant is used in traditional medicine for treating wounds and 
ulcers, and decoctions of the roots are used for gastrointestinal disorders. Jukuns of Northern 
Nigeria use the roots of T. avicennoides for the treatment of syphilis (Irvine, 1961). The stem 
bark of T. avicennioides has been found to be fungicidal against the dermatophytic 
Epidermophyton floccosum, Microsporum gypseum and Trichophyton mentagrophytes and 
fungistatic against Candida albicans (Baba-Moussa et al., 1999), the first mentioned finding 
supporting the traditional use of this species for treatment of wounds and the second for 
gastrointestinal disorders. Extracts of the stem bark of T. avicennoides contain large quantities of 
saponins and tannins (Baba-Moussa et al., 1999), which might be responsible for the good 
antifungal effects. Aqueous root extracts of T. avicennoides possess antidiarrheal effects 
(Abdullahi et al., 2001), supporting the uses of root extracts of this plant for the treatment of 
gastrointestinal disorders. 
 
Terminalia glaucescens  
In the Central African Republic Terminalia glaucescens Planch. ex Benth is used for treatment of 
dysentery and other microbial infections and the leaves are reported to be useful in the last phase 
of AIDS (Koudou, 1995). The traditional use of this plant is in agreement with the good 
antimicrobial effects shown by this species against both bacteria and fungi. Leaf and root extracts 
of T. glaucescens have been found to be highly active against both Candida species (MIC 0.25 
mg/ml) and dermatophytes such as Trichophyton spp. (Batawila et al., 2005). T. glaucescens is 
used as chewing sticks in some countries in West Africa, and extracts made from the sticks (the 
stem wood and bark) showed a wide spectrum of antibacterial activity against different bacterial 
species including methicillin-resistant Staphylococcus aureus (MRSA) and dentally relevant 
bacteria (Taiwo et al., 1999). A triterpenoid, Terminalin A, was isolated from the stem bark of T. 
glaucescens (Atta-ur-Rahman et al., 2002), but the biological effects of this compound have not 
been investigated. 
 
Terminalia macroptera 
Terminalia macroptera Guill & Perr. is a tree widely distributed in Africa. In Guinea-Bissau, 
West-Africa, it is used by traditional healers for the treatment of hepatitis and other infectious 
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diseases, including venereal diseases (Diniz et al., 1996). The traditional uses of this species 
agree well with the findings of several authors that T. macroptera possesses strong in vitro 
antibacterial and antifungal effects. Root extracts of T. macroptera have been found to give slight 
activity against Candida albicans as well as showing an interesting profile of activity against 
enteropathogenic microorganisms, including Shigella dysenteriae, ethanol and water extracts 
being especially active (Silva et al., 1996). The four major compounds in the root extract of T. 
macroptera were identified as ellagitannins (Silva et al., 2000) and thus some of these 
compounds might be responsible for the good antibacterial effects observed for T. macroptera 
roots. Also the leaves of T. macroptera possess antimicrobial potency, a diethyl ether fraction 
being especially active against Neisseria gonorrhoeae (Silva et al., 2002). The leaves were found 
to contain chlorogenic acid, quercetin, isoorientin, ellagitannins and their monomers gallic acid 
and ellagic acid (Silva et al., 2002). The stem bark of T. macroptera contains antifungal and 
antibacterial triterpenes active against Bacillus subtilis and Pseudomonas fluorescens at MIC 
values of 2.5 – 5 μg/ml (Conrad et al. (1998). The triterpenoids were less active against the 
fungal species, Cladosporium cucumerinum, except from sericic acid, which inhibited the growth 
of this fungus with a MIC value of 5 μg/ml. The hydrolysable tannins isoterchebulin and 4,6-O-
isoterchebuloyl-D-glucose from the stem bark of T. macroptera showed bacteriostatic effects 
against Bacillus subtilis and none of the tannins were found to be active against Pseudomonas 
fluorescens even at the highest concentration used (1024 μg/ml) (Conrad et al. (2001). 
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Table 1. Antimicrobial activity of extracts and their active compounds as well as uses in traditional medicine of some African Terminalia species according to 
literature.  
 
Species Extract Compounds  Screening method Uses in traditional medicine 
T. avicennoides Guill. 
& Perr. 
Stem bark: dermatophytes 
(fungicidal), Candida albicans 
(fungistatic) (Baba-Moussa et al., 
1999); roots: antidiarrheal 
(Abdullahi et al., 2001). 
Saponins and tannins in 
stem bark * (Baba-
Moussa et al., 1999) 
Agar diffusion 
(Baba-Moussa et al., 
1999) 
Remedy for wounds and ulcers; decoctions 
of the roots for gastrointestinal disorders; 
Jukuns of Northern Nigeria use the roots 
for syphilis (Irvine, 1961). 
T. brachystemma Welw. 
ex Hiern 
Acetone and MeOH extr. of 
leaves: Candida albicans 
Cryptococcus neoformans (MIC 
0.124- 0.163 mg/ml) (Masoko et 
al., 2005). 
Unknown Microwell plates, 
bioautography 
(Masoko et al., 2005) 
For fungal infections in South African 
traditional medicine (Masoko et al., 2005). 
T. gazensis Bak. Acetone and MeOH extr. of 
leaves: Candida albicans 
Cryptococcus neoformans (MIC 
0.124- 0.163 mg/ml) (Masoko et 
al., 2005).  
Unknown Microwell plates, 
bioautography 
(Masoko et al., 2005) 
For fungal infections in South African 
traditional medicine (Masoko et al., 2005). 
T. glaucescens Planch. 
ex Benth 
Extracts of leaves, roots: Candida 
spp. (MIC 0.25 mg/ml), 
Trichophyton spp. (Batawila et 
al., 2005); extracts of stem wood 
and bark: MRSA, dental bacteria 
(Taiwo et al., 1999). 
The triterpenoid 
Terminalin A from stem 
bark * (Atta-ur-Rahman 
et al., 2002)  
Aqueous dilution 
(Batawila et., 2005) 
 
Agar diffusion 
(Taiwo et al., 1999) 
In Central African Republic decoctions of 
leaves for dysentery and microbial 
infections related to AIDS (Koudou et al., 
1995); as chewing sticks in West Africa 
(Taiwo et al., 1999). 
T. kaiserana F. Hoffm. No reports Unknown No reports Roots in combination with Dalbergia 
nyassae and Bridelia cathartica to treat 
kidney pains; leaf sap and root decoction 
for schistosomiasis, scabies, cough and 
cardiac problems; bark and root decoctions 
with rice or cooked in a meal gruel as an 
aphrodisiac (Haerdi, 1964); roots for 
gonorrhea, bilharzia and as diuretics 
(Kokwaro, 1976; Haerdi, 1964); roots for 
headache and backache (Chhabra et al., 
1989).  
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Table 1. (continued) 
 
T. macroptera Guill & 
Perr. 
Extracts of roots: Candida 
albicans, Shigella dysenteriae 
(MIC 313 μg/ml), Vibrio cholerae 
(MIC ≤ 156 μg/ml) (Silva et al., 
1996 and 1997); extracts of 
leaves: Neisseria gonorrheae 
(Silva et al., 2002). 
Triterpenes from stem 
bark: Bacillus subtilis, 
Pseudomonas 
fluorescens (MIC 2.5 – 
5 μg/ml) (Conrad et al., 
1998); ellagitannins 
from stem bark: 
Bacillus subtilis 
(Conrad et al. 2001); 
ellagic acid, gallic acid, 
ellagitannins from roots 
and stem bark* (Silva et 
al., 2002); flavonoids, 
ellagitannins from 
leaves *(Silva et al., 
2002).  
Agar diffusion, agar 
dilution, microwell 
plates, bioautography 
(Silva et al., 1996, 
1997 and 2002) 
 
Bioautography 
(Conrad et al., 1998) 
 
Microwell plates 
(Conrad et al., 2001) 
In West-Africa for hepatitis and other 
infectious diseases, including venereal 
diseases (Diniz et al., 1996).  
T. prunioides M. A. 
Lawson 
Acetone and MeOH extr. of 
leaves: Candida albicans, 
Cryptococcus neoformans (MIC 
0.124- 0.163 mg/ml) (Masoko et 
al., 2005). 
Unknown  Microwell plates, 
bioautography 
(Masoko et al., 2005) 
Used for fungal infections in South 
African traditional medicine (Masoko et 
al., 2005). 
T. sambesiaca Engl. & 
Diels 
Extracts of stem bark: 
Staphylococcus aureus, 
Pseudomonas aeruginosa, 
Salmonella typhi and Shigella 
boydii (Chhabra et al., 1989); 
extracts of leaves: Candida 
albicans, Cryptococcus 
neoformans MIC 0.232 – 0.64 
mg/ml (Masoko et al., 2005; 
Masoko & Eloff, 2005). 
Unknown Agar diffusion 
(Chhabra et al., 1989) 
 
Microwell plates 
(Masoko et al., 2005 ; 
Masoko & Eloff, 
2005) 
The root bark for bloody diarrhea, and the 
stem bark and leaves for cancer, stomach 
ulcers and appendicitis (Chhabra, 1989). 
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Table 1. (continued) 
 
T. sericea Burch ex DC. Aqueous extracts of the roots: 
gram-positive bacteria; 
chlorophorm extracts inactive 
against the bacterial species used 
in study (Tshikalange et al., 
2005); root extracts: Aspergillus 
niger, Candida albicans, S. 
aureus, Escherichia coli (Moshi 
& Mbwambo, 2005); MeOH and 
aqueous extracts of stem bark: S. 
aureus (MIC 1 mg/ml) and 
Streptococcus pyogenes 
(Steenkamp et al., 2004); 
ethylacetate extr. of roots: 
Bacillus subtilis, Klebsiella 
pneumoniae, MIC 0.3-1.5 mg/ml 
(Eldeen et al., 2005). 
The triterpenoids 
sericoside and 
arjunglucoside from 
roots and stem bark * 
(Bombardelli, 1974 and 
1986); the lignan 
Anolignan B from 
roots, MIC from 3.8-31 
μg/ml against various 
bacterial species 
(Eldeen et al., 2005). 
Agar dilution 
(Tshikalange et al., 
2005)  
 
Agar diffusion 
(Moshi & Mbwambo, 
2005) 
 
Microwell plates 
(Steenkamp et al, 
2004) 
Diarrhea, dysentery, colic, diabetes (Watt 
& Breyer-Brandwijk, 1962); colic, 
pneumonia, eyewash (Drummond & 
Coates-Palgrave, 1973); bilharzia 
(Kokwaro, 1976); gonorrhea (Hedberg et 
al., 1982); stomach problems, wounds, 
inflammation and venereal diseases 
(Neuwinger, 1996; Tshikalange et al., 
2005; Moshi & Mbwambo, 2005); skin 
diseases, cough, general body weakness, 
pneumonia, venereal diseases (Neuwinger, 
2000); diarrhea, fever, hypertension, 
bacterial infections (Fyhrquist et al., 
2002); dried fruits for tuberculosis (Eldeen 
et al., 2005). 
T. spinosa Engl. Young branches: Enterococci, S. 
aureus (MIC90% 1 mg/ml), not 
active against Mycobacterium 
tuberculosis (Fabry et al., 1996)  
Alkaloids?, coumarins 
and tannins * (Okemo, 
1996)  
Microwell plates 
(Fabry et al., 1996)  
Leaf sap for malaria (Kokwaro, 1976); 
bark chewed or added to tea to reduce 
fevers (Heine & Brenzinger, 1988); young 
branches and leaves produce a juice which 
is used for wounds (Chhabra et al., 1989).  
 
* no activity tests performed; MIC, minimum inhibitory concentration. 
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2.5.1.2. Asian species of Terminalia 
 
Many Asian species of Terminalia have been investigated for their antimicrobial effects, both 
against bacterial and fungal species. Many of the species reported to have antimicrobial 
properties in vitro have applications in traditional medicine for the treatment of microbial 
infections, such as diarrhea and venereal diseases. Since the fruits of Terminalia spp. are 
frequently used in Asian traditional medicine (Barthakur et al., 1991), investigations of the 
antimicrobial effects of this organ predominate, although also other plant parts, such as leaves 
and bark have been screened for antimicrobial effects. Antimicrobial hydrolysable tannins, 
flavonoids, triterpenoids, saponins, anthraquinones and lignans have been isolated from Asian 
Terminalia spp. The antimicrobial effects of some Asian species of Terminalia are summarized 
in Table 2. 
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Table 2. Antimicrobial activity of extracts and active compounds as well as uses in traditional medicine of some Asian Terminalia species according to literature.  
 
Species Extract Compounds  Screening 
method 
Uses in traditional medicine 
Terminalia alata 
D. Dietr. 
MeOH extract of stem bark: 
Staphylococcus aureus, Candida albicans 
and Sacharomyces cerevisae (Taylor et al., 
1996). 
Flavanone and triterpene 
saponin from roots active on 
Candida albicans and 
Aspergillus niger (Srivastava 
et al., 2001). 
 
Agar diffusion 
(Taylor et al., 
1996).  
 
Agar diffusion 
(Srivastava et al., 
2001). 
In Indian and Nepalesian traditional 
medicine for diarrhea, dysenthery and 
ulcers and as a diuretic and 
cardiotonic (Chopra, 1986). 
Terminalia arjuna  
(Roxb.) Wight & 
Arn. 
Leaves, fruits and bark active on Bacillus 
subtilis, MIC 2.89 mg/ml (Elegami et al., 
2002). 
Tannins, flavonoids, 
saponins and terpenes * 
(Elegami et al., 2002); gallic 
acid, ethyl gallate, ellagic 
acid, luteolin, arjunin (Pettit 
et al., 1989; Kandil & 
Nassar, 1997).  
Agar diffusion and 
agar dilution 
(Elegami et al., 
2002) 
Treatment of dysenthery and earache 
(Dwivedi & Udupa, 1988); bark as a 
tonic, astringent and febrifuge 
(Chopra et al., 1992; bark for 
abdominal pain, diarrhea and 
vomiting (D`Souza, 1993).  
T. bellerica Roxb., EtOH extracts of fruits possess broad 
antimicrobial spectrum, hexane extr. 
inactive (Ahmad et al., 1998); 80 % EtOH 
extract of fruit active against gram-
positive and gram-negative bacteria, 
Candida albicans and Aspergillus niger 
(Valsaraj et al., 1997).  
Lignans and a flavan 
antifungal against 
Penicillium expansum 
(Valsaraj et al., 1997). 
Agar diffusion 
(Ahmad et al., 
1998) 
 
Direct 
bioautography 
(Valsaraj et al., 
1997) 
Component of the Ayurveda 
medicinal preparation called 
“Triphala” (three fruits), used for 
treatment of fever, cough, diarrhea, 
dysenthery and skin diseases (Kirtikar 
& Basu, 1991; Pushpangadan et al., 
1986).  
 
T. chebula Retz. Aqueous and EtOH fruit extracts and 
powder of dried fruits inhibit Helicobacter 
pylori, Shigella dysenteriae and Shigella 
typhimurium (Malekzadeh et al., 2001); 
EtOH extract of fruits active against 
methicillin resistant and sensitive 
Staphylococcus aureus (Sato et al., 1997);  
EtOH and aqueous extracts active, 
whereas hexane extract inactive (Ahmad et 
al., 1998); aqueous extract inhibits growth, 
adherence and aggregation of 
Streptococcus mutans (Jagtap et al., 1999); 
extracts of ripe seeds very active against S. 
aureus, MIC 0.62 mg/ml (Shahidi Bonjar, 
2004).  
Gallic acid, ethyl gallate, 
MIC 7- 62.5 µg/ml (Sato et 
a., 1997). 
Agar diffusion 
(Malekzadeh et al., 
2001). 
 
Agar diffusion, 
microwell plates 
(Sato et al., 1997).  
 
 
Agar diffusion 
(Shahidi Bonjar, 
2004). 
 
Remedy for human gastritis and 
peptic ulcers in Iranian traditional 
medicine (Malekzadeh et al., 2001); 
for prevention and treatment of caries 
(Chopra & Handa, 1958); fruits for 
chronic ulcers, wounds and as 
laxative (Iyenger, 1985); prevention 
of infectious diseases in Ayrvedic 
system (Barthakur & Arnold, 1991).  
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Table 2. (continued) 
 
T. citrina Roxb. Methanol extracts of fruits antimicrobial 
(Burapadaja & Bunchoo, 1995).  
Five hydrolysable tannins 
with antibacterial and anti-
Candida activity 
(Burapadaja & Bunchoo, 
1995).  
Microwell plates 
(Burapadaja & 
Bunchoo, 1995) 
In Thai traditional medicine for 
treatment of diarrhea and infections 
of the skin (Burapadaja & Bunchoo, 
1995).  
T. pallida Brandis MeOH extract of fruits gave broad 
spectrum of antibacterial activity, 
including gram-negative bacteria (Shigella 
dysenteriae and Escherichia coli) as well 
as activity against Aspergillus niger and 
Candida albicans (625 – 5000 μg/ml) 
(Gupta et al., 2002). 
Tannins, steroids, 
triterpenoids, anthraquinones 
and saponins * (Gupta et al., 
2002).  
 
Agar diffusion 
(Gupta et al., 
2002).  
Fruits used for diarrhea, venereal 
diseases and ulcers by the tribal 
people of Thirupati hills, India (Gupta 
et al., 2002). 
 
* no activity tests performed; MIC, minimum inhibitory concentration. 
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2.5.2. Combretum species 
 
At least twenty four species of Combretum are well known in African traditional medicine, and 
used for the treatment of a variety of ailments and diseases, ranging from scorpion and snake 
bites, mental problems, heart and worm remedies to fever and microbial infections (Watt and 
Breyer-Brandwijk, 1962, Table 3). Of the African species of Combretum, none have been 
recorded for the treatment of cancer before our record on the use of the roots and leaves of C. 
zeyheri for the treatment of cancer in Mbeya, southern Tanzania (Fyhrquist et al., 2002). On the 
other hand it is questionable whether cancer (or other internal diseases with complicated and 
diverse symptoms) can be diagnosed by traditional healers. In Africa, all parts of the Combretum- 
species, in some cases even the fruits (Watt & Breyer-Brandwijk, 1962; Van Wyk & Van Wyk, 
1997), are used for medicinal purposes. The fruits and seeds are, although, in general considered 
poisonous by traditional healers in various African countries and have been reported to give toxic 
effects on humans (Rogers & Verotta, 1996; Van Wyk & Van Wyk, 1997). In some cases 
different plant organs from the same species of Combretum are mixed as a herbal remedy. 
Species of Combretum are prepared for herbal remedies as hot water decoctions, cold water 
extracts or mixed with food, such as maize porridge. Sometimes fresh leaf sap is used as such. 
The remedies made from Combretum species are used both internally and externally. Sometimes 
the curing compounds of the plants are inhaled through fumes of steam baths of hot water 
extracts or from the smoke of burnt plant material. Dressings and ointments of different plant 
parts are used mainly for the treatment of wounds and infections on the skin. It is very common 
to mix different species of Combretum or to mix Combretum spp. with other medicinal plants for 
herbal remedies. 
Since species of Combretum frequently are used for the treatment of microbial infections in 
traditional medicine, many authors have investigated the in vitro antimicrobial effects of various 
species of Combretum. Many species of Combretum have been found to possess powerful 
antibacterial and antifungal effects (Table 3). The large number of antimicrobial compounds 
found in species of Combretum might explain why they are so widely used in African traditional 
medicine (Martini & Eloff, 1998). In many cases the in vitro effects of decoctions and infusions 
have been investigated, since this is the way in which the traditional medicines from this plant 
group are prepared. In some cases these decoctions have proved to be as effective as alcoholic 
and acetone extracts, but in other cases water extracts/decoctions have not yielded any 
antimicrobial components (Martini & Eloff, 1998). Among antimicrobially active compounds 
isolated from Combretum spp. are combretastatins (bibenzyle compounds), acidic tetracyclic and 
pentacyclic triterpenes/triterpenoids, ellagitannins, phenanthrenes, flavonoids, saponins and 
cycloartane glycosides (Table 3). There exists a chemotaxonomic link between the genera 
Terminalia and Combretum, since pentacyclic triterpenes, based on the 23-hydroxylated aglycone 
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with antibacterial activities are found in both Terminalia stuhlmannii and Combretum imberbe 
(Katerere et al, 2003). 
 
In the following some African species of Combretum which have been found to possess good 
antibacterial and antifungal effects, as well as having applications in traditional medicine are 
presented. Special emphasis is taken on species which are included in this doctoral thesis, such as 
C. molle, C. apiculatum C. padoides, C. zeyheri and C. fragrans. 
 
Combretum molle 
Combretum molle R. Br. Ex G. Don., Soft-leaved combretum, Velvet bushwillow (Vernacular 
name in Swahili: Mlama; Nyakyusa: Mpula, Kapula) occurs throughout tropical Africa in areas 
where woodlands and wooded grasslands predominate, often forming pure stands on hillsides 
(Wickens, 1973; Drummond & Coates-Palgrave, 1973). It also occurs on the Arabian Peninsula. 
This species is one of the most common constituents in Brachystegia-Julbernardia (Miombo) 
woodland. It is a deciduous tree reaching heights of 5-7 m, sometimes even 10-17 m (Drummond 
& Palgrave, 1973; Wickens, 1973). The bark is dark grey to black, rough, reticulately fissured, 
resembling crocodile skin. The bark of the branchlets is peeling in grey, fibrous strips. The leaves 
are arranged oppositely (sometimes 3-verticillately). The lamina is narrowly elliptic or narrowly 
ovate-elliptic. The leaf apex is acute or obtuse. The lamina is typically pubescent above and 
densely grey tomentose beneath. Leaf scales are silvery to reddish. Flowers are borne in axillary 
spikes, 7- (11) cm long, the flowers being greenish-yellow and fragrant. The fruit is 4-winged, 
subcircular to elliptic in outline, pale straw coloured to yellow brown. The apical peg of the fruits 
is up to 1 mm long (Wickens, 1973). Wickens (1973) claims that C. molle is extremely variable 
in leaf shape, reticulation and size of the fruits. These characters appear in various combinations 
throughout the distribution range and further confusion is caused through the presence of 
intermediate forms. 
Combretum molle is widely used in African traditional medicine for treatment of various ailments 
and diseases. Various organs such as the leaves, roots, and to a lesser extent the fruits and stem 
bark have applications in traditional medicine. The most commonly used part are the roots, 
although also the leaves of this species are used frequently for medicinal purposes. The inner part 
of the root is powdered and used as a wound dressing (Drummond & Coates-Palgrave, 1973; 
Watt & Breyer-Brandwijk, 1962). Decoctions of the roots of C. molle seem to have a variety of 
uses such as for hookworm, stomach pains, snake bite, leprosy, fever, dysentery, general body 
swellings, abortion (Kokwaro, 1976; Chhabra et al., 1989) as well as for swelling of the 
abdomen, sterility and constipation (Chhabra et al., 1989). Root extracts are used as 
galactogogues (Neuwinger, 2000). Extracts of the roots are used for cough remedy (Drummond 
& Coates-Palgrave, 1973). Very often C. molle is mixed with other species of Combretum as well 
as with other plant species since remedies made from mixtures of plant species are thought to be 
more powerful in their healing effects. The roots of C. molle are mixed with the roots of Annona 
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chrysophylla Boj. or Annona senegalensis, and this remedy is used as an expectorant. Decoctions 
of the roots of C. molle are mixed with Securinega virosa Pax et K. Hoffm. (Euphorbiaceae), 
Psorospermum febrifugum var. ferrugineum Keay & Milne-Redhead and Premna senensis 
Klotsch (Verbenaceae) and drunk for the treatment of syphilis (Hedberg et al., 1982). To treat 
snakebites a mixture of small chips of the roots of C. molle and roots of Markhamia obtusifolia 
Sprague (Bignoniaceae) and Vangueria rotundata Robyn (Rubiaceae) is applied to the bite 
(Hedberg et al., 1982) and wounds from poisoned arrows are treated in the same way (Haerdi, 
1964). There are only two reports on the medicinal use of the stem bark of C. molle: an aqueous 
suspension of the stem bark is used for gargling and is drunk to treat angina (Kerharo, 1974) and 
decoctions of the inner bark is used for treatment of stomach problems (Watt & Breyer-
Brandwijk, 1962). The leaves of C. molle are used in various ways for medicinal purposes. 
Decoctions of dried leaves are boiled with salt and water and sprinkled on wounds. Fresh leaves, 
or moistened dry leaves, are used as dressings for wounds (Drummond & Coates-Palgrave, 
1973). The juice of the leaves of C. molle is mixed with a decoction of the roots to treat abortions 
and as an antidiarrhoic (Haerdi, 1964). Aqueous extracts of the leaves are used to treat chest 
complaints, as anthelmintics and as inhalants in steam baths. Leaves of C. molle are used 
externally together with the roots of Senecio lyratipartitus to heal wounds (Kokwaro, 1976). Leaf 
decoctions are used for the treatment of dropsy. The dried leaves are mixed with food for the 
same purpose (Kerharo, 1974). An infusion of the leaves is drunk as an aid in child birth and a 
hot application is applied to the vulva and abdomen (Watt & Breyer-Brandwijk, 1962). Even if 
the fruits of Combretum species in general are reported to be toxic, the fruits of this species are 
used as an aid in child birth in the same way as the leaves (Watt & Breyer-Brandwijk, 1962). In 
addition to the above mentioned uses C. molle is reported to be used for treatment of HIV/AIDS 
related infections (Bessong et al., 2005) and malaria, (Abebe & Ayehu, 1993). 
C. molle has been found to possess both antibacterial (Eloff, 1998b; Eloff, 1999; Khan et al., 
2000), antimycobacterial (Asres et al., 2001a) and antifungal effects (Pegel & Rogers, 1985), 
which is in accordance with the uses of this plant for treatment of infectious diseases and wounds 
in African traditional medicine (Table 3). Eloff (1999) found that a leaf extract of C. molle was 
especially active against Enterococcus faecalis (MIC < 0.2 mg/ml). Pegel & Rogers (1985) found 
that the compound responsible for the antifungal effects of the leaf extract was the triterpenoid 
mollic acid-3-β-D-glucoside. Also the stem bark of C. molle contains antibacterial compounds, 
and its acetone fractions have been found significantly to inhibit the growth of Mycobacterium 
tuberculosis typus humanus (ATCC 27294) (Asres et al., 2001a). A hydrolysable tannin, 
punicalagin, was found to be responsible for the antimycobacterial effect of the stem bark, 
whereas the isolated saponins were found to be inactive (Asres et al., 2001a). Peeled twigs of C. 
molle are used as chewing sticks in Tanzania, among other plant species, and the bark of these 
sticks was found to possess both antibacterial and antifungal effects, whereas extracts of the 
wood were inactive or showed slight activity (Khan et al., 2000). Thus Khan et al. (2000) 
recommended the use of unpeeled twigs of C. molle for chewing. 
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Combretum padoides 
Combretum padoides Engl. & Diels is a tree or many-stemmed scandent shrub, up to 12 m tall. 
The leaves are oppositely to suboppositely arranged, elliptic to oblong-elliptic with an acuminate 
apex. The lamina is glabrous or very sparsely pubescent. The inflorescences occur solitary or 
rarely 2-3 in the axils of the upper leaves to form branched terminal panicles. The flowers are 
yellowish- white and scented. The fruit is subcircular- elliptic, 4-winged, golden, and glabrous 
with an apical peg. C. padoides occurs in riverine, coastal and swamp forests as well as 
deciduous tickets. (Wickens, 1973). 
Combretum padoides was among the seven most efficient species in a survey over the 
antimicrobial effects of 27 species of members of the family Combretaceae (Eloff, 1999). 
Extracts of the fresh leaves were in general more active than extracts of dried leaves, and 
especially good MIC values were obtained against E. coli and Enterobacter faecalis, which both 
were inhibited at 0.8 mg/ml of the extract. Rogers (1989) isolated mono- and bi-desmosidic 
triterpenoids from the leaves of C. padoides, why it is possible that these compounds in part 
might be responsible for the antibacterial effects of this species. Combretum padoides is not used 
for the treatment of infectious diseases in African traditional medicine, but the leaves are used for 
snakebites and the roots for eliminating hookworms (Neuwinger, 2000). 
 
Combretum apiculatum 
Combretum apiculatum Sond., Red bushwillow, Rooibos (not to be confused with Rooibos tea, 
Aspalanthus linearis) (Vernacular name according to Zigua tribe: Muhuluka). This species can be 
found in East, South and Southwestern Africa. C. apiculatum grows into a small deciduous tree, 
up to 10 m high and is rarely a shrub. The bark is grey to grayish black, smooth or reticulated; 
leaf buds are black or dark brown. The leaves are opposite; lamina glutinous when young, 
broadly to narrowly obovate-elliptic or oblong-elliptic or ovate to subcircular, 3-14 cm long, 1.5-
7.5 cm wide. Leaf apex is usually apiculate or mucronate and usually twisted. Mature leaves are 
usually glabrous in East-Africa. The inflorescences are axillary spikes, up to 3-7 cm long. The 
flowers are yellow with no fragrance recorded (Wickens, 1973). The fruit is four-winged, 20-30 
× 15-25 mm, glutinous when young, yellowish green, often tinged with red (van Wyk & van 
Wyk, 1997). C. apiculatum occurs on granitic, rhyolitic and basaltic soils in Brachystegia 
woodland (Miombo), wooded grassland and in Acacia-Commiphora bushland, and is also 
common on rocky hillslopes, often on well-drained soils (Wickens, 1973; van Wyk & van Wyk, 
1997). 
The root decoction of C. apiculatum is used for the treatment of mental illness and a necklace of 
the roots is used for the same purpose (Chhabra et al., 1989). Roots are chewed and the sap is 
swallowed for the treatment of snakebite and leaf decoctions are drunk for treatment of scorpion 
sting (Kokwaro, 1976). Root decoctions of C. apiculatum are used for the treatment of leprosy 
and bloody diarrhea (Kokwaro, 1976). The leaves are used for abdominal disorders and the stem 
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bark for conjunctivitis (Watt & Breyer-Brandwijk, 1962). Von Koenen (1996) reports that 
stomach problems are treated by a vapor bath of C. apiculatum, combining this treatment with 
drinking the leaf decoction of this plant. Leaves of C. apiculatum are introduced vaginally for 
treatment of body exhaustion in women (Gelfland et al., 1985). The leaves are also used to 
disinfect the navel after birth (Van Wyk, 1997; Von Koenen, 1996; Kokwaro, 1976). 
In accordance with the traditional uses of C. apiculatum for treatment of bacterial infections, this 
species has been found to possess substantial antibacterial activity. In a survey on the 
antibacterial effects of 27 South African species of Combretaceae, Eloff (1999) found that leaf 
extracts of C. apiculatum gave excellent effects against most of the bacterial species used in the 
investigation and, notably, showed that extracts of fresh leaves gave low MIC values against the 
gram negative bacteria E. coli (1.6 µg/ml). C. apiculatum leaf material was also found favourable 
to use, since the extraction yield was good; up to 16.2 % of the dry weight of the leaf material 
(Eloff, 1999). In a qualitative TLC survey of the patterns of components in different species of 
Combretum, Carr & Rogers (1987) found that C. apiculatum ssp. leutweinii leaves contains 
triterpenoids, but no assays on the biological activity of these compounds were performed. 
Substituted dihydrostilbenes, phenanthrenes and 9,10-dihydrophenanthrenes have been isolated 
from the heartwood of C. apiculatum (Letcher & Nhamo, 1971; Malan & Swinny (1993) and 
three of these compounds showed total inhibition against Penicillium expansum when 20 μg of 
the compounds were spotted on a TLC plate (Grayer & Harborne, 1994). 
 
Combretum zeyheri 
Combretum zeyheri Sond., Large-fruited combretum, Large-fruited bushwillow (vernacular name 
in Swahili: Mlamamweupe, Mlama; Nyakyusa: Kakati) occurs from Kongo and Tanzania 
southwards to South West Africa, Botswana, the Transvaal and Natal. It occurs in Brachystegia 
woodland, wooded grassland and Acacia-Commiphora bushland, usually on sandy soils, also on 
termite mounds. C. zeyheri is reported to be very tolerant to soils of high metal or serpentine 
content. In South Africa C. zeyheri is a common tree together with Diplorhynchos condylocarpon 
(Apocynaceae) (Drummond & Palgrave, 1973). C. zeyheri is a slender, deciduous tree reaching 
heights of 10-13 m, or rarely a shrub. The bark is brown or greyish-brown. The branchlets are 
light brown, pubescent. The leaves are oppositely arranged or 3-verticillate. The lamina is 
broadly to narrowly elliptic to obovate-elliptic, up to 14 (-16) cm long and 8 (-10) cm wide. The 
leaf apex is usually rounded to obtuse. The leaves are tomentose-pubescent to almost glabrous. 
Inflorescences are unbranched axillary spikes, up to 8 cm long. The flowers are greenish yellow. 
The scent, if any, is not recorded. The large fruit is subcircular to elliptic, 4-winged, usually 6.5 
cm long and 5.5 -6 cm wide, straw coloured to light brown, usually glabrescent. The apical peg is 
very short or absent. The wings of the fruit are up to 4 cm wide. 
The leaves, roots and stem bark of C. zeyheri are used medicinally. The leaves are used 
frequently and have a variety of uses in African traditional medicine. The smoke of burnt leaves 
is inhaled for treatment of coughs. Colic is cured with the bitter tasting water extracts of dried, 
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milled leaves. The Mankoya people in Zambia use the leaves and stem bark of C. zeyheri 
together with the roots of cassava (Manihot esculenta) to prepare a cure for smallpox. The 
treatment is divided into three parts; an enema, eye drops and an ointment. The enema is prepared 
by pounding the leaves of C. zeyheri and then warming these in water. The enema is then applied 
using a small calabash as a syringe. Eye drops are prepared by soaking the cassava roots in water 
for ten minutes and a few drops are put into the eye four times a day during a week. An ointment 
is prepared from the inner bark of C. zeyheri by pounding and stamping the bark, adding some 
water until a thick paste is formed. The pustules of smallpox are then pricked with a splinter of 
wood after which the ointment is smeared on them. The ointment is used only once. Throughout 
the treatment for smallpox the patient has to lie on a bed of earth made from a particular type of 
small termite nest (Drummond & Palgrave, 1973). Rheumatism and joint pain is treated with 
crushed leaves of C. zeyheri, which are mixed with melon seed oil and rubbed in on the hurting 
body parts (Kremnitz et al., 1988). Decoctions of finely ground leaves are reported to be very 
effective for treatment of eye inflammation and conjunctivitis (Kremnitz et al., 1988). Leaves are 
pounded with oil and rubbed in for the treatment of back pain (Von Koenen, 1996). The leaves 
are used externally to treat scorpion bites (Watt & Breyer-Brandwijk, 1962) or macerated 
together with roots for the same purpose (Von Koenen, 1996). The roots and stem bark of C. 
zeyheri are also used for medicinal purposes, although there are not such a variety of reports as 
for the leaves of this species. Hot water extracts and infusions of the roots and stem bark are 
added to porridge to treat diarrhea, dysentery, ankylostomiasis and vomiting (Kokwaro, 1976; 
Hedberg et al., 1982; Gelfland et al., 1985; Neuwinger, 2000). Roots are chewed for the treatment 
of schistosomiasis (Neuwinger, 2000). Powdered stem bark is put in the vagina to arrest 
menstrual flow (Watt & Breyer-Brandwijk, 1962). Combretum zeyheri is sometimes used 
together with other medicinal plants, such as the tree violet, Securidaca longopedunculata 
(Polygalaceae) and Pterocarpus angolensis (Fabaceae) for the treatment of nose bleeding. 
Malaria is treated with roots and leaves of C. molle together with Ochna pulchra (Ochnaceae), 
Burkea africana (Caesalpiniaceae) and Diospyros chamaethamnus (Ebenaceae) (Von Koenen, 
1996). 
Only a few authors have investigated the antimicrobial effects of Combretum zeyheri. Eloff 
(1999) reports that this species has some antibacterial potential, although it was not among the 
most promising of the 27 species of Combretaceae investigated. Three antimicrobial compounds 
have been isolated from the stem bark and leaves of C. zeyheri, but the identity of the compounds 
was not investigated in this study (Breytenbach & Malan, 1989). 
 
Combretum fragrans 
Combretum fragrans F. Hoffm., syn. C. adenogonium, Four-leaved bushwillow (vernacular name 
in Swahili: Mlama; Nyakusa: Hansebwe). This species is shrublike or a small tree, up to 10 (-12) 
m high. The bark is grey and reticulately fissured, the branches peeling to give dark reddish color. 
Leaves are opposite or 3-(4)-verticillate, the lamina is broadly ovate- elliptic. The leaves are 
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rarely tomentose in East Africa. The inflorescences are axillary, either single or simple spikes or 
clusters of such spikes, borne on very much reduced axillary shoots or single axillary spikes on 
elongated shoots. The shoots are leafless during flowering, thus giving the appearance of a 
branched inflorescence. The flowers are greenish yellow to white and fragrant, particularly at 
night. The fruit is subcircular to elliptic in outline, yellow-brown to brown. C. fragrans is 
common in deciduous woodland (Miombo) and wooded grassland associated with seasonally 
waterlogged clay soils and is sometimes also found growing on shallow, stony soils (Wickens, 
1973). 
Combretum fragrans has many uses in African traditional medicine. Root decoctions are drunk 
for the treatment of leprosy (Chhabra et al., 1989) cough and syphilis (Kokwaro, 1976) and root 
infusions as aphrodisiacs (Gelfland et al., 1985). The leaves are burnt to ashes, mixed with castor 
(Ricinus communis) oil and used topically for treatment of leprosy (Chhabra et al., 1989). Leaf 
decoctions are used to treat snakebites (Neuwinger, 2000) and for cleansing chronic wounds 
(Adjanohoun et al., 1986). The roots of C. fragrans have been found to contain anthracene 
glycosides, coumarins, flavonoids, starch, steroids/triterpenoids and tannins. Chhabra et al. 
(1984) showed that the roots give antibacterial effects against Staphylococcus aureus, Klebsiella 
pneumoniae and Shigella boydii and thus the traditional use of this plant for treatment of leprosy, 
syphilis and chronic wounds is in accordance with the in vitro antibacterial effects of this species. 
 
Combretum collinum 
Combretum collinum Fresen., Variable bushwillow (vernacular name according to the Mgunku 
tribe: Mnama; Swahili: Mlama) is widespread in tropical and subtropical Africa (Wickens, 1973). 
It grows to a small tree, up to 12 m high or to a coppicing shrub. C. collinum is considered to be a 
highly variable species and is thought to consist of several subspecies, differing from each other 
only in minor characters (Van Wyk & Van Wyk, 1997). At least 11 subspecies of C. collinum 
have been distinguished, of which six occur in East Africa (Rogers & Coombes, 1999), and some 
of them are distinguished from each other according to the pattern of triterpene glycosides in their 
leaves. Van Wyk & Van Wyk (1997) report that four subspecies can be distinguished in South 
Africa on the basis of the leaf morphology and occurrence of hairs on leaves. The bark is reddish 
brown to pale yellow. Leaves are opposite, alternate or verticillate; the lamina is very variable in 
shape, up to 22 cm long and 8 cm wide, the upper surface drying to reddish olive or yellowish 
brown, usually somewhat “metallic” in appearance. The inflorescences are simple spikes or 
panicles up to 10 cm long, axillary or supra-axillary from bracts or reduced leaves on the current 
year’s shoots. The flowers are yellow, cream or white and fragrant. The fruit is brown, reddish 
brown, greyish brown to dark purple, usually somewhat metallic in appearance, variable in shape, 
2.5-5.9 cm. 
Combretum collinum has various medicinal uses in African traditional medicine. Decoctions of 
the roots of C. collinum are used together with roots and bark of Kigelia africana Benth., the 
sausage tree (Bignoniaceae) for the treatment of excessive menstrual bleeding beyond the normal 
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time. C. collinum is hot water extracted together with other medicinal plants, such as Combretum 
molle (Mlama) and Phyllanthus reticulatus Poir. (Euphorbiaceae) for the treatment of diarrhea 
accompanied by mild anal bleeding. The powdered stem bark is mixed with porridge or put in tea 
and used against rectal prolapse (Hedberg et al., 1982). According to Haerdi (1964) decoctions of 
roots and leaves are drunk for the treatment of malaria. Kokwaro (1976) reports that the roots are 
decocted for the treatment of dysentery and chewed to treat snake bites. Root decoctions are used 
for the treatment of “Madi”, a blood disease and pains in the side (Watt & Breyer-Brandwijk, 
1962). Vapours of leaf decoctions are used to treat malaria (Haerdi, 1964). Gastroenteritis is 
treaten with three teaspoons of decoction of fresh roots (Adjanouhoun et al., 1993). The leaves of 
C. collinum are covered with trichomes which secrete triterpenoids (Rogers & Coombes, 1999), 
but no investigations have been performed on the antimicrobial effects of these compounds or 
crude extracts of C. collinum. 
 
Combretum micranthum 
The West-African species Combretum micranthum G. Don (name for the drug: kinkeliba) is 
widely used in traditional medicine and is even inscribed in the French Pharmacopoeia (Baba-
Moussa et al., 1999). Leaf infusions of this species are drunk for the treatment of colds, fever, 
colic, vomiting and gastrointestinal problems (Prost, 1971). Root decoctions are used as 
anthelminthics as well as for washing wounds (Irvine, 1961). C. micranthum is also reported to 
be used for the treatment of malaria on the Ivory Coast in West Africa (Benoit et al., 1996). In 
accordance with the traditional uses, C. micranthum has been found to show antibacterial 
activities, but the compounds producing these activities are unknown. The leaves of C. 
micranthum were bactericidal against Shigella dysenteriae, S. paratyphi B and Klebsiella ozenai, 
and extracts made of fresh plant material were found to be more active than those made from 
dried leaves (Karou et al., 2005). Karou et al. (2005) demonstrated that the leaf extracts of C. 
micranthum are rich in polyphenols, and show good antioxidative activities, and thus they 
speculated that the polyphenols might be the antibacterially active compounds in this plant. The 
good antimicrobial effects in vitro, showed by extracts of C. micranthum are thus consistent with 
its uses in traditional medicine in West Africa. 
 
Combretum woodii 
Combretum woodii Duemmer is a bushweld species growing to a small tree found in northern 
Kwazulu-Natal, Swaziland and Mpumalanga in South Africa (van Wyk & van Wyk, 1997). Eloff 
et al. (2005) were the first to report that a stilbene, 2`,3`, 4-trihydroxyl-3,5,4`-trimethoxybibenzyl 
(combretastatin B5), isolated from a chloroform fraction of C. woodii leaves gave significant 
antibacterial effects against Staphylococcus aureus (MIC = 16 μg/ml) as well as some activity 
against the gram negative E. coli and P. aeruginosa (MIC = 125 μg/ml), and was more potent 
than chloramphenicol and ampicillin. There are no reports on the uses of C. woodii in traditional 
medicine and the study of Eloff et al. (2005) now suggests that leaves of this species might be 
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used for the treatment of microbial infections in poor communities in South Africa. 
Combretastatin B5 has previously been isolated by Pelizzoni et al. (1992) from the seeds of C. 
kraussii, but they did not investigate its antimicrobial effects. 
 
Combretum caffrum  
Combretum caffrum Eckl. & Zeyh. grows on the banks of rivers in the Eastern Cape Province in 
Southern Africa. Local historians believe that for over 2000 years Arabians traded for the bark 
with the San people (Bushmen). The bark was probably used as a general tonic in those days, 
because, apart from its anti-cancer properties, the bark also produces a feeling of general well 
being. The Zulu use it as a poison for spears (Pettit et al., 1987), which illustrates that the extracts 
of this plant are poisonous at high doses 
(http://www.chm.bris.ac.uk/motm/combretastatin/combh.htm). Decoctions of the roots are added 
to bath water before bedtime to treat pains in the body (Bath & Jacobs, 1995). 
Stilbenes, such as combretastatins A-1, A-2, A-3 and A-4 as well as combretastatins B-1, B-2, B-
3 and B-4 have been isolated from the wood of the South African species of Combretum caffrum, 
and have mainly been noticed because of their outstanding antineoplastic activities (Pettit et al., 
1987, 1988, 1989, 1995 and 1999). Masika & Afolayan (2002) showed that acetone, MeOH, 
water extracts and a water decoction of the stem bark of C. caffrum inhibited the growth of most 
of the gram-positive bacteria and some fungal pathogens used in their study. Interestingly, the hot 
water decoction, prepared in the traditional way, was more active than the water extract against 
the gram-positive bacteria. The MeOH extract showed good activity also against the gram-
negative bacteria used in this study and was very active against most of the fungal species, 
including Aspergillus and Penicillium species. The compounds responsible for this excellent 
antibacterial and antifungal activities of extracts of C. caffrum might be combretastatins, since 
Eloff et al. (2005) found that combretastatin B5 gave good antibacterial activity. 
 
Combretum pentagonum and C. hartmannianum 
Elegami et al. (2002) have found in their screening of forty eight extracts of four members of 
Combretaceae that leaf, bark, fruit and stem bark extracts of both Combretum pentagonum 
Lawson and C. hartmannianum Schweinf. gave good effects against gram-positive and gram-
negative bacteria, and most of the activity was found in water and methanol extracts, whereas 
chloroform extracts were devoid of activity. Extracts made from different parts of the plants did 
not differ much from each other in antimicrobial activity. The species of Combretum included in 
this study were found to be rich in flavonoids, saponins and terpenes as well as tannins, why the 
authors speculated that the good antibacterial effects shown by these species might be due to 
tannins and flavonoids. The antibacterial effects of C. hartmannianum are in accordance with the 
use of this plant in traditional medicine in Sudan, where it is used for treatment of fever, jaundice 
and bacterial infections (El Ghazali et al., 1994; Al Magboul et al., 1988). 
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Combretum erythrophyllum 
Martini & Eloff (1998) have detected at least 14 antimicrobial compounds of a wide range of 
polarities from leaf extracts of Combretum erythrophyllum (Burch.) Sond. The chloroform 
fraction was found to contain the highest concentration of antimicrobial compounds. The most 
effective fraction (35 % MeOH) gave MIC values of 0.05 mg/ml (50 μg/ml) against 
Staphylococcus aureus, compared to 0.08 and 0.16 mg/ml for ampicillin and chloramphenicol. 
Good results were also obtained against Enterococcus faecalis and E. coli. A notable discovery in 
this investigation was also that water did not extract any antibacterial compounds with activity 
against Staphylococcus aureus, at least at the concentration used in this study. This means that all 
the antimicrobial compounds cannot be extracted when this plant is prepared as water decoctions 
(Arnold & Gulumian, 1984; Watt & Breyer-Brandwijk ) in traditional medicine. Root and bark 
decoctions of C. erythrophyllum are used for treatment of cough and infertility as well as an 
aphrodisiac, whereas leaves are not known to be used in traditional medicine (Arnold & 
Gulimian, 1984; Watt & Breyer-Brandwijk, 1962). The excellent results on the antimicrobial 
activity of this species now indicate that it could be used for the treatment of bacterial infections 
in traditional medicine as well. Later on Martini (2001) and Martini et al. (2004) have isolated 
seven antimicrobial flavonoids from leaf extracts of C. erythrophyllum, and all compounds were 
found to give good activity against Vibrio cholerae and Enterococcus faecalis, with MIC values 
ranging from 25 – 50 μg/ml. Comparing these MIC values of the isolated compounds with the 
crude leaf extract suggested, however, either that the most effective antibacterial compounds had 
not been isolated or that the compounds in the extract act synergistically. Martini et al. (2004) 
thus suggested that leaf extracts of C. erythrophyllum might be used for the purification of water 
contaminated by Vibrio cholerae. This would be a cheap low-tech solution to cholera in rural 
areas in Africa. Schwikkard et al. (2000) have isolated combretastatin A-1 and (-)-combretastatin 
from the wood of C. erythrophyllum, but they did not investigate the antimicrobial effects of 
these compounds. 
 
Combretum imberbe 
Combretum imberbe Wawra grows up to a 33 m high tree or remains as a shrub (Wickens, 1973). 
It grows in dry, hot savanna areas with sandy soils, and is also found in savanna woodland. The 
local people in different African countries use both the leaves and roots for treatment of diarrhea 
and cough. Ashes of the wood is used for toothpaste (Neuwinger, 2000). Rogers & Subramony 
(1988) have isolated pentacyclic triterpenes from the leaves of C. imberbe. Also related 
glycosides have been isolated, all based on the aglycon imberbic acid (Rogers, 1988). Katerere et 
al. (2003) isolated two new glycosidic derivatives of hydroxyimberbic acid and they found that 
particularly imberbic acid had potent activity against Mycobacterium fortuitum and 
Staphylococcus aureus. They also found that one of the isolated pentacyclic triterpenes showed 
good activities against Candida albicans. The in vitro antibacterial effects of C. imberbe are thus 
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in accordance with the traditional use of this plant for the treatment of diarrhea and cough, 
symptoms which can be related to bacterial/fungal infection. 
 
Combretum mkhuzense 
Recently, antimicrobial lectin-like proteins have been isolated from the stem bark of Combretum 
mkhuzense (Gaidamashvili & van Staden, 2002). These proteins, which are non-enzymatic, bind 
with high specifity to carbohydrates, both oligosaccharides and monosaccharides, and thus are 
thought to bind to surface-exposed carbohydrates of microbes. In the plant these proteins might 
serve as a defense against microbial attacks. Gaidamashvili and van Staden (2002) were able to 
show that lectins isolated from C. mkhuzense elicited selective aggregation reactions within 
bacterial strains, and that the highest activities were achieved against Staphylococcus aureus 
whereas Bacillus subtilis was more resistant. This investigation is one of the few showing that 
plant derived lectins both elicit aggregation and possibly via this, inhibit the growth of microbial 
pathogens. 
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Table 3. Antimicrobial activity of extracts and active compounds and uses in traditional medicine of some African Combretum species according to literature.  
 
Species Extract Compounds  Screening 
method 
Uses in traditional medicine 
C. apiculatum Sond. Leaf extracts antimicrobial 
against gram-positive and gram-
negative bacteria, E. coli (MIC 
1.6 μg/ml) (Eloff, 1999). 
 
Leaves contain triterpenoids * (Carr 
& Rogers, 1987); dihydrostilbenes, 
phenanthrenes (Letcher & Nhamo, 
1971; Malan & Swinny, 1993) from 
heartwood active against 
Penicillium expansum (Malan & 
Swinny, 1993).  
Bioautography 
(Malan & Swinny, 
1993).  
 
Microwell plates 
(Eloff, 1999)  
 
Stomach problems, scorpion stings, 
disinfect the navel after birth (Van 
Wyk, 1997; Von Koenen, 1996; 
Kokwaro, 1976)  
C. caffrum Eckl. & 
Zeyh. (Kuntze) 
Acetone, MeOH, water extracts 
and a water decoction of the 
stem bark antimicrobial against 
gram-positive bacteria and some 
fungal pathogens, MeOH extract 
active also against gram-
negative bacteria (Masika & 
Afolayan, 2002). 
Combretastatins A-1, A-2, A-3, A-4, 
B-1, B-2, B-3 and B-4 *from the 
wood (Pettit et al., 1987, 1988, 
1989, 1995 and 1999).  
Agar dilution 
(Masika & 
Afolayan, 2002). 
The bark as a general tonic for 
production of general well being; the 
Zulu use it as a poison for spears 
(Pettit et al., 1987); for treatment of 
pains in the body (Bath & Jacobs, 
1995). 
C. collinum Fresen. * Triterpenoids * in leaves (Rogers & 
Coombes, 1999). 
* Decoctions of roots and leaves are 
drunk for malaria (Haerdi, 1964); 
Roots with Kigelia africana for 
excessive menstrual bleeding; roots 
with Combretum molle and 
Phyllanthus reticulatus for diarrhea; 
stem bark mixed with porridge or in 
tea for rectal prolapse. (Hedberg et 
al., 1982); roots for dysentery and 
chewed to treat snake bites (Kokwaro, 
1976); decoctions for “Madi”, a blood 
disease and pains in the side (Watt & 
Breyer-Brandwijk, 1962); leaf 
decoctions for malaria (Haerdi, 
1964); fresh roots for gastroenteritis 
(Adjanouhoun et al., 1993). 
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Table 3. (continued) 
 
C. erythrophyllum 
(Burch.) Sond. 
14 antimicrobial compounds of 
different polarities detected from 
acetone extract of the leaves, 
most of them in chloroform 
fraction of this extract (MIC 
0.08-0.16 mg/ml) (Martini & 
Eloff, 1998). 
Flavones apigenin, genkwanin, and 
the flavonols kaempferol, 
rhamnocitrin, rhamnazin and 
quercetin-5,3-dimethylether, all 
active against Vibrio cholerae and 
Enterococcus faecalis (MIC 25-50 
μg/ml) (Martini, 2001; Martini & 
Eloff, 2005); combretastatin A-1 
and (-) combretastatin * from wood 
(Schwikkard et al., 2000). 
Microwell plates, 
bioautography 
(Martini & Eloff, 
1998) 
Root and bark decoctions for cough 
and infertility and as an aphrodisiac 
(Arnold & Gulimian, 1984; Watt & 
Breyer-Brandwijk, 1962). 
C. fragrans F. 
Hoffm. 
Roots antibacterial against 
Staphylococcus aureus, 
Klebsiella pneumoniae and 
Shigella boydii (Chhabra et al., 
1984).  
Roots contain anthracene 
glycosides, coumarins, flavonoids, 
starch, steroids/triterpenoids and 
tannins (Chhabra et al., 1984). 
Agar diffusion 
(Chhabra et al., 
1984). 
Root decoctions for leprosy (Chhabra 
et al., 1989) cough and syphilis 
(Kokwaro, 1976); root infusions as 
aphrodisiacs (Gelfland et al., 1985); 
leaves mixed with Ricinus communis 
oil for leprosy (Chhabra et al., 1989); 
leaf decoctions for snakebites 
(Neuwinger, 2000) and for cleansing 
chronic wounds (Adjanohoun et al., 
1986). 
 
C. hartmannianum 
Schweinf. 
Water and MeOH extracts of 
leaves, fruits and stem bark 
active against gram-positive 
bacteria and E. coli, chloroform 
extract inactive (Elegami et al., 
2002) 
Flavonoids, saponins, terpenes, 
tannins * (Elegami et al., 2002). 
Agar diffusion 
(Elegami et al., 
2002).  
Fever, jaundice, bacterial infections 
(El Ghazali et al. ; Al Magboul et al., 
1988)  
C. imberbe Wavra Dichloromethane fraction of the 
leaves active against bacteria 
(Katerere et al., 2003).  
Pentacyclic triterpenes (Rogers & 
Subramony, 1988); glycosides based 
on imberbic acid (Rogers, 1988); 
glycosidic derivatives of 
hydroxyimberbic acid, imberbic acid 
active against Mycobacterium 
fortuitum and S. aureus, no activity 
against E. coli (Katerere et al., 
2003);  
five new pentacyclic triterpenoids 
active against E. coli and 
Staphylococcus aureus (Angeh et 
al., 2006). 
Microwell plates 
(Katerere et al., 
2003). 
 
Microwell plates, 
bioautography 
(Angeh et al., 
2006). 
Leaves and roots for diarrhea, coughs, 
ashes of wood for toothpaste 
(Neuwinger, 2000). 
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Table 3. (continued) 
 
C. micranthum G. 
Don.  
Aqueous acetone (70 % v/v) 
extracts of leaves bactericidal 
against Shigella dysenteriae, S. 
paratyphi B and Klebsiella 
ozenai, fresh plant material more 
active than dried (Karou et al., 
2005). 
 
 
Polyphenols * with antioxidative 
effects from leaves (Karou et al., 
2005). 
Agar diffusion 
(Karou et al., 2005) 
Leaf infusions drunk for colds, fever, 
colic, vomiting and gastrointestinal 
problems (Prost, 1971); root 
decoctions as anthelminthics and for 
washing wounds (Irvine, 1961); for 
treatment of malaria on the Ivory 
Coast in West Africa (Benoit et al., 
1996). 
C. mkhuzense  Leaf extracts active against 
Staphylococcus aureus and 
Bacillus subtilis (Gaidamashvili 
& Van Staden, 2002).  
Lectins from leaf extracts induce 
selective aggregation reactions in 
bacterial strains, highest activities 
against Staphylococcus aureus; 
Bacillus subtilis more resistant 
(Gaidamashvili & Van Staden, 
2002). 
Dilution method 
and microscopy 
(Gaidamaswhili & 
Van Staden, 2002) 
Not reported 
C. molle R. Br. Ex 
G. Don 
Leaf extracts especially active 
against Enterococcus faecalis, 
MIC < 0.2 mg/ml (Pegel & 
Rogers, 1985; Eloff, 1998b; 
Eloff, 1999). 
 
Acetone fractions of stem bark 
inhibit the growth of 
Mycobacterium tuberculosis 
typus humanus (ATCC 27294) 
(Asres et al., 2001a).  
 
Bark of twigs antibacterial and 
anti-candidal, whereas extracts 
of stem wood inactive (Khan et 
al., 2000). 
 
Leaf extracts antifungal against 
Microsporum gypseum and 
Trichophyton mentagrophytes 
(Baba-Moussa et al., 1999). 
 
Root extract: large inhibition 
zones against Candida albicans 
(Runyoro et al., 2006). 
Antifungal mollic acid-3-β-D-
glucoside from leaf extracts 
effective against Penicillium 
expansum (Pegel & Rogers, 1985) 
 
The hydrolysable tannin, 
punicalagin, gives antimycobacterial 
effects (Asres et al., 2001a)  
Bioautography 
(Pegel & Rogers, 
1985) 
 
Microwell plates 
(Eloff, 1998b; Eloff, 
1999) 
 
Broth dilution 
method with tubes 
(Asres et al., 2001a) 
 
Agar diffusion 
(Khan et al., 2000) 
 
Agar dilution, 24 
well plates (Baba-
Moussa et al., 
1999). 
 
Agar diffusion 
(Runyoro et al., 
2006). 
Fresh leaves, moistened dry leaves 
and roots as wound dressings 
(Drummond & Palgrave, 1973); roots 
for cough, syphilis, snakebites 
(Hedberg et al., 1982); for treatment 
of poisonings from snakebites/arrows 
(Haerdi, 1964; Hedberg et al., 1982); 
roots for hookworm, stomach pains, 
snake bite, leprosy, fever, dysentery, 
general body swellings, abortifacient, 
swelling of the abdomen, abortion, 
constipation, sterility (Chhabra et al., 
1989); stem bark for gargling and 
angina (Kerharo, 1974); malaria 
(Abebe & Ayehu, 1993) ; infections 
related to HIV/AIDS (Bessong et al., 
2005). 
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Table 3. (continued) 
 
C. padoides Engl. & 
Diels 
Acetone extracts of leaves 
antimicrobial (fresh leaves more 
effective than dried), MIC 0.8 
mg/ml against E. coli and 
Enterobacter faecalis (Eloff, 
1999). 
Mono- and bi-desmosidic 
triterpenoids from leaves (Rogers, 
1989) 
Microwell plates 
(Eloff, 1999) 
Leaves for snakebites and the roots 
for eliminating hookworms 
(Neuwinger, 2000).  
 
C. pentagonum 
Lawson 
Leaf, bark, fruit and stem bark 
extracts antimicrobial, most of 
the activity in water and 
methanol extracts whereas 
chloroform extracts were devoid 
of activity (Elegami et al., 2002). 
Flavonoids, saponins, terpenes, 
tannins * (Elegami et al., 2002). 
Agar diffusion 
(Elegami et al., 
2002). 
Roots for ankylostomiasis, wounds, 
oedema, gonorrhea, loose tooth, gum 
bleeding; leaves for gonorrhea, 
oedema (Haerdi, 1964) 
C. woodii Duemmer Acetone extracts of leaves 
antimicrobially active (Eloff et 
al., 2005). 
A stilbene, 2`,3`, 4-trihydroxyl-
3,5,4`-trimethoxybibenzyl, 
combretastatin B5, gave significant 
antibacterial effects against 
Staphylococcus aureus (MIC 16 
μg/ml) and some activity against E. 
coli and P. aeruginosa (MIC 125 
μg/ml) (Eloff et al., 2005) 
Microwell plates 
(Eloff et al., 2005) 
Not reported 
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Table 3. (continued) 
 
C. zeyheri Sond. Acetone extracts of leaves have 
some antibacterial potential 
(Eloff, 1999). 
Three compounds with 
antimicrobial effects have been 
isolated from stem bark and leaves 
(Breytenbach & Malan, 1989). 
Microwell plates 
(Eloff, 1999)  
Leaves for coughs, colic, smallpox 
(Drummond & Palgrave, 1973), 
rheumatism, joint pain (Kremnitz et 
al., 1988), eye inflammation, 
conjunctivitis (Kremnitz et al., 1988), 
back pain (Von Koenen, 1996), 
scorpion bites (Watt & Breyer-
Brandwijk, 1962; Von Koenen, 
1996). Roots & stem bark for diarrhea 
and vomiting (Hedberg et al., 1982); 
root infusions for bloody diarrhea 
(Gelfland et al., 1985); root powder 
with porridge for dysentery, 
ankylostomiasis, schistosomiasis 
(Kokwaro, 1976 Neuwinger (2000); 
powdered stem bark to arrest 
menstrual flow (Watt & Breyer-
Brandwijk, 1962); in combination 
with Securidaca longopedunculata 
(Polygalaceae) and Pterocarpus 
angolensis (Fabaceae) for nose 
bleeding; roots and leaves of C. molle 
with Ochna pulchra (Ochnaceae), 
Burkea africana (Caesalpiniaceae) 
and Diospyros chamaethamnus 
(Ebenaceae) for malaria (Von 
Koenen, 1996).  
 
 
* antimicrobial effect not investigated 
 
 69
2.5.3. Pteleopsis species 
 
There are probably about nine species of Pteleopsis in tropical Africa. The genus is intermediate 
in many characters between Combretum and Terminalia (Wickens, 1973). Three species of 
Pteleopsis are used in African traditional medicine, such as the East-African P. myrtifolia and the 
West-African species, P. hylodendron and P. suberosa (Hedberg et al., 1982: Baba-Moussa et al., 
1999; Ngounou et al. 1999). Two other East African species, P. anisoptera and P. tetroptera, do 
not apparently have any uses in traditional medicine. 
 
Pteleopsis myrtifolia 
Pteleopsis myrtifolia Engl. & Diels. (Vernacular name: Mgonji). This species occurs in tropical 
and south Africa (Hedberg et al., 1982). It is a tree and can grow up to 30 m high, but reaches 
more often heights of 8-20 m, and sometimes grows shrublike. The wood is red and very hard. 
Leaves are petiolate, opposite to subopposite, almost glabrous or hairy. The flowers are 
andromonoecious (male and hermaphrodite flowers on the same inflorescence), 4 (-5) merous, 
pedicellate, in terminal and/or axillary or extra-axillary subcapitate racemes, white to yellowish. 
The fruit is 2-5 winged, wings are often decurrent into the comparatively long, slender stipe. 
Pteleopsis myrtifolia can be found in dry evergreen and riverine forest, deciduous woodland, 
coastal bushland and wooded grassland (Wickens, 1973). 
The roots of P. myrtifolia are boiled with chicken and this is eaten to treat sterility and infertility 
(Hedberg et al., 1982). Decoctions of the roots are used for the treatment of venereal diseases 
(Kokwaro, 1976). Juice from the leaves of P. myrtifolia is drunk against abortion; a mixture of 
the leaf juice of P. myrtifolia with leaf juice of Royena amnicola B. L. Burtt is drunk to treat 
dysentery (Haerdi, 1964). The leaf sap and root decoctions of P. myrtifolia are used for the 
treatment of dysentery together with Diospyros zombensis (Ebenaceae) (Haerdi, 1964; Hedberg 
et al., 1981; Kokwaro, 1976). These uses indicate that P. myrtifolia contains antimicrobial 
compounds. No reports of the antimicrobial effects of P. myrtifolia exist, however. 
 
Pteleopsis suberosa 
The West African species Pteleopsis suberosa Engl. & Diels is a popular medicinal plant in 
Senegal, Guinea, Ivory Coast, Ghana, Togo, Benin and Nigeria. In Mali folk medicine Pteleopsis 
is known by the common name “Terenifu” (De Pasquale et al., 1995). The bark decoction is used 
for the treatment amoebic dysentery; root and leafy twig decoctions for dysentery and the roots 
for jaundice (Adjanohoun et al., 1986). Decoctions of the stem bark have antitussive and antiviral 
properties (De Pasquale et al., 1995). The uses of P. suberosa in traditional medicine are in 
accordance with the finding of Baba-Moussa et al. (1999), who reported that extracts of the stem 
bark and the shoots of P. suberosa are effective inhibitors of the growth of dermatophytes 
(Epidermophyton and Trichophyton species) and Candida albicans. P. suberosa has also been 
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reported to exhibit antibacterial effects against different strains of Helicobacter pylori (Germanò 
et al., 1998), the causative agent of ulcers, and this justifies the use of P. suberosa for the 
treatment of gastric ulcers in Mali traditional medicine (De Pasquale et al., 1995). Germanò et al. 
(1998) found that especially the water decoctions of this species were active against the 
Helicobacter strains, and also, together with an earlier investigator (De Pasquale et al., 1995) that 
these decoctions contained a high content of tannins (27 %) as well as triterpenoid saponins, 
which are known to be both antibacterial and to protect the outermost layer of the gastric mucosa 
and render it less impermeable (tannins) as well as protecting the mucosa from acid by selectively 
inhibiting PGF2α (triterpenoid saponins). 
 
Pteleopsis hylodendron 
Pteleopsis hylodendron Mildbr. grows into a big tree found in the forest regions of West and 
Central Africa (Irvine, 1961). P. hylodendron is highly valued in West African folk medicine. 
The aqueous decoction of the stem bark is used for treatment of sexually transmitted diseases, 
female sterility, liver and kidney disorders as well as dropsy. The indigenous use of P. 
hylodendron for the treatment of venereal diseases indicates that it contains antibacterial 
compounds. No investigations of the in vitro effects of this plant on bacteria has been performed, 
but Ngounou et al. (1999) have isolated saponins from the stem bark of this plant. 
 
2.6. Anticancer drugs 
 
Synthesis or modification of known anticancer drugs is an important aspect of research. 
However, a vast amount of synthetic work has contributed to relatively small improvements over 
the prototype drugs. There is a continued need for new templates to use in the design of potential 
chemotherapeutic agents. Natural products are important templates for chemotherapeutic agents. 
Studies on tumor inhibiting compounds originating from plants have yielded an impressive array 
of novel structures. Since 1961, nine plant-derived compounds have been approved for use as 
anticancer drugs in the United States; vinblastine (Velban), vincristine (Oncovin), navelbine 
(vinorelbine), etoposide (VP-16), teniposide (VM-26), taxol (paclitaxel), taxotere (docetaxel), 
topotecan (Hycamtin) and irinotecan (Camptosar) (Lee, 1999). 
 
Apoptotic induction has been a target for innovative mechanism-based drug discovery. 
Resistance to programmed cell death (apoptosis) is an integral part of cancer cell development, 
and reestablishment of control of apoptosis is a known target mechanism for anticancer drugs 
(Gibb et al., 1997; Joshi et al., 2002). Certain products from plants are known to induce apoptosis 
in neoplastic cells, but not in normal cells, which would be the ideal characteristic of a successful 
anticancer drug (Hirano et al., 1995). Alkylating agents, such as cisplatin (Gibb et al., 1997), act 
directly on the DNA by cross-linking the guanine nucleobases and thus hindering the strands of 
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DNA to uncoil and separate and therefore making replication impossible. This in turn, triggers 
apoptosis of the cells. Plant derived compounds comprise a diverse group with different 
mechanisms of action, but ultimately seem to have the ability to induce apoptosis (Tharapadar et 
al., 2001). Understanding the modes of action of plant-derived anti-cancer compounds should 
provide useful information for their possible application in cancer prevention and perhaps also in 
cancer therapy (Tharapadar et al, 2001). It is thus important to screen apoptotic inducers from 
plants, either in the form of crude extracts or as components isolated from them (Tharapadar et 
al., 2001). Screening plants which are used as anticancer remedies in traditional medicine 
increases the chance of finding new active anti-cancer compounds. 
 
Mitosis is a fundamental process in cellular development and depends on many factors including 
essential DNA enzymes and cellular microtubules which are composed of tubulin proteins. The 
correct topographic structure of DNA is maintained by the enzymes topoisomerase I and II 
during translation, transcription and mitosis. Polymerization/depolymerization of microtubules 
plays an essential role for cell division. All these systems are therefore important targets for new 
anticancer chemotherapeutic agents. (Lee, 1999). 
 
One of the major problems in cancer chemotherapy is the development of multi drug resistance 
(MDR) against anti-cancer drugs. It has been discovered that drug resistance in cancer cells 
results from elevated expression of certain proteins, such as cell membrane ATP-binding cassette 
transporters (Choi, 2005), which can result in an increased efflux of the cytotoxic drugs from the 
cancer cells (Ambudkar et al., 1999; Thomas & Coley, 2003). The problems of acquired drug 
resistance may be circumvented by targeting endothelial cells associated to the tumor instead of 
the tumor cells themselves (Boehm et al., 1997). Endothelial cells are genetically more stable and 
thus are less likely to develop MDR compared to cancer cells. The process of angiogenesis, the 
development of new blood vessels, is an attractive target of cancer therapy since tumors are 
dependent on a functioning vascular system, and metastasis is dependent on the formation of new 
vessels around the cell foci (Griggs et al., 2001). Also already established tumor vasculature is a 
good target for anticancer therapy since it differs from normal vasculature in its permeability, the 
absence of vascular smooth muscle cells and lymphatic drainage (Matsumura & Maeda, 1986). 
There are a number of promising anti-angiogenic and antivascular agents, some of them 
originating from higher plants, and are undergoing clinical trials. Among them the stilbene 
combretastatin-A4, originally isolated from the South African tree Combretum caffrum (Pettit et 
al., 1987, 1988, 1989 and 1999). 
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2.6.1. Cytotoxic effects of species of Combretum reported in the literature 
 
Some African species of Combretum, such as C. caffrum and to a lesser extent C. 
erythrophyllum, C. woodii and C. kraussii contain very interesting small molecular stilbene 
cytotoxic compounds, the combretastatins. Only two species of Combretum, C. zeyheri 
(Fyhrquist et al., 2002) and the Asian C. latifolium (Hartwell, 1982) have been reported to be 
used for the treatment of cancer in traditional medicine. Quite a few species of Combretum have 
been subjected to studies on their cytotoxic/antimutagenic effects, and even a smaller number of 
studies have contributed to the isolation of the compounds producing the cytotoxic/antimutagenic 
activity (Table 4). On the other hand the anticancer research on some Combretum species, such as 
C. caffrum has been extensive, and has lead to the production of a new anticancer lead 
compound, combretastatin A4 (Pettit et al., 1989; Woods et al., 1995). Combretum species 
contain in addition to stilbenes also flavonoids (Martini, 2001; Martini et al., 2004; Elegami et 
al., 2002) and pentacyclic triterpenoids (Simon et al., 2003a, Pettit et al., 1987, 1988, 1989, 1995 
and 1999; Schwikkard et al., 2000), some of them having antiproliferative and cytotoxic 
potential. 
 
Combretum caffrum and the combretastatins 
Combretum caffrum Eckl. & Zeyh has a background of use in Zulu traditional medicine as a 
general tonic for improved well being, as a poison on Zulu spears and as a charm to harm the 
enemy (http://www.chm.bris.ac.uk/motm/combretastatin/combh.htm, Pettit et al., 1987). These 
uses in traditional medicine indicate that C. caffrum contains cytotoxic compounds. Pettit et al. 
(1987, 1988, 1989, 1995 and 1999) have isolated a large group of anti-tubulin stilbene 
compounds, the combretastatins, rare natural products which resemble colchicine in structure, 
primarily from the stem bark, but also from the twigs, leaves and the fruits of C. caffrum (Table 
4). In total 15 different bibenzyls, stilbenes and dihydrophenanthrenes, designated the 
combretastatins, all with growth inhibitory properties against a murine lymphocytic leukemial 
cell line (P-388) were isolated (Pettit et al., 1987; Pettit et al., 1988). Combretastatins A-1, A-2, 
A-3, B-1 and B-2 were all found to be very effective inhibitors of the growth of the murine 
lymphocytic P-388 and L1210 leukemial cell lines, with IC50 values ranging from 0.011 μg/ml to 
0.6 μg/ml (Pettit et al., 1987 and 1988). All the combretastatins caused leukemial cells to 
accumulate in mitosis at cytotoxic drug concentrations. Many of the combretastatins have been 
found to inhibit microtubule assembly very effectively, and especially combretastatin A-1 and B-
1 have been found to be very effective inhibitors, giving the same IC50 values as podophyllotoxin 
(4 µg/ml) (Pettit et al., 1988). 
In 1989 Pettit et al. isolated combretastatin A-4 from the stem wood and bark of C. caffrum, and 
they found that this compound was the most potent of all the combretastatins isolated in 
inhibiting the growth of murine lymphocytic leukemia and colon cancer cell lines as well as 
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inhibiting microtubule assembly, and that CA-4 was as potent as podophyllotoxin and more 
potent than colchicines and steganacin (Pettit et al., 1989). CA-4 shows potent cytotoxicity 
against a wide variety of human cancer cell lines, including multidrug-resistant cancer cell lines, 
and is thus an attractive lead molecule for the development of new anticancer drugs (El Zayat et 
al., 1993). Combretastatin A-4 has been found to competitively inhibit the binding of colchisin to 
tubulin, since it binds to the same site on β-tubulin, but with different characteristics that impart 
selective toxicity to tumor vasculature (Pettit et al., 1989; Woods et al., 1995). 
A number of studies have reported on the relation between structure and activity (SAR) of 
combretastatins (Lin et al., 1989). Minimum requirements for activity are that the diaryl system 
should be separated through a double bond and the presence of a trimethoxy system in one of the 
rings (Srivastava et al., 2005). Also, it has been found that the cis (Z) isomer is preferred over the 
trans (E), as cis seems to be much more active than trans (Srivastava et al., 2005). 
Both combretastatin (CA-4) and combretastatin A-4-phosphate (CA-4P), the more soluble 
phosphate salt prodrug of CA-4, have been found to show in vitro antiangiogenic effects 
(Kanthou et al., 2002; Kanthou et al. 2004). It has been shown that CA-4 and CA-4P induce 
apoptosis in human umbilicalial vein endothelial cells (HUVEC), impair HUVEC migration, and 
disrupt the endothelial cytoskeleton (Grosios et al., 1999; Iyer et al., 1998). Recent work shows 
that CA-4 can have dramatic effects on the three-dimensional shape and microtubule stability of 
newly formed endothelial cells, but less effects on quiescent cells (Dark et al., 1997; Galbraight 
et al., 2001; Kanthou et al., 2002). It is believed that newly formed endothelial cells are more 
sensitive than mature endothelial cells since the latter have a more highly developed actin 
cytoskeleton, which maintains cell shape despite depolymerization of the tubulin cytoskeleton 
(Chaplin & Dougherty, 1999). 
A number of studies of the in vivo anti-vascular effects of CA-4 have been performed using 
rodent tumor models. Several studies in mice have shown that a single administration of 
combretastatin A4 (100 mg/kg) does not significantly affect the growth of the primary tumor 
(Grosios et al., 1999; Chaplin et al., 1999). Repeated administration of CA-4 at 12.5-25.0 mg/kg 
twice daily for periods of 10-20 days retarded the growth of Lewis lung carcinoma and T138 
murine breast tumors about 50 %. In these tumors CA-4 induced haemorrhagic necrosis, 
consistent with the antivascular mode of action (Griggs et al., 2001). The antivascular effects of 
CA-4 seem to be rapid, since Dark et al. (1997) could measure a large reduction in red-blood-cell 
velocity of rat P22 carcinosarcoma in 10 minutes after treatment. CA-4P has also been shown to 
possess potent anti-metastatic activity in the Lewis lung carcinoma model and induced necrosis 
in metastases from an adenocarcinoma primary tumor (Grosios et al., 1999). The antivascular 
effects of CA-4P seem to be mediated through endothelial cell damage, but the acute vascular 
damaging effects seen both in rodents and humans suggest a mechanism distinct from apoptosis 
(El Zayat et al., 1993; Iyer et al., 1998; Griggs et al., 2001). Analysis with the aid of magnetic 
resonance imaging show that the antivascular effects of CA-4 are restricted to the core of the 
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primary tumor, leaving a small rim of viable cells remain at the periphery of the tumor, which can 
subsequently grow after withdrawal of drug (Beauregard et al., 1998). 
The combretastatin A-4 prodrug, combretastatin A-4 disodium phosphate, began phase I clinical 
trials in October 1998 at the Ireland Cancer Center, as one of the most promising new 
antiangiogenic drugs (Pettit et al., 1999; Griggs et al., 2001). The clinical effects of 
combretastatin A-4-phosphate administered together with carboplatin in patients with advanced 
cancer have been investigated, and it seemed that the disease of some of the patients was kept 
stable during the treatment. However, this study showed that dose limiting thrombocytopenia 
occurs when CA-4P and carboplatin are administered together (Bilenker et al., 2005). 
 
Combretum nigricans 
Combretum nigricans Lepr. is a small tree widespread on the Sahelian savanna. It is used for the 
treatment of cataract, conjunctivitis, icterus and rheumatism, as well as for gastrointestinal 
disorders (Boullard, 2001; Kerharo, 1974). In a systematic search for cytotoxic compounds in 
Burkinabe plants, West Africa, Simon et al. (2003a) discovered that methanolic extracts of the 
leaves of C. nigricans gave cytotoxic effects against the glioblastoma (U-373), colon (HCT-15), 
non-small lung (A549) and bladder (J82) cancer cell lines (Table 4). They found that pentacyclic 
triterpenes, in part, were responsible for this activity, although the activity of these compounds 
was not very high. The pentacyclic triterpenoids arjungenin, arjunglucoside and combregenin, as 
well as the saponin combreglucoside have been isolated from this species as well (Jossang et al., 
1995), but the cytotoxic activities of these particular compounds have not been investigated. 
Betulinic acid, a pentacyclic triterpenoid isolated from Betula species, has been found to 
selectively inhibit the growth of human melanoma tumors in nude mouse xenograft models and 
was shown to cause cytotoxicity by inducing apoptosis (Pisha et al., 1995). Various cycloartane-
type triterpenoid glycosides from Astragalus species have been found to possess antileukemic 
effects (Calis & Sticher, 1996). It is possible that some of the triterpenoid compounds in 
Combretum nigricans might have good cytotoxic potential and that some of the triterpenoid 
compounds found from this species of Combretum would be able to induce apoptosis in certain 
cancer cell lines. 
 
Combretum erythrophyllum 
Schwikkard et al. (2000) found that methanol extracts of the stem wood of C. erythrophyllum 
(Burch.) Sond induced DNA damage in a yeast based assay. Bio-assay guided fractionation 
yielded combretastatin A-1 and (-) - combretastatin, as well as two new bioactive glucosides, 
combretastatin A-1,2´-β-D-glucoside and combretastatin B-1,2`-β-D-glucoside. Combretastatin 
A-1,2´-β-D-glucoside inhibited the growth of HeLa cervical and A549 lung carcinoma cells with 
IC50 values of 1.5 and 7.0 µg/ml respectively. For comparison the IC50 values of AC-7739, a 
synthetic combretastatin analogue in clinical development, were 0.001 and 0.004 µg/ml 
respectively, in these cell lines. All the isolated combretastatins were investigated for inhibitory 
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activity of topoisomerase I and where found inactive against this enzyme. The flavones apigenin, 
genkwanin, 5-hydroxy-7,4`-dimethoxyflavone and the flavonols kaempferol, rhamnocitrin, 
rhamnazin and quercetin-5,3-dimethylether have been isolated from the leaves of C. 
erythrophyllum (Martini, 2001; Martini et al., 2004), but the cytotoxic potentials of these 
compounds were not investigated. Many flavonoid compounds (e.g. luteolin, cryptocaryone) are 
known to possess cytotoxic effects (Middleton et al., 2000; Blank et al., 2004; Dumontet et al., 
2001; Ko et al., 2002; Dumontet et al., 2001). 
 
Combretum apiculatum, C. mossambicense and C. hereroense 
In a survey of the biological effects of several African species of Combretum, McGaw et al. 
(2001) found that Combretum apiculatum Sond., C. mossambicense Klotzsch and C. hereroense 
Schinz. gave positive results in an assay measuring DNA damaging activity (Table 4). This 
suggests that these species have potential anti-cancer activity. No further investigations have 
however been performed on the in vitro cytotoxic effects of these species. Triterpenoids (Carr & 
Rogers, 1987), as well as dihydrostilbenes and phenanthrenes (Malan & Swinny, 1993) have 
been isolated from the leaves of C. apiculatum, and thus some of these compounds may be 
responsible for the DNA damaging effect of this species. 
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Table 4. Cytotoxic and antitumor effects as well as uses in traditional medicine of some Combretum species reported in the literature. 
 
Species Cytotoxic effects of 
extract 
Compounds  Screening method Uses in traditional medicine 
C. apiculatum Sond. MeOH, acetone and ethyl 
acetate extracts of leaves 
DNA damaging in a BIA 
assay (McGaw et al., 2001)  
Leaves contain triterpenoids* Carr & 
Rogers (1987); substituted 
dihydrostilbenes and phenanthrenes in 
heartwood * (Malan & Swinny, 1993) 
Biochemical Induction 
Assay (BIA) based on 
production of β-
galactosidase by E. coli in 
response to DNA damage 
(McGaw et al., 2001) 
Stomach problems, scorpion 
stings, disinfect the navel after 
birth (Kokwaro, 1976; Von 
Koenen, 1996; Van Wyk & Van 
Wyk, 1997).  
C. caffrum Eckl. & 
Zeyh. 
MeOH:CH2Cl2 (1:1) extracts 
of stem wood and bark, twigs, 
fruits, leaves as well as 
chloroform and methylene 
chloride fractions of crude 
extract active against murine 
P-388 lymphocytic leukemia 
in vitro and in vivo as well as 
showing astrocyte reversal of 
51-90 % (Pettit et al., 1987; 
Pettit et al., 1988).  
Combretastatins B1, B2, A-1, A-2, A-3 
inhibitory against murine P-388 
lymphocytic leukemia and L1210 
leukemial cells causing cells to 
accumulate in mitosis (IC50 0.011 
μg/ml to 0.6 μg/ml) (Pettit et al., 
1987); CA-1, CA-2 and CA-3 inhibit 
tubulin polymerization and 
microtubule assembly with same IC50 
values (4 μg/ml) as podophyllotaxin 
(Pettit et al., 1988). 
 
Combretastatin A-4 powerful inhibitor 
of microtubule assembly, IC50 2-3 μM 
( (Pettit et al., 1989); CA-4 shows 
potent cytotoxicity against a wide 
variety of human cancer cell lines (El 
Zayat et al., 1993). 
 
CA-4 antivascular and anti-angiogenic 
in vitro, alters cell shape and 
microtubule stability and causes 
apoptosis in HUVEC cells (Kanthou & 
Tozer, 2002; Kanthou et al., 2004; 
Grosios et al., 1999); CA 4 gave in 
vivo antivascular effects in rodent 
tumor models (Grosios et al., 1999; 
Chaplin et al., 1999; Griggs et al., 
2001; Dark et al., 1997). 
 
Phase I clinical trials of CA-4P began 
in 1998 at Ireland Cancer Center 
(Stratford et al., 2000).  
Astrocyte glioma cell 
reversal, murine P-388 cell 
growth and viability, in vivo 
effects using rodent tumor 
model (Pettit et al., 1987 and 
1988). 
 
Tests for inhibitory capacity 
of tubulin polymerization 
and microtubule assembly 
(Pettit et al., 1987, 1988).  
 
HUVEC network formation 
assay, HUVEC migration 
assay, tubulin staining. 
Assessment of tumour 
growth by measuring tumor 
volume, haematoxylin and 
eosin staining, Hoechst 
33342 staining (Grosios et 
al., 1999). 
 
Trypan blue exclusion cell 
viability assay, microtubule 
staining, Western blotting for 
β-tubulin, endothelial 
permeability assay, HUVEC 
cells (Kanthou & Tozer, 
2002). 
 
  
Decoction of bark general tonic 
for improved well being and is 
reported to have anticancer 
effects; poison on Zulu spears, as 
a charm to harm the enemy 
(Pettit et al., 1987); decoctions 
of roots are used to treat body 
pain (Bath & Jacobs, 1995).  
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Table 4. Continued. 
 
C. erythrophyllum 
(Burch.) Sond. 
Methanol extracts of the wood 
induce DNA damage in yeast 
(Schwikkard et al., 2000) 
Combretastatin A-1, (-)-
combretastatin, combretastatin A-1,2'-
β-D-glucoside cytotoxic against HeLa 
cervical cancer and A549 lung 
carcinoma cells (IC50 1.5-7.0 μg/ml), 
combretastatin B-1,2'-β-D-glucoside, 
all compounds inactive against 
topoisomerase I (Schwikkard et al., 
2000); flavonoids* in leaf extracts 
(Martini & Eloff, 2004)  
Yeast bioassay 
(Saccharomyces cerevisiae) 
for DNA damaging agents 
using 96-well microtiter 
plates (Schwikkard et al., 
2000). 
Root and bark for cough and 
infertility, as aphrodisiacs, 
leaves not known to be used in 
traditional medicine (Arnold & 
Gulimian, 1984; Watt & Breyer-
Brandwijk). 
C. hereroense 
Schinz. 
MeOH, acetone and ethyl 
acetate extracts of leaves 
DNA damaging in a BIA 
assay (McGaw et al., 2001).  
Phenanthrenes in heartwood* (Letcher 
et al., 1972; flavonoids in leaf 
extracts* (Carr & Rogers, 1987) 
Biochemical Induction 
Assay (BIA) based on 
production of β-
galactosidase by E. coli in 
response to DNA damage 
(McGaw et al., 2001)  
Root decoctions for 
schistosomiasis (Kokwaro, 
1976); leaves for chest problems, 
root decoctions for leprosy 
(Bally, 1937); powdered young 
shoots for toncillitis 
(Samuelsson et al., 1991). 
C. mossambicense 
Klotzsch 
MeOH, acetone and ethyl 
acetate extracts of leaves 
DNA damaging in a BIA 
assay (McGaw et al., 2001).  
No reports Biochemical Induction 
Assay (BIA) based on 
production of β-
galactosidase by E. coli in 
response to DNA damage 
(McGaw et al., 2001) 
Decoctions of roots and leaves 
for ailments of jaw and hip 
bones, facial swelling from tooth 
abscess, eye inflammation, nasal 
furuncle, mouthwash, eye bath 
(Von Koenen, 1996) 
C. nigricans Lepr. MeOH extracts of leaves 
cytotoxic against glioblastoma 
(U-373), colon (HCT-15), non 
small lung (A549), bladder 
cancer (J82) cell lines (Simon 
et al., 2003a). 
Pentacyclic triterpenes in part 
responsible for the cytotoxicity (Simon 
et al., 2003a). 
96 well microwell plates, 
MTT assay (Simon et al., 
2003a). 
Cataract, conjunctivitis, icterus, 
rheumatism (Kerharo & Adam, 
1974 ; Boullard, 2001) ; 
expectorant, stomach problems 
(Kerharo & Adam, 1974). 
 
* cytotoxic effects not investigated 
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2.6.2. Cytotoxic and antimutagenic effects of some species of Terminalia 
according to the literature 
 
At least seven species of the genus Terminalia are used for treatment of cancer in traditional 
medicine (Hartwell, 1982). Studies on the cytotoxic and antimutagenic as well as anti-tumor 
effects, have mainly concentrated on Asian species of Terminalia (Pettit et al., 1996; Kandil & 
Nassar, 1997; Cheng et al., 2002; Kaur et al., 2002a), whereas African species of Terminalia have 
been investigated for their antimicrobial but not for their anti-cancer effects, although some of the 
African species of Terminalia, such as T. sambesiaca, are known to be used for treatment of 
cancer in traditional medicine (Chhabra et al., 1989). Asian Terminalia species have been found 
to possess antimutagenic (cancer preventive) as well as antitumor and cytotoxic effects (Table 5). 
The active compounds in these species have been found to be hydrolysable tannins, of which 
ellagitannins (Kandil & Nassar, 1997; Saleem et al., 2002) as well as their monomer, ellagic acid 
(Saleem et al., 2002) are especially well represented. Also gallic acid, ethyl gallate and the 
flavone luteolin, have been isolated from species of Terminalia, and all of them are reported to 
possess moderate anti-cancer effects (Pettit et al., 1996). 
 
Terminalia arjuna  
Terminalia arjuna (Roxb.) Wight & Arn. has been found to possess both antimutagenic (Kaur et 
al., 2000; Kaur et al., 2002a, Kaur et al., 2002b) as well as cancer cell growth inhibitory effects 
(Pettit et al., 1996; Kandil & Nassar, 1997) (Table 5). When the antimutagenic effects of a tannin 
rich fraction from this plant against the mutagen 4-nitro-o-phenylene-diamine (NDP) was 
compared to ellagic acid (also isolated from T. arjuna) using the Ames mutagenicity test, it was 
found that the tannin rich fraction was far more antimutagenically potent (Kaur et al., 2000). 
Thus, it seems that the antimutagenic potential of a hydrolysable tannin is related to its degree of 
polymerization, so that oligomeric forms are more active than monomeric (Kaur et al., 2002). 
Kaur et al. (2000) speculated that the hydrolysable tannins from T. arjuna might inactivate 
cytochrome P 448/P 450 dependent enzymes in rat liver microsome extract, used in the Ames test 
for investigating mutagenicity, and thus hinder these enzymes to activate chemical mutagens. 
This might be one of many possible anticancer, antitumor and anticarcinogenic mechanisms that 
hydrolysable tannins exert. Gallic acid, ethyl gallate and luteolin, isolated from the bark, stem 
and leaves of T. arjuna (Pettit et al., 1996) have been found to possess antiproliferative (Post & 
Varma, 1992; Chen et al., 1992) and anti-tumor effects (Ryu et al., 1994; Matsukawa et al., 
1993). The hydrolysable tannin, arjunin, isolated from the leaves of T. arjuna showed moderate 
cytotoxic effects against BT-20 human breast carcinoma (Kandil & Nassar, 1997). 
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Terminalia chebula 
Terminalia chebula Retz. (black myrobalan) is an important plant in both Indian as well as 
Korean and Chinese traditional medicine (Lee et al., 1995), where fruits of T. chebula are used 
for treatment of diarrhea, as an astringent, as an ingredient in Triphala, a mixture containing T. 
chebula, T. bellerica and Emblica officinalis, (Ram Chandra Reddy et al., 1990), as well as for 
their diuretic and cardiotonic properties (Singh, 1990) (Table 5). Gallic acid, chebulinic acid, 
chebulagic acid and 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose, isolated from a methanolic 
fruit extract of T. chebula were found to show moderate cytotoxic effects against melanoma and 
ovarian cancer cell lines (Lee et al., 1995). Saleem et al., (2002) found that a 70 % methanol 
extract of the fruits of T. chebula decreased cell viability, inhibited cell proliferation and induced 
cell death in a dose dependent manner against human breast carcinoma (MCF 7), mouse breast 
carcinoma (S155), human osteosarcoma (HOS-1) and a prostate cancer cell line (PC-3). 
Chebulinic acid, tannic acid and ellagic acid were the most cancer cell growth inhibitory 
phenolics isolated from the fruits of T. chebula (Saleem et al., 2002) (Table 5). Ellagic acid may 
arise from the hydrolysis of ellagitannins in the human gut and it has been found to be ten times 
more antioxidative than tannic acid (Puech et al., 1999). Thus, the good in vitro anticancer effects 
Saleem et al. (2002) observed for this compound might be due to its antioxidative properties. 
Ellagic acid has also been found to induce cell cycle arrest and apoptosis (Narayanan et al., 
1999), as well as inhibit tumor formation and growth in animals (Stoner & Morse, 1997; 
Khanduja et al., 1999). Triphala has been found to possess antimutagenic properties, and 
especially extracts made in acetone and chloroform were effective, whereas a water extract gave 
no activity (Kaur et al., 2002b). 
 
Terminalia catappa 
Terminalia catappa L. (Indian Almond) is a popular medicinal plant in Asia, and the leaves, 
trunk bark and fruits of this tree are used for treatment of dermatitis, hepatitis and fever as well as 
for its hemostatic effects in India, Philippines, Malaysia and Indonesia (Lin et al., 1997). Herbal 
tea of the leaves is used for treatment of liver cancer (hepatoma) and hepatitis in Taiwan (Lin, 
1992; Chen et al., 2000). The leaves of Terminalia catappa have been found to contain many 
hydrolysable tannins, such as terflavin A and B, tergallacin, tercatin, punicalin, punicalagin, 
chebulagic acid, geraniin, granatin B and corilagin (Tanaka et al., 1986). Both the crude extract 
of the leaves of T. catappa, as well as its major tannin component, punicalagin, possess 
antioxidative (Lin et al., 2001) and anti-genotoxic affects (Liu et al., 1996; Chen et al., 2000) 
(Table 5). A leaf extract was found to significantly suppress the production of micronuclei in 
mitomycin-C treated CHO cells (Liu et al., 1996) and the major tannin component of this extract, 
punicalagin, effectively inhibited bleomycin induced mutagenesis in CHO cells (Chen et al. 
2000). Mitomycin-C has been shown to damage DNA by generating reactive oxygen species 
(ROS) or by alkylating DNA to form adducts, and Chen et al. (2000) speculated that the water 
extract of T. catappa might exert its protective effect against DNA damage through inhibition of 
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ROS generation or reducing DNA adduct formation. Chen & Li (2005) studied the eventual 
mechanisms of action by which the extract of the leaves as well as punicalagin might act on 
cancer cells, and found that both the extract and punicalagin inhibited the proliferation and the 
anchorage-independent growth of H-ras-transformed NIH3T3 fibroblasts. The crude extract was 
found to be even more potent than punicalagin in inhibiting the proliferation of H-ras-
transformed NIH3T3 cells, and thus it is possible that there are other effective inhibitory 
compounds in the crude extract in addition to punicalagin. Punicalagin inhibited the superoxide 
anion generation in H-ras-transformed NIH3T3 cells, and this modulation of the intracellular 
redox status might subsequently cause a reduction of JNK-1 kinase activation, thereby 
contributing to the suppression of proliferation. It has been found that approximately 30 % of 
human tumors have mutations in their ras oncogene, and thus punicalagin could be a novel 
compound for preventing H-ras-associated tumors (Chen & Li, 2005). 
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Table 5. Cytotoxic, antitumor and antimutagenic effects as well as uses in traditional medicine of some Asian Terminalia species reported in the literature. 
 
Species Cytotoxic effects of extract Compounds  Screening method Uses in traditional medicine 
T. arjuna Roxb. 1-butanol, methylenechloride and 
water fractions of a MeOH extract 
of stem, leaves and bark were 
active against ovarian (OVCAR-
3), renal (A498), lung (NCI-
H460), colon (KM20L2) and 
melanoma (MEL-5) human 
cancer cell lines (Pettit et al., 
1996). 
 
Extract of leaves gave moderate 
activity against a BT-20 human 
breast carcinoma cell line (Kandil 
& Nassar, 1997). 
 
Acetone extract of bark 
antimutagenic against 4-nitro-o-
phenylenediamine (Kaur et al., 
2000); acetone and MeOH 
fractions of stembark extract 
antimutagenic (Kaur et al., 2002). 
Gallic acid, ethyl gallate and 
luteolin (Pettit et al., 1996). 
 
Tannin rich fraction more 
antimutagenic than a fraction 
containing ellagic acid: 
antimutagenic capacity related 
to degree of polymerization. 
Bark reported to be rich in 
polyphenols (60-70 %), 
including flavones, 
phenylpropanoids and tannins 
(20-24 %) (Kaur et al., 2002); 
Hydrolysable tannins might 
inactivate P 448/P 450 
dependent enzymes (Kaur et 
al., 2000).  
 
Arjunin, a tannin from leaves, 
active against BT-20 human 
breast carcinoma (Kandil & 
Nassar, 1997). 
Growth inhibition of cancer cell 
lines, method not reported in 
paper, IC50 values reported for 
pure compounds (Pettit et al., 
1996).  
 
Ames Salmonella / mammalian 
microsome mutagenicity test 
(Kaur et al., 2000; Kaur et al., 
2002). 
Treatment of dysentery and 
earache (Dwivedi & Udupa, 
1988); treatment of fractures, 
ulcers, blood diseases, anaemia, 
asthma, hepatic, congenital, 
venereal and viral diseases 
(Kumar & Prabhakar, 1987). 
T. catappa L.  Water extracts of leaves suppress 
mitomycin-C induced micronuclei 
formation in CHO-K1 cells (Liu 
et al., 1996).  
 
Crude extracts of the leaves 
antioxidative (Lin et al., 2001) 
and water extracts active against 
bleomycin induced genotoxicity 
in CHO-K1 cells (Chen et al., 
2000). 
 
Water extract of leaves inhibits 
selectively the proliferation of H-
ras transformed NIH3T3 mouse 
fibroblasts, but to a lesser extent 
non-transformed cells (Chen & 
Li, 2005). 
Punicalagin, a hydrolysable 
tannin, inhibits bleomycin 
induced genotoxicity in CHO-
K1 cells (Chen et al., 2000).  
 
Punicalagin inhibits selectively 
the proliferation of H-ras 
transformed NIH3T3 mouse 
fibroblasts possibly partly 
through inhibition of 
superoxide anion formation 
which might decrease levels of 
phosphorylated JNK-1 and p38 
leading to decreased cell 
proliferation (Chen & Li, 2005) 
Micronucleus assay in vitro 
using CHO cells and mitomycin 
C as an inducer of mutagenesis 
(Liu et al., 1996). 
 
Antimutagenicity assay using 
Chinese hamster ovarian cells 
(CHO-K1) treated with the 
mutagen bleomycin (Chen et al., 
2000). 
 
MTT assay for cell proliferation 
using 96 well microplates (Chen 
& Li, 2005). 
 
Cell cycle analysis using flow 
cytometer (Chen & Li, 2005). 
 
Western blot (Chen & Li, 2005). 
The leaves, trunk bark and fruits 
are used for antidiarrheic, 
antipyretic and hemostatic 
purposes in Indian and Malesian 
traditional medicine (Lin, 1992); 
in Taiwan leaves are used as a 
herbal tea for hepatoma and 
hepatitis (Liu et al., 1996; Chen 
et al., 2000).  
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Table 5. Continued. 
 
T. chebula Retz. 70 % MeOH extracts of the fruits 
decreased cell viability, inhibited 
cell proliferation and induced cell 
death in a dose dependent manner 
against human breast carcinoma 
(MCF 7), mouse breast carcinoma 
(S155), human osteosarcoma 
(HOS-1) and a prostate cancer 
cell line (PC-3) (Saleem et al., 
2002). 
 
In a mixture together with T. 
bellerica and Emblica officinalis, 
acetone and chloroform extracts 
showed inhibition of 
mutagenicity, whereas a water 
extract was found to be inactive 
(Kaur et al, 2002). 
Chebulinic acid, tannic acid 
and ellagic acid the most 
growth inhibitory phenolics 
(Saleem et al., 2002). 
Coulter count, [3H] thymidine 
incorporation, ATP levels in 
cells, Hoechst DNA staining, 
flow cytometry (Saleem et al., 
2002). 
 
Salmonella histidine point 
mutation assay (Kaur et al., 
2002). 
Syn. black Myroblans, Harad 
(Hindi). Homeostatic, 
antitussive, laxative, diuretic, 
cardiotonic, infectious diseases 
(Barthakur & Arnold, 1991; 
Singh, 1990); for human gastritis 
and peptic ulcers in Iranian 
traditional medicine 
(Malekzadeh et al., 2001); for 
prevention and treatment of 
caries (Chopra & Handa, 1958). 
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3. AIMS OF THE STUDY 
 
The aims of this study have been to A) investigate the traditional medicinal uses of some selected 
species of the genera Terminalia, Combretum and Pteleopsis in some villages in Tanzania and B) 
to evaluate the biological activities of extracts of these plant species as well as C) to isolate the 
antimicrobially active fractions from the most promising species. The plant species were selected 
according to their uses in African (literature studies), especially Tanzanian traditional medicine 
(our own interviews with traditional healers) and on the basis of their taxonomic relations, all 
belonging to Combretaceae, as well as on the basis of a literature search on previous studies of 
the biological effects of related species. 
 
The goals of this study have been achieved by the following investigations: 
 
1) This work was initiated with a five weeks ethnobotanical expedition to Tanzania in spring 
1999 during which a study on the traditional medicinal uses of selected species of Combretum, 
Terminalia and Pteleopsis collected in different field locations in the Iringa and Mbeya regions of 
Tanzania was conducted. The other important goal of this expedition was to collect plant material 
of Combretaceae for later investigations on the biological activities of these plants (I). 
 
2) A suitable method (agar diffusion) was established for investigation of the antimicrobial 
effects of crude plant extracts (I, II). 
 
3) A study on the antibacterial effects of twenty-one extracts of six species of Combretum and 
five of Terminalia was conducted. In this study the effects of the crude extracts of different parts 
of the plants were investigated against two gram-negative and five gram-positive bacteria, most 
of them common human pathogens. The antibacterial effects were compared with our results on 
the traditional medicinal uses of the plant species (I). 
 
4) The antifungal effects of thirty-five crude extracts of five species of Terminalia, ten of 
Combretum and Pteleopsis myrtifolia were investigated on five pathogenous species of yeast, 
Candida spp. and the basidiomycet Cryptococcus neoformans, all causing serious systemic 
fungal infections in immunocompromised individuals. The results were again compared to the 
ethnopharmacological uses of the species. Antifungally active fractions of Terminalia 
sambesiaca, the most antifungal species in our screening, were isolated with RP18 column 
chromatography and thin layer chromatography (TLC) (II). 
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5) Twenty-seven extracts of eight species of Combretum, five species of Terminalia and 
Pteleopsis myrtifolia have been investigated for their in vitro antiproliferative and cytotoxic 
effects on three human cancer cell lines (HeLa cervical carcinoma, T 24 bladder carcinoma, 
MCF7 breast carcinoma) and an endothelial cell line (BBCE, bovine brain capillary cell line) 
(III). 
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4. EXPERIMENTAL 
 
4.1. Selection of study area, plant material and bioactivity assays 
 
Tanzania was chosen as the area of study for this investigation since the flora is rich with an 
estimated number of 10.000 known plant species (http://www.earthtrends.wri.org), and the 
country has a long tradition of using medicinal plants as nearly 80 % of the population relies on 
traditional medicine for their primary health care (Hedberg et al., 1982). Since most of the 
existing information on the medicinal uses of the plants is oral, it is important to document it 
before it is forgotten. Young people move to the cities, and the practice of using plants for health 
care is diminishing. Although, still a quite large part of the population in the Tanzanian cities use 
traditional medicine for their primary health care, and medicinal plants can be seen on the 
marketplaces, for example in Dar-es-Salaam. The Mbeya region, which is situated in the southern 
parts of Tanzania was chosen, since this region is the home area of Mr. Leonard Mwasumbi (M. 
Sc., former super-intendent of the Botanical Museum, University of Dar-es-Salaam). Mr. 
Mwasumbi was also acting as the interpreter during the interviews with local traditional healers. 
The Mbeya region was also chosen since it seems to be relatively poorly known at least when it 
comes to traditional medicine, although some studies have been performed on religious and 
magical rites, some of them associated to traditional medicine of the Nyakyusa (Wilson, 1954; 
Swantz, 1966). Luoga et al. (2000) points out that the uses and ethnobotanical aspects of plants in 
Tanzania have not been documented adequately. There are still regions in Tanzania which are 
relatively unexplored for their medicinal plants. 
 
In this study we have used both the ethnobotanical and the chemotaxonomical approach when 
selecting some species of Combretum, Terminalia and Pteleopsis myrtifolia (Combretaceae) for 
screening their antibacterial, antifungal and cytotoxic effects. This particular plant family and 
genera were chosen since Pettit et al. (1987) had isolated some powerful anti-tubulin stilbenes, 
the combretastatins, from the stem bark of Combretum caffrum and also since some species of 
Terminalia and Combretum were known to possess antibacterial and antifungal properties. It 
seemed thus worthwhile to study some other species of Combretum and Terminalia, some of 
which have not yet been investigated for their biological effects, since it is likely that closely 
related plants contain chemically similar compounds. Another criterion for choosing this 
particular group of plants was the frequent and successful use of Combretum and Terminalia 
species in African traditional medicine according to several authors (Watt & Breyer-Brandwijk, 
1962; Haerdi, 1964; Bouquet & Debray, 1974; Kokwaro, 1976; Hedberg, 1982; Chhabra, 1989; 
Neuwinger, 2000). According to Farnsworth & Soejarto (1991), the possibility of finding plants 
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containing active compounds gets higher if the plants are chosen on the basis of their 
ethnopharmacological uses. 
 
Bacterial infections are an important and increasing cause of mortality in Africa due to the AIDS 
epidemic (Iwu et al., 1999). The misuse and increasing use of antibiotics has also led to bacteria 
becoming more resistant to antimicrobial treatments. Because of these reasons we decided to 
study the antibacterial effects of the species of Combretum, Terminalia and Pteleopsis collected 
from Tanzania, some of them frequently used for the treatment of infectious diseases in 
Tanzanian traditional medicine. In this study we used some common pathogenous gram-positive 
and gram-negative bacteria. There is a constant need for new antibacterial molecules, and species 
of Pteleopsis, Terminalia and Combretum might be good sources for antibacterial compounds. 
 
We studied the antifungal effects of some extracts and fractions of the selected species of plants 
against some of the most common species of Candida and Cryptococcus neoformans, causing 
serious infections in man. Some of the species of Terminalia and Combretum included in our 
study are used for the topical treatment of infections as well as diarrhea in Tanzanian traditional 
medicine, thus we assumed that these plants would give good antifungal effects. Fungal 
infections are often resistant and difficult to cure and there are only three classes of antifungal 
drugs available up to date. Because of the increasing number of immunocompromised patients, 
partly due to AIDS, the numbers of serious systemic fungal infections are increasing. Some of the 
species of Candida which cause serious systemic infections have developed resistance against the 
conventionally used drugs, so new molecules with new modes of action would be needed. 
 
We investigated the antiproliferative effects of crude extracts of fourteen species of Combretum, 
Terminalia and Pteleopsis on cancer cell lines representing some common cancer forms with 
focus on some cancers common in Africa. Of the fourteen species we used in this investigation 
only Combretum zeyheri and Terminalia sambesiaca are used as anti-cancer remedies in 
Tanzania. 
In this study a cervical (HeLa) and a breast cancer cell line (MCF 7) were included because they 
represent two common forms of cancer in women. Breast cancer accounts for approximately 30 
% of all cancer diagnosed in women in the United States (Hilakivi-Clarke et al., 2004) and is the 
second leading cause of cancer death in women (Zafonte et al., 2000). In Western countries 
cervical cancer represents nearly 10 % of all cancers in women, and organized screening has 
contributed to a decline of this cancer form in the past 50 years. Recent trends show a resurgence 
of the disease in developed countries (Franco et al., 2001). Cervical cancer remains globally an 
important cause of female mortality (Critchlow & Kiviat, 2000). In Africa there seems to be an 
exceptionally high mortality among women with cervical cancer (Ferlay et al., 1998) and cervical 
cancer is the most common form of cancer in women in Sub-Saharan Africa (IDe Vuyst et al., 
2003; http://www.nccc.online.org/malawi_project.php). Human papilloma virus (HPV) infections 
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have been found to be the main cause of cervical cancer (Lorincz et al., 1992; Muñoz et al., 1992; 
Schiffman et al., 1993) and in some populations in Sub-Saharan Africa the prevalence of HPV is 
high, 40 % of the women being HPV positive in some rural villages in Mozambique 
(Castellsague et al., 2001). HIV/AIDS is a serious problem on the African continent and is the 
cause of a multitude of diseases. A clear and significant relationship has been showed between 
HIV-infection, and the development of cervical intraperitoneal squamous lesions (SIL) (Leray et 
al., 1999). 
The T-24 bladder cancer cell line was included in this study since bladder cancer is one of the 
most commonly occurring cancers in most African countries, and at least in Egypt it constitutes 
30.3 % of all cancers (el-Mawla et al., 2001). In Africa bladder cancer arises in a background of 
schistosomiasis/bilharzias (Cooper et al., 1997; el-Mawla et al., 2001). The median age of 
diagnosis is rather young, being 46 years with a male preponderance (el-Mawla et al., 2001). 
The de novo formation of blood vessels (angiogenesis), composed of endothelial cells, is crucial 
for both tumorigenesis and metastasis, the vessels supplying the tumor with oxygen and nutrients. 
Thus we also investigated whether some of the extracts of Combretum and Terminalia might 
have the ability to cause antiproliferative effects on BBCE endothelial cells. Since 
combretastatins with antiangiogenic and antivascular effects have been isolated from Combretum 
caffrum, we speculated that related compounds might be found in the species of Combretum we 
included in this study. 
 
4.2. Ethnobotanical and -pharmacological survey in Tanzania 
4.2.1. Description of the study area 
 
The ethnobotanical and -pharmacological excursion was carried out in the Mbeya and Iringa 
regions of southern Tanzania. Iringa, the main city of the Iringa region, is situated 502 km from 
Dar-es-Salaam on the main Tanzania-Zambia road beyond the Mikumi National Park. Mbeya city 
is further west from Iringa and is situated 875 km from Dar-es-Salaam and only 114 km from the 
Zambian border. Both regions are located in the so called Southern highlands in the southern part 
of Tanzania. The Southern highlands of Tanzania form the largest blocks of highlands within 
East Africa. They mostly have a high rainfall and because of their high altitude they are cool. 
Temperatures average 22 °C (max) and 10 °C (min), and from May to July frosts are common on 
higher ground with temperatures dropping to - 7 °C on Kitulo Plateu (in Mbeya region). Like the 
rest of Southern Tanzania this region has, unlike to the northern parts of the country, one long 
wet season (October-May) and one long dry season (June-November). The southern highlands 
receive all its rainfall via convectional uplift from Lake Nyasa (syn. Lake Malawi) 
(http://www.southernhighlandstz.org/southernhighlands.html). As with most highland areas in 
Africa the southern highlands of Tanzania are associated with the Rift Valley System, and there 
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has been much volcanic activity in the area over the years. Due to rich soils and high rainfall this 
area is agriculturally productive in both food and crops and some coffee and tea which are the 
major cash crops of the area (Hodd, 1998). On the other hand there are also areas with very 
unfertile soil, and these are often covered by Miombo woodland vegetation. 
 
The Southern highlands comprise mountain ranges and volcanoes capped by forest-grassland 
mosaic. The two highest peaks in southern Tanzania are included in the area: Mtorwi (2961 m) 
and Mt Rungwe (2960 m). Despite initial surveys revealing significant biodiversity this area has 
received very little conservation attention. Over 120 plant and animal taxa are endemic for the 
area and some 2 000 species of vascular plants occur, approaching a quarter of the total flora of 
East Africa. The main vegetation types of the area are: 1) woodland (Miombo woodland), 2) 
bushland, 3) wooded grassland, 4) bushland-grassland, 5) grassland , 6) afromontane forest, 7) 
afroalpine grassland (Strömqvist and Johansson, 1976). The forest-grassland mosaics of the 
Southern highlands form the WWF- designated ecoregion AT 1015, with its conservation status 
described as critical/endangered (http://www.southernhighlandstz.org/southernhighlands.html). 
As in the other parts of Tanzania the area of forests are declining due to the high demand for fuel 
wood. The forests of Tanzania are declining at 1.2 % a year, which is higher than the African 
average of 1 %. 
 
4.2.1.1. Brief description of Miombo and Combretum woodlands 
 
Most of the species of Combretum, Terminalia and Pteleopsis used in this study were found from 
Miombo and Combretum woodlands, and thus a brief description of these habitats is needed here.  
Miombo woodlands occur in the sub humid tropical vegetation zone and represent a biotope in 
the spectrum of different savannas. In Africa the Miombo forest covers an area of 2.7 million km2 
and extends over seven different countries: Angola, Democratic Republic of Congo, Malawi, 
Mozambique, Tanzania, Zambia and Zimbabwe. Miombo woodland in general occurs on old and 
nutrient poor soil. The canopy in the Miombo woodland is dominated by genera of leguminous 
plants, such as Brachystegia, Julbernardia and Isoberlinia (Caesalpiniaceae) (Haanpää, 1998), 
which vary in number of species in different areas (Chidumayo, 1994). Also Combretum and 
Terminalia as well as Pteleopsis species can be present in this kind of vegetation, but often to a 
lesser extent than the dominating leguminous trees. The composition of tree species is believed to 
depend on soil moisture, soil nutrients and on the frequency of fire. The dominance of the three 
leguminous tree genera might be related to their roots having ectomycorrhizae, facilitating the 
uptake of nutrients (Chidumayo, 1994). The species diversity is relatively high probably due to 
variation of nutrient retention and this diversity is important to maintain ecological stability and 
nutrient cycling (Chidumayo, 1994). The field layer is composed of grasses (Digitaria sp., 
Sporobolus sp., Pennisetum sp.) and to a lesser extent of herbs. 
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In some cases Miombo woodlands can be dominated by Combretum spp., and are then called 
Combretum woodland (Högberg, 1982). The soil in Combretum woodland is often shallow and 
therefore limit the growth of often more deep rooted Brachystegia and Julbernardia species 
(Savory, 1963). On deeper soil these woodlands can be composed of large Combretaceous trees, 
occasionally together with Pterocarpus spp. (Caesalpiniaceae) and then form almost closed 
canopies. In these forests very few shrubs are present, and the ground is covered by grasses 
(Strömquist and Johansson, 1976). 
 
4.2.2. Methods for the fieldwork 
4.2.2.1. Ethnobotanical fieldwork (I) 
 
Seven different villages in the Mbeya region (Figure 7) were visited for the 
ethnopharmacological survey. These villages were Isalavani (Saadani division), Mayale, Itaka, 
Mlowo (Mbozi district), Ikumbilo (Ileje district) and Itumba (Chunya district). Seven traditional 
healers, one woman and six men, most of them belonging to the Nyakyusa and the others to the 
Bena, Mhehe and Mnyika ethnic groups, were interviewed on their traditional medicinal uses of 
species of Combretum, Terminalia and Pteleopsis. The structured interviews were performed 
with the aid of a questionnaire which consisted of general and more specific questions (Figure 8). 
Species of Combretum, Terminalia and Pteleopsis collected in the field were shown to the 
healers, and they were asked about their species preferences and uses of these plants. The 
interviews were usually started with general questions about the village after which more specific 
questions were asked about the medicinal plants shown to the healers. The questionnaire made it 
possible to get as comparable results as possible between the different villages. 
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Figure 7. Map of Tanzania (http://www.maparchive.org). Plant collections were carried out in the 
Mbeya and Iringa regions, as well as in the vicinity of Dar-es-Salaam. The interviews on the 
medicinal uses of the plants were performed in Mbeya region. The study area is indicated on the 
map. 
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Figure 8. Questionnaire used during field work in Tanzania in spring 1999. 
Village and date: 
Informant (Name, Age, Sex, Education, Ethnic group, Origin, Occupation): 
A) General questions about village:  
1. When was your village founded? 
2. Could you tell me something about the history of the village? 
3. Has it been isolated for a long time? 
4. How many inhabitants do you have in your village? 
5. How many women, men and children do you have? 
6. How does the age-structure look like?  
7. Is there some migration to or from the village? 
8. How do people earn their living? 
9. What kinds of plants do you cultivate? For domestic use or sale? 
10. What kind of agricultural practice is the most usual? 
11. Do you cultivate some medicinal plants? 
12. Which are the most important cash crops? 
13. Are some crops exported to cities nearby or far away? 
14. Which are your main planted trees? For what purposes? 
15. Do you sell timber? 
16. From where do you collect firewood? 
17. What kinds of domestic animals do you keep? 
18. Could you tell me about the different kinds of work men and women do? Do women have the right for the 
ownership of land? 
 
B) General questions about use of medicinal plants/Western medicines: 
1. Do you prefer plant medicines or Western medicines (pills and capsules?) 
2. How easily accessible are Western medicines? 
3. Do you have a health station nearby, or do people rely on traditional medicine?  
4. If you prefer plant medicines, why? 
5. Do people in general prefer Western/plant medicines in your village? 
6. From where do you collect the medicinal plants? Own garden/outside the village? 
7. How do you collect medicinal plants? 
8. Do you collect many species at the same time? How are the plants transported to the village? 
9. Do you sell your remedies on the local marketplace? Do you then inform your customers how they should use the 
medicine? 
10. Which are your favorite medicinal plants? How do you use them?  
11. Do you store some medicinal plants (dried, milled?) 
 92
C) Specific question about specimens of Combretum, Terminalia or Pteleopsis shown to the traditional healer: 
Specimen number: 
1. Does this plant have any use/uses 
2. Is it used as a medicinal plant? 
3. Is it easy/difficult to find in nature? 
4. Is it possible to confuse the medicinal plant with some other species with similar morphology? 
5. How do you recognize this plant? 
6. Is it widely known and used as a medicinal plant in your village? 
7. Against what kinds of diseases/symptoms is this species used? 
8. What parts of the plant are used? 
9. How do you collect the plant?  
10. Is there some special time of the day/season the plant should be collected? 
11. Does the plant have to be in a particular state of its life when used as a medicine? (In bloom, bearing fruit) 
12. Is a young tree better than an old or vice versa? 
13. Is the medicinal plant used as such, or is it prepared in some way? 
14. How is it prepared? 
a) water extract 
b) infusion 
c) decoction 
d) mixed with food 
e) in some other way 
15. Is the drug used orally or externally? 
16. In what kind of dosages is the drug used? 
17. Are there any myths, beliefs or rituals connected with the use of the plant as medicine?  
18. Is the plant selled at the market-place? What parts of the plant are then for sale? 
19. Who in the village has the authority to collect the plant? Is it for example collected only by traditional healers or 
do women/men/children of the village collect it? 
20. Does the use of this plant as a medicine have a long tradition? 
21. Has the use of this plant as a medicine decreased/increased if you compare to old times? 
22. Is some part of the plant suitable as food? If it is, how is it prepared? 
23. Are some parts of the plant known to be poisonous? 
24. Is it possible to witness how you prepare this plant into medicine? 
25. Does the plant have any economical value? 
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4.2.2.2. Botanical fieldwork (I) 
 
The field work was carried out in the Mbeya and Iringa regions, as well as in the vicinity of Dar-
es-Salaam. The plants were collected in the beginning of the rainy season (Dar-es-Salaam area) 
or in the middle of the rainy season (Mbeya region) (February-March) when most of the species 
of Terminalia and Combretum were in the fruiting stage in order to make the species 
identification more easy. During the expedition seventeen species, ten of Combretum, six of 
Terminalia and one species of Pteleopsis, P. myrtifolia, were collected (Table 6). Fresh plant 
material was collected in large sacks for grains and the specimen number was written, using a 
running number system. All different plant parts which were available were collected, such as 
roots, stem bark, leaves, fruits and in some cases even flowers. Because most of the species were 
abundant roots were also collected, and care was taken in the handling of the plants so that they 
were not destroyed. Voucher samples were collected for each specimen to deposit both in the 
Botanical Museum (H) of the Finnish Museum of Natural History, University of Helsinki and at 
the Herbarium of the University of Dar-es-Salaam, Tanzania. For each specimen the geographical 
location of growth, soil type, type of vegetation and associated plant species was noted (Table 6). 
Also, important characters of the plants were noted, such as height, growth habit (tree, shrub, 
climber), scent of flowers, characteristics of the bark, color of fruits etc. Pictures were taken with 
200 ASA film of all the collected specimens. The voucher specimens were put in a plant press for 
tropical conditions with a large number of grey, absorbing papers between the plants. The rest of 
the plant material, to be used for assays on the biological activities, was dried as quickly as 
possible in the shade, after which the dried plant material was packed in small paper bags. 60 kg 
dried plant material with a phytosanitary certificate was transported to Finland through airline 
cargo transport. The plant material was then grained and stored dry and dark at room temperature 
until use. This dried material has been used for antimicrobial and cytotoxicity assays performed 
at both the Division of Pharmaceutical Biology, Faculty of Pharmacy, University of Helsinki and 
at the Institute for Preventive Nutrition, Medicine and Cancer, Folkhälsan Research center during 
the years 1999- 2006. 
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Figure 9. Fieldwork in Tanzania. Collections of Terminalia kaiserana in a Miombo forest. Photo: Pia 
Fyhrquist. 
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Table 6. Combretum-, Terminalia and Pteleopsis-species (Combretaceae) collected by the author and Mr. L. Mwasumbi for this thesis work in 
Tanzania in February –March 1999. 
 
Genus and Species Voucher 
specimen 
number  
Place of collection Vegetation type Associated species 
 
Combretum spp.     
C. apiculatum Sond.  
 
1697025 
 
 
 
 
1697026 
 
 
 
 
112513  
Njelenje B, Mapogolo new 
settlement 
 
 
 
Njelenje B, Mapogolo new 
settlement 
 
 
 
Njelenje B, Mapogolo new 
settlement  
Miombo woodland 
 
 
 
 
Miombo woodland 
 
 
 
 
Miombo woodland  
Pseudolachnostylis sp., 
Margaritaria sp., Parinari, 
sp., Annona senegalensis, 
Terminalia kaiserana 
 
Pseudolachnostylis sp., 
Margaritaria sp., Parinari, 
sp., Annona senegalensis, 
Terminalia kaiserana 
 
Combretum spp., 
Terminalia spp., Parinari 
sp. 
C. collinum Fresen.  
 
112481  
 
 
 
 
1697031 
1697033 
Igomaa village, Mufindi 
district 
 
 
 
Igoma village, near Madibira, 
Mafinga district 
Miombo woodland 
 
 
 
 
Miombo woodland  
Terminalia sp., Cussonia 
sp., Swartzia sp., 
Commiphora sp., 
Pterocarpus sp., 
Brachystegia sp.  
 
Bachystegia sp., 
Julbernardia sp., 
Terminalia sp. 
C. constrictum Laws.  
 
112476  Ruvu flood plain, 80 km from 
Dar-es-Salaam 
Road embankment, ruderal 
vegetation, flooded during wet 
season 
Commicarpus sp., Solanum 
incanum, Panicum 
maximum, Pluchea 
discoides 
C. fragrans F. Hoffm. 
 
112532  
 
 
 
 
 
112501  
Mtipule village, near the 
roadside to Mkata ranch 
 
 
 
 
Manyala village, Ileje district 
Brachystegia woodland 
 
 
 
 
 
Former farmland, meadow 
regenerating to secondary 
vegetation 
Maerua crassifolia, 
Commelina africana, 
Acacia robusta, Albizia sp., 
Acacia sp., Sclerocarya 
birrea 
 
Piliostigma thonningii, 
Lonchocarpus capassa, 
Cassia singueana, Cassia 
auriculata, Thespesia 
daenis, Acacia nilotica  
 96
Table 6. Continued. 
 
C. hereroense Schinz.  
 
112531  Mtipule village, near the road 
side to Mkata ranch 
Combretum-Acacia woodland Acacia nilotica, Albizia sp., 
Lonchocarpus capassa, 
Pseudolachnostylis 
maprouneifolia 
C. molle G. Don. 
 
112490  
 
 
112488  
 
112500  
 
 
 
 
 
112524  
 
 
112498  
 
 
 
 
 
112478  
 
 
 
 
 
 
 
112502  
Luanda village, Mbozi district 
near Mbeya 
 
Itaka village, Mbozi district 
 
Manyala village, Ileje district 
 
 
 
 
 
Inyala Mwakyenje, Mbeya 
district 
 
Manyala village, Ileje district 
 
 
 
 
 
Saadani village, Mufindi 
district 
 
 
 
 
 
 
Manyala village, Ileje district 
Miombo woodland 
 
 
Roadside vegetation, farmland 
 
Former farmland, meadow 
regenerating to secondary 
vegetation 
 
 
 
Miombo woodland 
 
 
Former farmland, regenerating 
to secondary vegetation 
 
 
 
 
Degraded Brachystegia 
woodland  
 
 
 
 
 
 
Former farmland, regenerating 
to secondary vegetation  
Brachystegia spp., 
Julbernardia spp.  
 
Poaceae 
 
Piliostigma thonningii, 
Lonchocarpus capassa, 
Cassia singueana, Cassia 
auriculata, Thespesia 
daenis, Acacia nilotica  
 
Brachystegia spp., 
Julbernardia spp.  
 
Piliostigma thonningii, 
Lonchocarpus capassa, 
Cassia singueana, Cassia 
auriculata, Thespesia 
daenis, Acacia nilotica  
 
Leptochloa panacea, 
Maytenus holstii, Maytenus 
heterophylla, Themeda 
triandra, Croton sp., 
Faurea sp., Hyparrhenia 
sp., Cyphostemma sp., 
Brachystegia sp. 
 
Piliostigma thonningii, 
Lonchocarpus capassa, 
Cassia singueana, Cassia 
auriculata, Thespesia 
daenis, Acacia nilotica  
 
C. obovatum F. Hoffm. 112509  Shalangwa village, Chunya 
district 
In riverine thicket on 
termitaria 
Thespesia sp., Combretum 
molle, Entada abyssinica, 
Pappea capensis 
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Table 6. Continued. 
 
C. padoides Engl. & Diels 
 
112528  Ruaha river valley, 6.6 km 
from the junction of the rivers 
Ruaha and Iyori 
Riverine forest Tamarindus indica, Albizia 
glabyrrhina, Ficus ingens, 
Pteleopsis myrtifolia 
C. psidioides Welw.  
 
112497  
 
 
 
 
112483  
Manyala village, Ileje district 
 
 
 
 
Igomaa village, Mufindi 
district 
Miombo woodland  
 
 
 
 
Miombo woodland 
Piliostigma thonningii, 
Lonchocarpus capassa, 
Cassia singueana, 
Thespesia daenis, Acacia 
nilotica 
 
Terminalia sp., Cussonia 
sp., Swartzia sp., 
Commiphora sp., 
Pterocarpus sp., 
Brachystegia sp. 
C. zeyheri Sond. 
 
112512  
 
 
 
112487  
 
 
 
 
 
 
112533  
Njelenje B village, Mapogolo 
new settlement, Mbeya district 
 
 
Chimala, Mbarari district. 
Near Chimala mission station. 
 
 
 
 
 
Mtipule village near the 
roadside to Mkata ranch.  
Miombo woodland 
 
 
 
Miombo woodland 
 
 
 
 
 
 
Miombo woodland 
Julbernardia sp., 
Brachystegia sp. 
Terminalia sp.  
 
Brachystegia manga, 
Julbernardia sp., 
Friesodielsia sp., 
Cydolachnostylus 
maprouneifolia, 
Margaritaria discoidea 
 
 
Maerua crassifolia, 
Commelina africana, 
Acacia robusta, Albizia sp., 
Acacia sp., Sclerocarya 
birrea 
Pteleopsis spp.     
P. myrtifolia Engl. & Diels 
 
112529  Ruaha river valley, 6.6 km 
from the junction of the rivers 
Ruaha and Iyori 
Riverine forest Tamarindus indica, Albizia 
glabyrrhina, Ficus ingens, 
Combretum padoides 
Terminalia spp.     
T. glaucescens Benth. 
 
112480  Igomaa village, Mufindi 
district 
Miombo woodland Sterculia quinqueloba, 
Lannea sp., Cussonia sp., 
Pterocarpus angolensis 
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Table 6. Continued. 
 
T. kaiserana F. Hoffm. 
 
112482  
 
 
 
 
112484  
 
 
 
112491  
 
 
112492  
 
 
112493  
 
 
112525  
 
Igomaa village, Mufindi 
district 
 
 
 
Ilembula road junction, Mbozi 
district 
 
 
Luanda village, Mbozi district 
 
 
Luanda village, Mbozi district 
 
 
Luanda village, Mbozi district 
 
 
Inyala Mwakyenje, Mbeya 
district 
Miombo woodland 
 
 
 
 
Degraded Miombo woodland 
 
 
 
Miombo woodland 
 
 
Miombo woodland 
 
 
Miombo woodland 
 
 
Miombo woodland 
Terminalia sp., Cussonia 
sp., Swartzia sp., 
Commiphora sp., 
Pterocarpus sp., 
Brachystegia sp. 
 
Brachystegia sp., 
Combretum molle 
 
 
Brachystegia sp., 
Julbernardia sp.  
 
Brachystegia sp., 
Julbernardia sp. 
 
Brachystegia sp., 
Julbernardia sp. 
 
Combretum molle 
T. sambesiaca Engl. & 
Diels  
 
112526  Kitonga gorge Roadside, near riverine course 
in primary Miombo woodland 
Brachystegia taxifolia, 
Pterocarpus angolensis, 
Dahlbergia nitidula, Ficus 
ingens, Ficus lutea, 
Combretum zeyheri, 
Dahlbergia melanoxylon, 
Diplorhyncus 
condylocarpon, Begonia 
sp., Ipomaea sp., Acalypha 
sp., Chlorophyton sp., Saint 
Paulia 
T. sericea Burch ex. DC.  
 
112494  
 
 
112477  
Ilembula road junction, Mbozi 
district 
 
Vigwasa, 80 km from Dar-es-
Salaam 
Degraded Miombo woodland 
 
 
Miombo woodland 
Julbernardia sp., 
Brachystegia sp. 
 
Brachystegia sp., 
Pterocarpus sp., 
Hymenocardia sp., 
Acanthus walleria  
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Table 6. Continued. 
 
T. spinosa Engl. 112534  Tegeta village, 25 km north of 
Dar-es-Salaam.  
Roadside with cashewnut trees  
T. stenostachya Engl. & 
Diels 
112479  
 
 
 
112514  
 
Igomaa village, Mufindi 
district 
 
 
Njelenje B, Mapogolo 
settlement, Mbeya district 
Hill slope in Miombo 
woodland 
 
 
Miombo woodland 
Sterculia quinqueloba, 
Lannea sp., Cussonia sp., 
Pterocarpus angolensis 
 
Julbernardia sp., 
Brachystegia sp.  
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4.3. Extraction and fractionation of the plant material for antimicrobial 
and cytotoxicity assays 
4.3.1. Crude extracts (I, II, III) 
 
Extraction was performed on dried and milled plant material of the Combretum, Terminalia and 
Pteleopsis species collected from Tanzania (Table 6). The dried plant material had been stored in 
the dark prior to extraction. Several organs of the plants were used, such as roots, stem bark, 
leaves and fruits in order to compare their biological effects. Water, methanol, ethanol and 
acetone were used to compare the extraction capacity of the solvents. 
 
For the methanol, ethanol and acetone extracts 4 g dried plant material was dissolved in 100 ml 
solvent and extracted for 2- 24 h of which 15 min in an ultrasonicator (Transsonic 460, Elma, 
Ultrasonics). The extracts were then filtered and evaporated under reduced pressure, after which 
they were freeze-dried and stored in -20 °C until use. 50 mg/ml of these extracts were dissolved 
in methanol for the antibacterial and antifungal assays (I, II) and in dimethylsulfoxide (DMSO) 
for cytotoxicity assays (III). The samples in DMSO for cytotoxicity screening were further 
diluted to 5 mg/ml with growth medium (DMEM or RPMI 1640) to reduce the percentage of 
DMSO. 
 
The water decoctions were made in the same way as they are prepared in traditional medicine in 
Tanzania. The same amount of plant material to solvent was used as for the other extracts, but 
then the decoction was brought to the boil for 5 minutes. The decoction was allowed to cool 
down and the extraction was continued for two ours at room temperature. The decoctions were 
then centrifuged at 2000 RPM for 5 minutes and filtered through Whatman filterpaper No. 5. The 
filtered samples were evaporated under reduced pressure and the residual extract was then freeze-
dried and stored at -20 °C until use. The freeze-dried extracts resulting from hot water decoctions 
were dissolved in MeOH to 50 mg/ml for the antimicrobial tests. 
 
4.3.2. Fractionation with medium pressure liquid chromatography (MPLC) 
and thin layer chromatography (TLC) (II) 
 
A glass column (460 mm x 26 mm, Büchi, AG, Flavil, Switzerland) filled with Lichrospher RP-
18 (particle size 15-25 um, Merck, Darmstadt, Germany) was used for the fractionation of the 
antimicrobially most potent extracts of Terminalia (II). The column was connected to an HPLC-
pump (Waters M-6000A, Waters Inc., Milford, MA, USA). 
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In brief, twenty grams of root powder of Terminalia sambesiaca was extracted in 500 ml of 
MeOH (HPLC-quality, Rathburn) and freeze-dried for four days. 750 mg freeze-dried extract was 
dissolved in MeOH to a final concentration of 50 mg/ml. This extract was applied to the column 
and eluted with MeOH (HPLC-quality, Rathburn) and water (Milli Q purified), using a step 
gradient, flow rate 3.0 ml/min: 0-40 min 5 % MeOH, 40-125 min 25 % MeOH, 125-185 min 50 
% MeOH, 185-235 min 80 % MeOH, 235-285 min 90 % MeOH. The fractions were collected 
with a fraction collector (LKB, Bromma, 2111 Multirac, Bromma, Sweden). The fractions 
obtained were investigated with reversed phase thin layer chromatography (RP-TLC) in order to 
be able to combine the fractions containing the same pattern of molecules. TLC was performed 
on RP-18F254s (Merck, Darmstadt, Germany) TLC plates. The plates were developed with 
methanol: water 1:1 (v/v) containing 1 % formic acid (v/v). The plates were observed under UV- 
light at 254 and 366 nm. A Camaq video documentation system was used for documentation of 
the plates. Fractions were combined according to the pattern information obtained by RP-TLC 
and freeze-dried. Prior to use the fractions were dissolved in MeOH at a concentration of 20 
mg/ml for the antifungal (II) and antibacterial investigations (unpublished results). 
4.4. Biological assays 
4.4.1. Bacterial and fungal strains (I, II) 
 
Two gram-negative and five gram-positive bacterial strains, representing common human 
bacterial pathogens were used for the antibacterial screenings (I). The gram-negative bacteria 
were Escherichia coli ATCC 8739 and Enterobacter aerogenes FOMK (Division of 
Pharmacognosy, University of Helsinki, Finland). The gram-positive were Staphylococcus 
aureus FOMK, Staphylococcus epidermidis ATCC 12228, Bacillus subtilis FOMK, Micrococcus 
luteus YMBO (Division of General Microbiology, University of Helsinki, Finland) and Sarcina 
sp. FOMK. 
 
The following five species of yeast, commonly causing systemic infections in 
immunocompromised patients were used (II): Candida albicans ATCC 90028, C. krusei ATCC 
6258, C. tropicalis LT (T-185), C. glabrata NL 2238 and C. parapsilosis ATCC 22019. The 
basidiomycet, Cryptococcus neoformans LT (KT V2), was also chosen since it causes severe 
meningoencephalitis in immunocompromised patients. 
 
4.4.2. Assay for antibacterial and antifungal activity (I, II) 
 
An agar diffusion method (Barry & Thornsberry, 1991; Ojala et al., 2000; Rauha et al., 2000) 
was used to screen the plants for antibacterial and antifungal activities, as well as for estimating 
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minimum inhibitory concentrations (MIC) of the most promising extracts. The method is 
described in papers I and II. In brief, in the beginning of the experiments, the bacterial or fungal 
strains to be used were inoculated on Nutrient agar and Saboraud agar respectively, and grown 
for 24 h. A small amount of the culture was transferred to sterile isotonic sodium chloride, and 
the turbidity was measured spectrophotometrically at 625 nm. The suspensions were diluted in 
0.9 % (w/v) NaCl to an absorbance of 0.1 at 625 nm. 240 µl of diluted suspension of 
bacteria/fungi was inoculated on agar dishes containing Isosensitest and Saboraud agar for the 
bacteria and fungi respectively. Sterile Whatman filter paper discs (∅ = 12.7 mm) containing 200 
μl of extracts (50 mg/ml; 10 mg on filter paper disc) were applied to the dishes (I, II). 
Alternatively, steel cylinders (∅ = 12.7 mm) or holes (∅ = 12.7 mm) boared in the agar loaded 
with 200 μl of extracts (10 mg extract/cylinder) were used (I). The petri dishes were kept in room 
temperature for one hour prior to incubation in the dark at + 35°C for 24 h. The diameter of the 
inhibition zones were measured after incubation and the results were expressed as the mean of 3-
9 diameters (0.1 mm precision). Ampicillin and streptomycin (Sigma-Aldrich Chemicals, USA) 
were used as positive controls for the bacteria. For the fungal species amphotericin-B (Sigma-
Aldrich Chemicals, USA) and itraconazol (Janssen-Cilag, Espoo, Finland) were used as positive 
controls. 
 
4.4.2.1. Estimating minimum inhibitory concentrations, MIC (I, II) 
 
The agar diffusion method was also used for determining minimum inhibitory concentrations 
(MIC) of the most promising plant extracts against the bacterial (I) and fungal species (II). For 
the bacteria five different concentrations; 50, 10, 2, 0.4 and 0.08 mg/ml were used for the first 
experiments. Then the next dilutions were made with a series of concentrations lying between the 
lowest concentration giving detectable inhibition (a clear zone of at least 1- 2 mm around the 
cylinder) and the next smallest concentration. A final series of 2.0, 1.75, 1.5, 1.2, 1.0, 0.95, 0.7 
and 0.4 mg/ml were chosen for the antibacterially most efficient extracts. Ampicillin and 
streptomycin were used as references, and MeOH as the solvent blank. The MIC values against 
the fungal species (Candida spp. and Cryptococcus neoformans) were obtained essentially in the 
same way as for the bacteria, but for them concentrations of 50, 25, 12.5, 6.25, 3.125, 1.562 and 
0.78 mg/ml of the plant extracts were used. All the tests were performed in triplicates. 
 
4.4.3. Cell lines (III) 
 
For the cytotoxicity and antiproliferative screening some cell lines representing common kinds of 
cancer were chosen. The following cancer cell lines were used: HeLa (cervical carcinoma, 
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human, ATCC CCL-2), MCF 7 (breast carcinoma, human, ATCC HTB-22) and T 24 (bladder 
carcinoma, human, ATCC HTB 4). Bovine brain capillary endothelial cells (BBCE) were used to 
study the eventual antiangiogenic effects of the extracts. The BBCE cells were grown in DMEM, 
low glucose variant (Gibco), containing 2 mM L- glutamine, non-essential amino acids (100 ×), 
penicillin-streptomycin (100 ×) and 10 % fetal calf serum (Gibco). 5 µl of fibroblast growth 
factor, FGF (Sigma) (0.5 µg/ml prepared in 0.2 % gelatin solution) was added to the BBCE cells 
once a week (in 10 ml cell suspension). The culturing of the cancer cell lines is described in paper 
III. 
 
4.4.4. Assays for measuring cytotoxic activities of the extracts (III) 
4.4.4.1. Alamar Blue method 
 
In order to estimate the amount of viable cells after treating them with plant extracts, the Alamar 
Blue method was chosen. Alamar Blue (Promega, Biofellows, Finland) is a redox indicator which 
contains blue non-fluorescent resazurin which is reduced to pink fluorescent resorufin by the 
metabolic activity of living cells. In brief, 5 x 103 cells/ml (MCF 7, T 24) or 5 x 104 cells/ml 
(HeLa) were seeded on ELISA 96 well microtitre culture plates (Costar®, Corning Inc.) to a final 
volume of 199 μl and incubated for 24 h at + 37 °C. The following day 1 µl of extracts (5 mg/ml) 
were added to the wells so that the final concentration of extracts in the wells was 25 μg/ml. The 
cells with extracts were incubated for two days at 37 °C, after which the medium was replaced 
with fresh medium and the same amount of the extracts were added for the second time and 
incubated for two more days. After a completed time of incubation with the plant extracts the old 
medium with the extracts was aspirated and fresh DMSO medium without phenol red (Gibco) 
was added to the wells. The cells were allowed to grow in this medium for 4 h, after which 10 μl 
Alamar Blue reagent was added to each well and the cells were incubated for 24 h at 37 °C. The 
fluorescence of the wells was measured with a Victor (Wallac, Finland) spectrophotometer at 540 
nm em./590 nm ex. The results were expressed as the percent cell growth of controls and were 
calculated as averages ± SEM of two-six experiments, each experiment with duplicate samples. 
4.4.4.2. Coulter count 
 
The antiproliferative effects of the plant extracts were also assayed by counting the cells after 
treating them with extracts, using Coulter count as a reference method to Alamar Blue. 5 x 103 
cells/ml (MCF 7, T 24 and BBCE) or 5 x 104 cells/ml (HeLa) were seeded on 24- well cell 
culture plates to a final volume of 1000 µl/well (Costar®, Corning Inc.) and incubated for 24 h at 
+ 37°C. The following day 5 µl of extracts (5 mg/ml, making final concentration to 25 μg/ml in 
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well) or serial dilutions of a leaf extract of Combretum fragrans (32.9 – 4.3 μg/ml) were added to 
the wells and the cells were incubated for an additional two days at + 37°C. The old medium was 
replaced with fresh medium and 5 µl of the extracts were added for a second time. The cells were 
incubated for an additional two days at + 37°C. The cell number was determined after five days 
of incubation when the untreated cells should be in their logarithmic phase of growth. For the cell 
count the medium was aspirated, the cells were washed with 500 µl PBS and detached from the 
wells with 500 µl trypsin-EDTA (Sigma). The cells in trypsin-EDTA were then added to 9.5 ml 
PBS and counted with a coulter counter apparatus (Beckman, USA). The experiments were done 
in duplicates and repeated four to six times. Cell proliferation was expressed as percent survival 
of control and the inhibition of proliferation as percent inhibition of control. 
 
4.4.4.3. Hoechst staining 
 
Hoechst staining was used to investigate if the antiproliferatively most effective extract caused 
fragmentation of the nucleus in the cancer cell lines. 5 x 103 or 5 x 104 cells/ml, depending on the 
cell line, were seeded on 24 well or 12 well tissue culture plates (Costar®, Corning Inc.) with 
aseptically inserted sterile glass coverslips. The cells were allowed to attach and grow for 24 h at 
37 °C after which 5 μl of a series of concentrations (final concentrations 9.7 – 4.3 μg/ml in wells) 
of Combretum fragrans were added to the wells. The cells were incubated together with the 
extracts for two days at 37 °C after which the medium was changed and the extracts added for a 
second time. The cells with extracts were incubated for two more days. When incubation was 
completed the medium was aspirated and the cells were washed with PBS. The cells were fixed 
with 500 µl 3 % (w/v) paraformaldehyde (Sigma) for fifteen minutes. The fixed cells were treated 
with 500 µl 50 mM NH4Cl2 for 15 minutes and washed with PBS. 500 µl Hoechst 33258 (Bio-
Rad) stain was added to the cells for 20 minutes at + 37 °C. The Hoechst stain was aspirated and 
the cells were washed with PBS and kept in this solution until mounted on microscope slides. 
The coverslips with the cells were put on a drop of gel/mount mounting medium (Biomeda, 
USA) on microscope slides (O. Kindler, GmbH, Freiburg, Germany). The cells were observed 
under a Zeiss Axioplan II fluorescence microscope (Zeiss, Oberkochen, Germany). 
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5. Results and Discussion 
5.1. Presentation of the traditional healers in the Mbeya region of 
Tanzania (I) 
 
Traditional healers in seven different villages in the Mbeya region (Figure 7) were interviewed 
with the aid of a questionnaire on their uses of medicinal plants with focus on species of 
Combretum, Terminalia and Pteleopsis. The villages visited were Isalavano, Mayale, Itaka, 
Mlowo, Ikumbilo, Itumba and Segela and the number of inhabitants varied from 300-4000 
people. Here I present the results of the general part of the questionnaire (Figure 8). This part of 
the questionnaire was used in order to obtain some general information of the villages and the 
people living in them, as well as getting familiar with the traditional healers to be interviewed. 
The median age of the traditional healers was 55 years, the youngest being 40 and the oldest 66 
years. Six of the healers were men and one was a woman. Four of the seven healers belonged to 
the Nyakyusa tribe and the three others belonged to the Mhehe, Bena and Mnyika tribes 
respectively. Some of the healers could show us a certificate that they had been officially 
recognized by the Tanzanian health authorities as traditional medicinal practitioners (TMP). The 
current policy in many African countries, including Tanzania, has been to increasingly 
incorporate traditional medicine into the formal health care sectors, and thus, traditional healers 
have been officially recognized and accepted as a part of the health care system (Tsey, 1997). 
All the traditional healers we interviewed were highly entrusted by the people in the villages. 
This is not only because of their skilful healing practices, but also due to the supernatural and 
magical capacities they are thought to hold, as well as participating in many aspects of life of the 
villagers. Traditional healers have been found to play an important role in promoting the 
traditional concepts and life of the ethnic groups in Tanzania (Swantz, 1974). The local people in 
the villages we visited seemed to prefer modern medicines if affordable and available, but have 
the traditional healer as their first point of contact (and in many cases only point of contact). Only 
in one village the people told us that they prefer traditional medicine because they think that they 
cannot get treated correctly with modern medicines. Most of the people in the villages we visited 
are not able to afford the expensive medicines or expensive treatments given in Western 
hospitals, and this seems to be the case in many African countries (Tsey, 1997). Most of the 
people in the villages we visited rely on traditional medicine for their primary health care and this 
is in agreement with Hedberg et al. (1982) according to whom 80 % of the population in African 
countries are dependent on traditional medicine for their primary health care. 
In contrast to the rest of the people in the villages, the traditional healers naturally preferred 
traditional medicine to modern, but some of them were ready to use western medicines as well, 
either alone, or in conjunction with traditional remedies, if the disease they were treating was not 
cured by traditional remedies alone. Some of the healers had the possibility to get western 
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medicines from hospitals nearby. One of the healers had been treating patients since 1962, and 
wanted to point out that he has seen that traditionally prepared plant remedies effectively cure 
various diseases. Illustrative for the trust in traditional healers and traditional medicines is that 
people have came from the big cities, like Dar-es-Salaam, to be treated by traditional healers in 
Mbeya (over 900 km away), when Western health care fails (unpublished information from one 
of our interviews). Most of the traditional healers we interviewed, expressed their concerns on the 
declining interest in traditional medicine among the young people in the villages. Young people 
are moving to the cities (Dar-es-Salaam, Dodoma) in search for work, and in many cases they 
seem not to be interested in traditional medicine since it is a rather poor source of income. 
All the traditional healers we interviewed do farming as their main income. Plant species 
generally grown in the villages are maize (Zea mays), beans (Vicia faba, Phaseolus vulgaris), 
cucumbers (Cucumis sativus), tobacco (Nicotiana tabacum), sunflowers (Helianthus annuus), 
groundnuts (Arachis hypogaea), coffee (Coffea arabica), millets (Panicum miliaceum), banana 
(Musa paradisiaca), tea (Camellia sinensis), mango (Mangifera indica) and papaya (Carica 
papaya), all of them mainly for domestic use. Groundnuts and maize are used in rotation for 
crops, the nitrogen-rich groundnuts fertilizing the soil. Tea and coffee are also cultivated as cash 
crops and selled to the marketplaces in Mbeya and Dar-es-Salaam. Two of the seven interviewed 
healers told us that they grow some of their medicinal plants in small gardens near their houses. 
Examples of medicinal plants grown in the gardens of the healers are species of Dioscorea 
(Mbinga), species of Ozoroa (Mwalukama), different species of Apocynaceae with milk sap 
(Mfua) and species belonging to Euphorbiaceae. The medicinal plants which were grown in the 
gardens were, however, not shown to us. During our stay in Tanzania we did not observe a single 
written document on how to use medicinal plants in the villages we visited. The traditional 
healers we interviewed sometimes used small memory notes, but most of the knowledge they 
keep in their minds. The information on how to use medicinal plants was mostly taught from 
father to son (daughter), and this is done during collection trips to the forests near the village as 
well as at home when preparing the plant remedies and treating the patients. There are quite big 
risks for making mistakes from this oral form of learning because the information taught may 
easily be wrongly remembered. There might also be some risks concerning the correct form of 
dosage and administration of the plant decoctions, even if we never heard of any poisonings 
during our expedition. Poisonings from traditional medicinal preparations are, however, reported 
to be a serious problem (Swantz, 1974). 
 
5.2. Ethnopharmacological uses of species of Combretum and 
Terminalia by traditional healers in Mbeya, Tanzania (I) 
 
By using a more specific part of the questionnaire (Figure 8), the traditional healers were 
interviewed on their medicinal uses of some species of Combretum and Terminalia shown to 
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them in the beginning of the interviews. The plants were collected from Miombo woodlands, 
riverine forests and ruderal vegetation (Table 6). In total ten different species, six of Combretum 
and four of Terminalia, were shown to the healers (Table 7).  
 
Of the ten species of Combretum and Terminalia shown to the healers, six were commonly used 
as medicinal plants in the villages we visited (Table 7). These were Combretum molle (Swahili: 
Mlama; Nyakusa; Mpula), Combretum fragrans (Swahili: Hansebwe), Combretum psidioides 
(Swahili: Mlama zambila), Combretum zeyheri (Nyakyusa: Kakati; Swahili: Mlama), Terminalia 
sericea (Nyakyusa: Namatipo; Swahili:Mplulu) and Terminalia kaiserana (Swahili: Mpululu; 
Nyakusa: Namatipo). All the healers reported that they easily recognize these species from fruit 
and leaf characters. Among botanical professionals the fruits are considered to be the most 
species-specific organs of Combretum and Terminalia species and are the most used organs in 
species identifications (Wickens et al., 1973). In some cases also the characters of the stem bark, 
like the color and degree of smoothness/fissures are used, both among botanists and traditional 
healers. One of the healers reported that he also uses the flowers as characters to distinguish 
Combretum and Terminalia species from each other. Most of the healers admitted that it is easy 
to confuse species of Combretum and Terminalia with closely related ones, and that the only way 
to learn them is through experience. Most of the species of Terminalia and Combretum seem to 
be abundant and easy to find by the healers. The roots were the most common part of the plants 
to be used for medicine and were used by all the seven healers interviewed. The leaves of the 
species were used in four cases and the stem bark by two out of seven interviewed traditional 
healers. 
 
In the following the species of Combretum and Terminalia which are used in traditional medicine 
in Mbeya are presented and the summary of these results can be read from Table 7 and I, Table 1.  
 
5.2.1. Results from our interviews on the traditional uses of Combretum 
spp. in Mbeya region 
 
Combretum molle (Soft-leaved combretum, velvet bushwillow, vernacular names in Swahili and 
Nyakyusa respectively: Mlama, Mpula) was the most popular species for medicinal purposes of 
all the Combretum species collected. It was used in six villages out of the seven visited, but our 
sample of interviews (n = 7) is not sufficiently large to draw any final conclusions of the 
popularity of this species among traditional healers in Tanzania. Most of the healers told us that 
C. molle is easy to find and very abundant, although it can be very variable in its leaf and fruit 
characters, and thus not very easy to identify. Wickens (1973) points out that C. molle can be 
very variable in leaf shape and size as well as in size of the fruits, and we also discovered this 
during the field collections of this species. The answers to the question of what time of the day 
 108
this species preferably should be collected were contradictionary since one of the healers reported 
that he mainly collects it during daytime, and one of the healers that she collects it nighttime in 
order to obtain maximal healing properties. When the healers were asked whether they prefer 
young or more mature trees, most of them told us that they collect individuals of all ages, 
whereas some preferred young and others more mature individuals. It has been shown that 
several secondary components are most abundant at the juvenile phase of leaf and shoot 
development (Julkunen-Tiitto, 1989), at least in plants occurring on temperate latitudes, but this 
might not be the case with tropical plants which continuously must defend themselves against 
herbivores, insects, fungi and bacteria. This might be the reason why the species of Combretum 
seem to be equally good as medicinal plants independent of the time of the day or of the stage of 
development/age they are collected. 
Combretum molle is used in a strikingly similar way among the healers in the different villages 
we interviewed. It is seldom used alone and often mixed together with other species of 
Combretum or with species of Terminalia. One of the healers reported that the roots of C. molle 
are mixed with Terminalia kaiserana for the treatment of diarrhea. The secondary compounds of 
these two species might act synergistically in these mixed decoctions, since both species are used 
for the treatment of diarrhea in single species decoctions. Most of the healers use dried samples 
of C. molle, but in one case also the use of fresh roots was reported. Gonorrhea and syphilis are 
treated with mixtures of the roots, stem bark or leaves of this species and another plant called 
“Muwofi”, which both are grounded and one teaspoon of the powder is added to maize porridge, 
“Ugali”. Sometimes C. molle is used alone for the treatment of gonorrhea and syphilis. Bacterial 
infections and diarrhea as well as venereal diseases are treated by allowing the patient to bath in 
an extract of the leaves, which are thought to be aseptic. Hot water decoctions of the dried roots 
and leaves or fresh roots cut into pieces, as well as mixtures of these plant parts, are put in maize 
porridge and used for the treatment of gonorrhea, syphilis, influenza, severe cold and oedema. 
Both leaf and root decoctions of Combretum molle are used for the treatment of malnutrition in 
children. The dried, powdered roots of C. molle are also used topically for the treatment of 
wounds and diseases of the skin, and for this purpose the roots are mixed with sheep fat to form a 
paste that is smeared on the skin. Some of the healers in Mbeya informed us that they use the 
roots and leaves of C. molle for treatment of oedema. The uses of C. molle by the traditional 
healers in Mbeya are in agreement with the medicinal uses of this plant in many African 
countries reported by other authors (Table 7). Some additional uses which were not reported by 
the traditional healers in Mbeya are the use of C. molle for hookworms, snake bites, sterility, 
abortions and as an aid for child birth (Watt & Breyer-Brandwijk, 1962; Haerdi, 1964; Kokwaro, 
1976). 
 
Combretum zeyheri (vernacular names in Swahili and Nyakyusa respectively: Mlama, Kakati) 
seemed to be one of the most popular species of Combretum among the traditional healers in 
Mbeya. The Nyakyusa vernacular name, Kakati, means “always used”. This species is recognized 
 109
mainly from the leaf characters, and is abundant and easy to find from the forests according to the 
traditional healers interviewed. It is reported to be collected during any time of the day. C. 
zeyheri is used for treatment of diarrhea and tumors (Table 7; I, Table 1). It was the only 
Combretum species we included in this investigation to have uses for the treatment of tumors and 
cancer. Powdered, dried roots or leaves are made into hot water decoctions and one teaspoon of 
this decoction is mixed in a cup of hot water administered daily for the treatment of stomach 
tumours as well as diarrhea. Alternatively, the dried roots/leaves can be mixed into maize 
porridge (Ugali) for the same purposes as above. Sometimes C. zeyheri is mixed with other 
species of Combretum for the treatment of diarrhea. 
Many other authors report traditional medicinal uses of C. zeyheri which agree with the ones we 
report: Hedberg et al. (1982) report that the roots and stem bark of C. zeyheri are made into hot 
water extracts and these are mixed into maize porridge for the treatment of diarrhea and 
vomiting; Gelfland et al. (1985) report that an infusion of the roots is used for the treatment of 
bloody diarrhea; Kokwaro (1976) reports that the root powder of C. zeyheri is mixed with 
porridge for the treatment of dysentery; the Mankoya people in Zambia use the leaves and bark of 
C. zeyheri to prepare a complex cure for treating smallpox (Drummond & Coates-Palgrave, 
1973). The traditional healers in Mbeya seem to be the only ones who use C. zeyheri for the 
treatment of cancer and tumours, since to the best of our knowledge there exists no other reports 
on this kind of use of C. zeyheri. 
 
Combretum psidioides (vernacular name in Swahili: Mlama zambila) is a large- and soft-leaved 
species, easy to identify and is fairly common on sandy soils in the Mbeya region. The leaves of 
this species are used as the main character for species identification by the healers in Mbeya. It is 
used either alone or in combination with other species of Combretum, such as C. molle and C. 
zeyheri, which are collectively called “Mlama” by the healers we interviewed. In combinations 
with the other species of Combretum it is used for the treatment of chest problems, pains in the 
spinal cord and oedema. All parts of C. psidiodes are used for medicinal purposes, but especially 
the roots are popular for medicine. The roots are made into hot water decoctions for the treatment 
of diarrhea and muscle pain. The leaves, either fresh or dried, are pounded and extracted in hot 
water or mixed with porridge, Ugali, to treat oedema. One teaspoon leaf extract is mixed with hot 
water in a tea cup for the same purpose. 
Just a few uses are listed for C. psidioides in the literature, and some of them are in accordance 
with the uses we report. For example, Haerdi (1964) reports that root decoctions of this plant are 
taken for treatment of rheumatic back pain and macerations of the stem bark for diarrhea. In 
addition this species is reported to have some uses we have not recorded during our stay in 
Mbeya. The stem bark is used as an aphrodisiac and the leaf sap and root decoction for the 
treatment of malaria (Haerdi, 1964). 
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Combretum fragrans (vernacular name in Swahili: Hansebwe) is fairly common in the Mbeya 
region and easy to identify from its fruit and leaf characters. The roots of this species are ground 
into a fine powder and mixed with hot water, brought to boil, filtered and drunk as a decoction 
for diarrhea (Table 7; I, Table 1). Sometimes the root powder is mixed into porridge or into tea 
for the same purpose. Many different medicinal uses of this species are reported by other authors, 
but none of them report of its uses against diarrhea. Apparently C. fragrans seems to contain 
antiseptic properties since it is used for the treatment of bacterial infections: Chhabra et al. (1989) 
report that both the roots and the leaves of C. fragrans are used for the treatment of leprosy; root 
decoctions are used for the treatment of coughs and syphilis (Kokwaro, 1976). Adjanohoun et al. 
(1986) report that leaves of this species are used for the cleaning of chronic wounds. In addition 
leaf extracts are used as an antidote against snake bites (Neuwinger, 2000) and according to 
Gelfland et al. (1985) root infusions are used as an aphrodisiac. 
 
5.2.2. Results from our interviews on the traditional uses of Terminalia spp. 
in Mbeya 
 
Two species of Terminalia, T. sericea and T. kaiserana were frequently used as medicinal plants 
among the traditional healers in Mbeya (Table 7; I, Table 1). Both species have a similar 
vernacular name in Swahili, Mpululu as well as two separate names in Nyakyusa (Bena for T. 
kaiserana and Namatipo for T. sericea) and it seems that the traditional healers often mix 
between these two. It is indeed known that hybrids between T. sericea and T. kaiserana occur, 
and they resemble T. sericea in terms of the degree of hairyness of the leaves (Wickens, 1973). It 
can be extremely difficult to distinguish between these two species if they are growing side by 
side. 
 
Terminalia sericea is a popular medicinal plant in most of the villages we visited. This species is 
abundant and easy to find. It is willow like in its appearance, with small silvery, hairy leaves. The 
traditional healers told us that they distinguish it from other species of Terminalia from its leaf-, 
fruit- and flower-characters. All parts of T. sericea are used for medicinal purposes, except the 
flowers. In most cases dry plant material is used, and in this form it can be stored for long periods 
of time. Plants of all ages are used, and there seems not to be age preferences when collecting this 
plant for medicinal purposes. The leaves, roots or stem bark are powdered and made into hot 
water decoctions, mixed into maize porridge (Ugali) or made into tea for diarrhea, fever and 
hypertension (Table 7; I, Table 1). The used dose is usually one teaspoon of leaf powder in one 
cup of hot water for the tea. It is important to administer this plant in the correct dosage since it is 
claimed to be poisonous in large doses (Watt & Breyer-Brandwijk, 1962). Sometimes T. sericea 
can be mixed with another plant called “Mololo”. 
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Terminalia sericea is a well known plant in African traditional medicine. Our results of the uses 
of this species are in part in accordance with the uses reported by other authors. In most African 
countries the roots of T. sericea seem to be the most frequently used part, although the roots are 
considered to be poisonous by many traditional healers (Watt & Breyer-Brandwijk, 1962). In 
addition to the roots, also leaves and stem bark are used for medicinal purposes, although to a 
lesser extent than the roots. There is only one report on the uses of the fruits of T. sericea for 
medicinal purposes (Eldeen et al., 2005). The roots are considered antiseptic and are decocted or 
infused in water for oral treatment of diarrhea (Drummond & Coates-Palgrave, 1973), gonorrhea 
(Hedberg et al., 1982) or used in mixtures with other medicinal plants such as Carica papaya, 
Citrus limon, Parinari excelsa for the treatment of venereal diseases (Neuwinger, 2000). 
Decoctions of the roots of T. sericea are also used topically for the treatment of certain eye-
diseases, such as trachoma, as well as for the treatment of skin diseases (Neuwinger, 2000). The 
vapour of a hot water decoction of the outer layer of the roots is inhaled for the treatment of 
pneumonia (Neuwinger, 1996). Leaf infusions are used for the treatment of diarrhea as well as for 
the treatment of “chest complaints” (pneumonia?) (Neuwinger, 2000). Dressings of the leaves 
and stem bark of T. sericea are used for the treatment of wounds (Neuwinger, 2000). 
 
Terminalia kaiserana is often used as a medicinal plant in the villages in Mbeya we visited. The 
use of it has, however declined, and a reason might be that it is extensively cut for fuel wood. 
Many of the traditional healers also told us that it is easily confused with other species of 
Terminalia, and they try to distinguish it from the other species with the aid of leaf and fruit 
characters. Both roots, leaves and stem bark of T. kaiserana are dried, grounded and made into 
hot water decoctions for the treatment of gonorrhea, diarrhea and vomiting (Table 7; I, Table 1). 
Sometimes leaf powder can be added to tea or porridge for the same purposes. One teaspoon of 
dried plant material in a cup of hot water is the usual dose administered to the patients. The roots 
of T. kaiserana can also be used together with C. molle for the treatment of diabetes. The 
treatment of patients with T. kaiserana is sometimes connected with some spiritual prayers. 
Some of the medicinal uses of Terminalia kaiserana reported by previous authors are in 
accordance with those reported by us. According to Kokwaro (1976) and Haerdi (1964) the roots 
of T. kaiserana are used for treatment of gonorrhea in the same way as the traditional healers in 
Mbeya, Tanzania use them. In addition the roots of T. kaiserana are used for treatment of 
bilharzia and as diuretics (Haerdi, 1964; Kokwaro, 1976). Sometimes root decoctions of T. 
kaiserana are mixed together with Dalbergia nyassae and Bridelia cathartica for the topical 
treatment of kidney pains. The fresh leaf sap and root decoctions are used for the treatment of 
schistosomiasis (bilharzia), scabies, cough and cardiac problems (Haerdi, 1964). 
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Table 7. Results from our investigation on uses of Combretum-, Terminalia and Pteleopsis-species (Combretaceae) in traditional medicine in some villages in the 
Mbeya region, Tanzania and medicinal uses reported by other authors. 
 
Species Vernacular 
name 
Traditional use in 
Tanzania/our results 
Preparation of plant for 
medicine/our results 
Traditional use reported 
in literature  
Combretum species     
C. collinum Fresen.  
 
Mlama No use reported in Mbeya 
region 
 Malaria (Haerdi, 1964); 
diarrhea, excessive 
menstrual bleeding, rectal 
prolapse (Hedberg et al., 
1982); dysentery, snake bites 
(Kokwaro, 1976); “madi”, a 
blood disease (Watt & 
Breyer-Brandwijk, 1962); 
gastroenteritis (Adjanouhoun 
et al., 1986). 
C. fragrans F. Hoffm. 
 
Hansebwe For treatment of diarrhea  1) Decoctions: roots are ground into a 
powder and mixed with hot water, 
brought to boil, filtered and decoction is 
drunk  
 
2) Mixed into porridge or made into 
tea: root powder  
Coughs, syphilis (Kokwaro, 
1976); aphrodisiac (Gelfland 
et al., 1985); chronic wounds 
(Adjanouhoun et al., 1986); 
leprosy (Chhabra et al., 
1989); snakebites 
(Neuwinger, 2000);  
C. hereroense Schinz.  
 
Mlama No use reported in Mbeya 
region 
 Cardiac problems, heartburn, 
venereal diseases, body pain, 
chest problems, coughs, 
stomach problems, headache, 
schistosomiasis (Watt & 
Breyer-Brandwijk, 1962); 
headache (Gelfland et al., 
1985); schistosomiasis 
(Kokwaro, 1976). 
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Table 7. Continued. 
 
C. molle G. Don. Mlama, 
Mpula, 
Kapula 
To treat gonorrhea, syphilis, 
influenza, oedema, skin 
diseases, diarrhea and wounds 
In mixtures with Combretum psidioides 
and Terminalia kaiserana. Mostly dried 
for use, but use of fresh material was also 
reported.  
 
1) Added to maize porridge, Ugali: 
powder of dried roots, stem bark or 
leaves in mixture with plant called 
“Muwofi” (gonorrhea, syphilis). 
 
2) Baths in extracts: leaf extracts for 
bacterial infections, diarrhea, venereal 
diseases.  
 
3) Hot water decoctions of dried/fresh 
roots and leaves put in maize porridge: 
gonorrhea, syphilis, influenza, severe 
cold, oedema, malnutrition in children.  
 
4) Topically for treatment of 
wounds/diseases of the skin: roots 
mixed with sheep fat to form a paste 
smeared on the skin. 
Wound dressing, stomach 
problems, snake bites, aid in 
child birth (Watt & Breyer-
Brandwijk, 1962); abortions, 
antidiarreic (Haerdi, 1964); 
wounds from poisoned 
arrows (Haerdi, 1964); 
wounds (Drummond & 
Coates-Palgrave, 1973); 
hookworm, stomach pains, 
snake bite, leprosy, fever, 
dysentery, general body 
swellings, chest complaints, 
abortifacient, wounds 
(Kokwaro, 1976); angina, 
dropsy (Kerharo, 1974); 
expectorant, syphilis, 
snakebites (Hedberg et al., 
1982); swelling of abdomen, 
abortion, constipation, 
sterility (Chhabra et al., 
1989); stomach problems, 
snake bites, wounds, 
dysenthery, galactogogue 
(Neuwinger, 2000) 
C. psidioides Welw.  Mlama 
zambila 
To treat diarrhea, muscle pain 
and oedema 
Used either alone or in combination with 
Combretum molle and C. zeyheri  
 
1) Hot water decoctions of roots for 
diarrhea and muscle pain and of leaves 
for oedema 
 
2) Extracts of leaves mixed with hot 
water in tea cup for oedema  
 
3) Mixed with porridge, Ugali: leaves, 
either fresh or dried to treat oedema.  
 
4) In combination with C. molle and C. 
zeyheri for chest problems, pains in the 
spinal cord and oedema. 
 
Aphrodisiac, diarrhea, 
malaria, rheumatic back pain 
(Haerdi, 1964); galactogogue 
(Gilges, 1985). 
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Table 7. Continued. 
 
C. zeyheri Sond. Mlama, 
Kakati 
(“always 
used”) 
To treat diarrhea and cancer 1) Hot water decoctions: powdered, 
dried roots/leaves decocted, one teaspoon 
of decoction mixed in a cup of hot water. 
Daily administration for stomach tumors 
as well as diarrhea. 
 
2) Mixed into maize porridge (Ugali): 
dried roots/leaves mixed in porridge for 
tumors and diarrhea. 
 
3) Sometimes mixed with other species 
of Combretum for the treatment of 
diarrhea. 
 
Scorpion bites (Watt & 
Breyer-Brandwijk, 1962); 
coughs, colic, smallpox 
(Drummond & Coates-
Palgrave, 1973); 
schistosomiasis, dry wounds, 
rheumatism, back pain, 
bloody diarrhea, coughs 
(Kokwaro, 1976); diarrhea, 
vomiting (Hedberg et al., 
1982); bloody diarrhea 
(Gelfland et al., 1985); 
rheumatism, joint pains, eye 
inflammation, conjunctivitis 
(Kremnitz et al., 1988); 
treatment of back pain, 
malaria (Van Koenen, 1996); 
schistosomiasis (Neuwinger, 
2000)  
Terminalia spp.     
T. glaucescens Benth.  Mpulu No use reported in Mbeya 
region 
 Burns, headache, stomach 
problems (Bouquet & 
Debray, 1974); AIDS related 
fungal infections (Koudou et 
al., 1995); fungal infections 
of skin (Batawila et al., 
2005); coughs, wounds, 
dental care (Neuwinger, 
2002). 
T. kaiserana F. Hoffm. Mpululu, 
Bena 
To treat gonorrhea, diarrhea, 
vomiting  
 
Together with C. molle for 
diabetes 
1) Hot water decoctions: dried roots, 
leaves and stem bark decocted for 
gonorrhea, diarrhea and vomiting  
 
2) Added to tea or porridge: leaf 
powder in tea or porridge for gonorrhea, 
diarrhea and vomiting. One teaspoon of 
dried plant material in a cup of hot water 
for the tea.  
 
- the roots of T. kaiserana can also be 
used together with C. molle for diabetes.  
Gonorrhea, bilharzia 
schistosomiasis, diuretics, 
aphrodisiac, headache, back 
and kidney pain, scabies, 
cardiac problems, cough 
(Haerdi, 1964; Chhabra et 
al., 1989) 
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Table 7. Continued. 
 
T. sambesiaca Engl. & Diels.  No use reported  Bloody diarrhea, cancer, 
gastric ulcers, appendicitis 
(Chhabra et al., 1989). 
T. sericea Burch ex. DC. Namatipo, 
Mpululu 
To treat diarrhea, fever, 
hypertension, bacterial 
infections  
1) Hot water decoctions: leaves, roots or 
stem bark powdered and decocted for 
diarrhea, fever and hypertension.  
 
2) Mixed into maize porridge (Ugali): 
leaves, roots or stem bark powdered and 
mixed with Ugali for diarrhea, fever and 
hypertension  
 
3) As a tea (infusion): one teaspoon 
dried powder of leaves, root or stem bark 
in cup of hot water for diarrhea, fever, 
hypertension 
 
- Sometimes mixed with another plant 
called Mololo for same purposes as above 
 
Diarrhea, dysentery, colic, 
diabetes (Watt & Breyer-
Brandwijk, 1962); diarrhea, 
colic, pneumonia, eyewash 
for certain diseases in the 
eyes (Drummond & Coates-
Palgrave, 1973); bilharzia 
(Kokwaro, 1976); gonorrhea 
(Hedberg et al., 1982); 
diarrhea, skin diseases, 
cough, general body 
weakness, pneumonia, 
venereal diseases 
(Neuwinger, 2000) 
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5.3. Antibacterial effects of extracts and fractions of Combretum and 
Terminalia spp. (I) 
 
Since many of the species of Combretum and Terminalia included in this thesis work, are used 
for the treatment of infectious diseases in African traditional medicine the in vitro antibacterial 
effects of these species was studied. 
 
A hole-plate agar diffusion method (Barry & Thornsberry, 1991; Ojala et al., 2002; Rauha et al. 
2002) was applied to study the antibacterial effects of 21 extracts of six Combretum species and 
five species of Terminalia, collected from Tanzania. In this study seven bacteria, two gram-
negative and five gram-positive species were used. All the species used were non-invasive, but as 
opportunists they are able to cause infections. Of the gram-positive bacteria used, Staphylococcus 
aureus is known to cause serious diseases such as pneumonia, meningitis, endocarditis and 
septicemia in immunocompromised hospital patients 
(http://www.en.wikipedia.org/wiki/Staphylococcus_aureus). The resistance of S. aureus to many 
commonly used antibiotics as well as to methicillin and vancomycin (VRSA) poses serious 
problems. Although serious infections caused by S. aureus are rare in otherwise healthy people, 
there have been some reports of strains of methicillin-resistant S. aureus (MRSA) isolated from 
children in the community (Chambers, 2001). Staphylococcus aureus is in addition a common 
cause of food-poisoning (Madigan et al., 2000). Staphylococcus epidermidis is responsible for a 
growing number of infections among hospital patients with weakened immune system. Infections 
with S. epidermidis often start at skin wounds caused by catheters. Micrococcus luteus is part of 
the normal flora of the skin, but seems to be an emerging nosocomial pathogen in 
immunocompromised patients. Among the gram-negative bacteria in our study, Enterobacter 
aerogenes is frequently isolated from nosocomial infections. In hospitalized intensive care unit 
patients Enterobacter aerogenes is known to cause bacteremia, lower respiratory tract infections, 
skin and soft tissue infections, urinary tract infections and endocarditis. Enterobacter species 
possess endotoxin which is known to play a major role in the pathophysiology of sepsis and its 
complications. Multidrug-resistant Enterobacter aerogenes (MREA) has gradually emerged as an 
important nosocomial pathogen in Belgium (Ronveux et al., 1999). Uropathogenic Escherichia 
coli causes 90 % of the urinary tract infections (UTI), and is also an important causative of 
travelers diarrhea as well as dysenthery-like diarrhea (enteroinvasive E. coli, EIEC) 
(http://www.textbookofbacteriology.net/e.coli.html). 
 
The results on the antibacterial effects of 21 extracts of six species of Combretum and four 
species of Terminalia showed that the species of Terminalia were in general more antimicrobial 
than the Combretum species (I, Table 2). Most of the species screened gave substantial 
antimicrobial effects (at 50 mg/ml), which is in accordance with the extensive use of various 
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species of Combretum and Terminalia in traditional medicine (Table 1, Table 2, Table 7, Table 
9). The extracts of the roots of Combretum and Terminalia species generally gave the best 
antibacterial effects, although extracts of stembark were also effective. Leaf extracts were less 
active than the other parts of the plants. Interestingly, none of the extracts, with the exception of a 
methanolic leaf extract of T. kaiserana, were active against Escherichia coli (I, Table 2), 
although Eloff (1999) reported good effects of many African species of Terminalia and 
Combretum against E. coli. Eloff (1999) used a more sensitive microplate dilution method, 
whereas our results were obtained with agar diffusion, which might explain this discrepancy. 
Eloff (1999) also used a different strain of E. coli, ATCC 27853, which might be more sensitive 
to extracts of Combretaceae than ATCC 8739 used in our investigation. All the species and 
extracts of Terminalia as well as those of Combretum were active against Enterobacter 
aerogenes, the other gram-negative bacterial species in our investigation. Taylor et al. (1996) did 
not find any antibacterial activity against E. aerogenes, when they screened an Indian species of 
Terminalia, T. alata, for its antibacterial potential. They, however, used ten times less extract 
than we, which might explain the result. Also, T. alata being an Asian species of Terminalia, 
might differ much in its chemical composition from the African species of Terminalia. 
 
In the following the antibacterial effects of some of the most potent species of Combretum, 
Terminalia and Pteleopsis, collected from Tanzania will be summarized. 
 
5.3.1. Results from the antibacterial screening of species of Terminalia 
collected from Tanzania 
 
The results of the antibacterial potential of the most effective species of Terminalia in our 
investigation in relation to their uses in traditional medicine in Mbeya, Tanzania are summarized 
in Table 9. 
 
Terminalia sambesiaca 
Of the 21 crude extracts of Combretum and Terminalia, screened for their antibacterial effects, 
the most outstanding effects were obtained with a root extract of Terminalia sambesiaca, which 
gave the widest zones of inhibition of all the extracts investigated and showed excellent 
antibacterial activities both against Enterobacter aerogenes and all the gram-positive bacteria (I, 
Table 2). This plant gave, however, similarly to most of the other species of Terminalia and 
Combretum in our investigation, no effects against the gram-negative Escherichia coli. The 
methanolic root extract of T. sambesiaca showed bactericidal effects against the gram-negative 
Enterobacter aerogenes and gave a very low MIC value of 0.9 mg/ml against this bacterial 
species (I, Table 3). The root extract of T. sambesiaca was effective also against the gram-
positive Staphylococcus aureus (MIC 1.8 mg/ml), S. epidermidis (MIC 1.5 mg/ml), Micrococcus 
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luteus (MIC 1.0 mg/ml) and Sarcina sp. (MIC 1.2 mg/ml), but the effects against these bacteria 
were bacteriostatic (I, Table 3). Six fractions of the root extract of T. sambesiaca, obtained by 
medium pressure liquid chromatography (MPLC) on reverse phase silica gel were also 
investigated for their antibacterial effects, and the crude extract was found to be less active than 
the polar fractions and as active as the less polar fractions. The polar fraction RF2 was most 
active of the fractions, although fractions RF1-RF4 were very similar to their antibacterial 
activities (unpublished results, Table 8). The more non-polar fractions (RF5-RF6) were not as 
active as RF1-RF4, although they also gave antibacterial effects. It thus seems that the root 
extract of T. sambesiaca contains several antimicrobial compounds of different polarity. This is 
in accordance with the finding of Martini & Eloff (1997) and Eloff (1999) that African species of 
Combretum and Terminalia contain a wide variety of different antibacterial compounds of 
different polarity. Similarly to us, also Tshikalange et al. (2005) and Moshi & Mbwambo (2005) 
found that the intermediate and polar extracts of the roots of Terminalia are antibacterially more 
active than less polar fractions (these authors used T. sericea for their investigations). Since hot 
water decoctions are one of the ways in which T. sambesiaca is prepared for medicine in 
Tanzania (Chhabra et al., 1989) this way of preparation would thus extract the highly 
antimicrobial polar compounds from T. sambesiaca. The antibacterial effects of the root extract 
of T. sambesiaca might be due both to polar compounds, such as hydrolysable ellagitannins 
which have been found in large quantities from many species of Terminalia (Burapadaja & 
Bunchoo, 1995; Baba-Moussa et al., 1999; Silva et al., 2000; Conrad et al., 2001; Silva et al., 
2002) and saponins (Masoko et al., 2005), as well as more nonpolar compounds, such as 
flavonoids (Srivastava et al., 2001; Elegami et al., 2002; Silva et al., 2002), lignans (Valsaraj et 
al., 1997) and triterpenoids (Bombardelli, 1974 and 1976; Conrad et al., 1998; Srivastava et al., 
2001; Atta-ur-Rahman, 2002) which are also known from many species of Terminalia. Also a 
methanolic extract of the stem bark of T. sambesiaca showed excellent antibacterial effects, 
although the zones of inhibition were smaller than those shown by the root extract (I, Table 2). 
The MIC value of the extract of the stem bark was also slightly higher than those shown by the 
extract of the roots against Sarcina sp. (I, Table 3). To the best of our knowledge there is only 
one earlier investigation on the antibacterial effects of T. sambesiaca (Chhabra et al., 1989) and 
according to this investigation an extract of the stem bark of T. sambesiaca gave antibacterial 
effects against Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi and Shigella 
boydii, but the active compounds were not identified. Masoko et al. (2005) and Masoko & Eloff 
(2005) found that leaf extracts of T. sambesiaca are antifungal, but they did not include bacterial 
species in their screening. In Tanzania powdered root bark of T. sambesiaca is mixed with 
porridge for the treatment of bloody diarrhea and the stem bark and leaves are decocted for the 
treatment of stomach ulcers and appendicitis (Chhabra et al., 1989). Our results on the 
antibacterial effects of T. sambesiaca are thus justified both by the uses of this plant in traditional 
medicine and by the good antibacterial results obtained by Chhabra et al. (1989). Our results 
show that it would be worth to investigate T. sambesiaca in depth for its antimicrobial potential 
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against a panel of bacterial species known to cause serious infections, and to isolate the active 
compounds responsible for the activity. 
 
Table 8. Antibacterial effects of a crude extract (50 mg/ml) and fractions RF1-RF6 (20 mg/ml) isolated from a root 
extract of Terminalia sambesiaca. Average diameters of the zones of inhibition in mm (n = 4–6) ± S.E.M. 
Streptomycin and ampicillin (10 mg/ml) were used as positive controls.  
 
Crude extract and 
fractions 
Enterobacter aerogenes Micrococcus luteus Staphylococcus aureus 
Extract 36.10 ± 0.53 39.30 ± 0.28 33.60 ± 1.26 
RF 1 33.35 ± 0.30 35.68 ± 0.55 30.53 ± 0.06 
RF 2 36.25 ± 0.60 37.53 ± 0.77 34.28 ± 1.36 
RF 3 33.48 ± 0.19 29.13 ± 3.65 31.41 ± 0.18 
RF 4 31.33 ± 0.09 32.23 ± 0.14 23.30 ± 0.41 
RF 5 21.50 ± 1.46 18.45 ± 0.04 * 
RF 6 18.30 ± 0.54 * * 
Ampicillin 51.00 ± 1.06 70.54 ± 1.78 60.80 ± 0.07 
Streptomycin 44.10 ± 1.03 48.30 ± 0.45 41.25 ± 0.25 
 
* not investigated 
 
 
 
Terminalia sericea 
Extracts of the roots of Terminalia sericea were nearly as effective as the root extract of T. 
sambesiaca against the bacteria used in our investigation (I, Table 2) and gave as low MIC 
values as the root extract of T. sambesiaca against Micrococcus luteus (1.0 mg/ml) and slightly 
higher values than the root extract of T. sambesiaca against Enterobacter aerogenes (1.5 mg/ml), 
Staphylococcus aureus (5.3 mg/ml) and Staphylococcus epidermidis (1.8 mg/ml) (I, Table 3). 
The MIC values we have found for the root extract of T. sericea correspond to the values given 
by Eloff (1999) for leaf extracts, although they report a lower MIC for S. aureus, 3.0 mg/ml, 
compared to our 5.3 mg/ml. The leaves and roots might differ to their chemical composition and 
quantity of compounds, and thus give totally different MIC values. We compared the 
antibacterial potential of a hot water decoction, a methanolic, acetone and ethanol extract of the 
roots to each other and found that they did not differ significantly from each other (I, Table 2). A 
chloroform extract obtained by liquid-liquid extraction of a methanol extract of T. sericea, which 
gave a yellowish, oily substance, was completely devoid of antibacterial activity in accordance 
with the findings of Tshikalange et al. (2005) who also found that this solvent did not extract any 
antibacterial compounds from the roots of T. sericea, at least against the bacteria they used in 
their investigation. The hot water decoction of the roots of T. sericea was as antibacterial as the 
methanol, ethanol and acetone extracts (I, Table 2), and this justifies the use of hot water 
decoctions of the roots of T. sericea in Mbeya, Tanzania and in many other African countries for 
the treatment of diarrhea, wounds, pneumonia, venereal, eye and skin diseases (Table 7; Table 9; 
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I, Table 1; II, Table 1; Drummond & Coates-Palgrave, 1973; Hedberg et al., 1982; Neuwinger, 
2000), since the antibacterial compounds seem to be extracted in hot water as well. In accordance 
with our results also Tshikalange et al. (2005) found good antibacterial effects of hot water 
decoctions of the roots of T. sericea against gram-positive bacteria and also that this extract did 
not affect the growth of E. coli. On the contrary, Moshi & Mbwambo (2005) have found that root 
extracts of T. sericea are active against E. coli. The differences in these results might be due to 
the method of screening used, since we have used agar diffusion and Moshi & Mbwambo (2005) 
used a micro plate dilution method which is more sensitive in detecting antimicrobial activity. 
Similarly to our findings, both Tshikalange et al. (2005) and Moshi & Mbwambo (2005) found 
that intermediate and polar extracts of the roots of T. sericea are the antibacterially most active 
ones. The lignan, Anolignan B, isolated from the roots of T. sericea has been found to be 
antibacterial against both gram-negative and gram-positive bacteria and gave a MIC value of 3.8 
µg/ml against Bacillus subtilis (Eldeen et al., 2005). Thus, part of the excellent antimicrobial 
activity we have seen for this extract might be due to this lignan. The triterpenoids sericoside and 
arjunglucoside have been isolated from the roots of T. sericea (Bombardelli, 1974 and 1986) but 
the antibacterial effects of these compounds have not been elucidated, to the best of our 
knowledge. The root is considered poisonous among traditional healers in Africa, and thus the 
plant is often administered in careful dosage (Watt & Breyer-Brandwijk, 1962). We found that 
methanolic extracts of the leaves of T. sericea were not as antimicrobial as those of the roots, 
although they also gave good antibacterial effects in accordance to the investigation of Eloff 
(1999), and especially good effects against Enterobacter aerogenes and Micrococcus luteus (I, 
Table 2). These results justify the use of leaf infusions for pneumonia and dressings of leaves for 
the treatment of wounds in African traditional medicine (Neuwinger, 2000) as well as leaves, 
roots and stem bark for diarrhea and bacterial infections in Tanzanian traditional medicine (I, 
Table 1; Table 7). 
 
Terminalia kaiserana 
We found that methanolic root extracts of T. kaiserana were as effective inhibitors of bacterial 
growth as the root extracts of T. sambesiaca and T. sericea (I, Table 2). This is, to our 
knowledge, the first time crude extracts of T. kaiserana are reported to possess excellent 
antibacterial activities. The leaf extract was less active than the extract of the roots, but was the 
only one of the plant extracts used in this investigation to inhibit the growth of E. coli, and the 
effect was found to be bactericidic. The excellent antibacterial activity of the root extract justifies 
the use of T. kaiserana in African traditional medicine for the treatment of diarrhea and 
gonorrhea (I, Table 1; Table 7; Table 9; Haerdi, 1964; Kokwaro, 1976). 
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5.3.2. Antibacterial effects of the species of Combretum collected from 
Tanzania 
 
The Combretum species showed in general less antibacterial activity than the species of 
Terminalia, although most of the species in our investigation were antibacterial to some extent. 
Three species of Combretum, C. fragrans, C. padoides and C. molle gave excellent antibacterial 
effects (I, Table 2), the results being summarized in Table 9 in relation to the uses of these plants 
in traditional medicine in Mbeya, Tanzania. 
 
Combretum padoides 
Methanolic extracts of the roots and the stem bark of C. padoides gave similar results against 
most of the bacterial species studied, and the best effects were obtained against Staphylococcus 
aureus and Enterobacter aerogenes (I, Table 2). This implies that the mechanism of action of the 
active compounds in these extracts are not very specific, but more general in nature, since it 
shows activity against both gram-positive and gram-negative bacteria. In accordance to us, Eloff 
(1999) found that leaf extracts of C. padoides are powerful inhibitors of the growth of 
Enterobacter, although they used another bacterial species, E. faecalis (MIC = 0.8 mg/ml). Eloff 
(1999) also found that a leaf extract of C. padoides inhibited the growth of E. coli (MIC = 0.8 
mg/ml) whereas we found no effect of C. padoides on this bacterial species. This might be due to 
use of extracts from different parts of the plant, since we used roots and stem bark, whereas Eloff 
(1999) used leaves. The compounds responsible for the antibacterial activity of C. padoides are 
unknown. Mono- and bi-desmosidic triterpenoids (Rogers, 1989) and saponins (Rogers and Carr, 
1987) have been isolated from the leaves of C. padoides, but as far as we know the antibacterial 
effects of these compounds have not been investigated. 
 
Combretum fragrans 
Extracts of the roots of C. fragrans gave excellent antibacterial activities against Enterobacter 
aerogenes and Micrococcus luteus. Leaf extracts were less active, but still gave very good effects 
against Micrococcus luteus (I, Table 2). To the best of our knowledge, this is the first time C. 
fragrans is reported to give good antibacterial effects. This species have been evaluated for 
antifungal effects by Batawila et al. (2005) and was found to possess excellent antifungal activity 
against different species of Candida, including C. albicans, and the leaf extract was found to 
contain antifungally active tannins, flavonoids and saponins. Rogers & Carr (1987) have isolated 
triterpenoids from the leaves of C. fragrans, and they might, in part, be responsible for the good 
antibacterial effects we observed. The good antibacterial effects we observed for C. fragrans are 
in agreement with the use of this species for treatment of bacterial infections, such as syphilis, 
leprosy and diarrhea, as well as for the treatment of incurable wounds in African traditional 
medicine (Kokwaro, 1976; Chhabra et al., 1989; Fyhrquist et al., 2002; Batawila et al., 2005). 
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The use of C. fragrans for the treatment of diarrhea in Tanzanian traditional medicine (I, Table 1; 
Table 7) is supported by the good activity this species showed against S. aureus, a common 
causative agent of food poisoning. 
 
Combretum molle 
A leaf extract of Combretum molle gave excellent antibacterial effects against Micrococcus 
luteus and Enterobacter aerogenes (I, Table 2). This is in accordance with the traditional use of 
leaf extracts and decoctions of this species for bacterial infections, diarrhea and venereal diseases 
in Mbeya, Tanzania (Table 7; I Table 1). 
 
Combretum zeyheri, C. psidioides and C. hereroense gave also substantial activity against the 
investigated bacterial species. Of these species, C. zeyheri and C. hereroense have been screened 
for their antibacterial effects before by Eloff (1999). C. psidioides has to our knowledge not been 
screened for its antibacterial effects earlier. The compounds responsible for the antimicrobial 
effects of C. hereroense are unknown. Three compounds with activity against S. aureus have 
been isolated from the stem bark of C. zeyheri (Breytenbach & Malan, 1989). 
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Table 9. Summary of the antibacterial effects of the most effective extracts of Combretum and Terminalia in our 
screening and correlation to ethnomedical use in Mbeya. Extracts are placed in activity order. * not investigated. 
 
Species and extract Results in screening  MIC values Traditional use in Mbeya 
Terminalia sambesiaca, 
roots 
The most antibacterial extract 
in this screening. Good 
activities against Micrococcus 
luteus, Sarcina sp., S. aureus 
and E. aerogenes 
Enterobacter aerogenes, 0.9 
mg/ml 
Micrococcus luteus, 1.0 mg/ml 
Sarcina sp., 1.2 mg/ml 
Staphylococcus epidermidis,1.5 
mg/ml 
Staphylococcus aureus, 1.8 
mg/ml 
No uses reported in Mbeya 
 
 
T. sambesiaca, stem 
bark 
Good activities against 
Micrococcus luteus, Sarcina 
sp., S. aureus and E. aerogenes 
Sarcina sp., 4.3 mg/ml No use reported in Mbeya 
 
 
T. sericea, roots Especially active against 
Micrococcus luteus, Sarcina 
sp., Staphylococcus aureus and 
Enterobacter aerogenes  
Micrococcus luteus, 1.0 mg/ml 
Enterobacter aerogenes, 1.5 
mg/ml 
Staphylococcus epidermidis, 
1.8 mg/ml 
Staphylococcus aureus, 5.3 
mg/ml 
For diarrhea, hypertension, 
fever and bacterial 
infections  
T. kaiserana, roots Good activities against S. 
aureus, Enterobacter 
aerogenes, Micrococcus luteus 
and Sarcina sp. In general 
stronger antimicrobial effects 
than leaf extract. 
Sarcina sp., 4.3 mg/ml 
Staphylococcus epidermidis, 
4.7 mg/ml 
For gonorrhea, diarrhea and 
vomiting 
T. kaiserana, leaves The only extract inhibiting 
growth of E. coli. Good 
activities also against 
Staphylococcus aureus, 
Micrococcus luteus and 
Sarcina sp. 
* For gonorrhea, diarrhea and 
vomiting 
T. sericea, leaves Good antimicrobial effects 
against Micrococcus luteus and 
Enterobacter aerogenes 
* For diarrhea, hypertension, 
fever and bacterial 
infections  
Combretum fragrans, 
roots 
Excellent antimicrobial activity 
against Micrococcus luteus and 
Enterobacter aerogenes.  
Sarcina sp., 7.3 mg/ml For diarrhea 
C. fragrans, leaves Excellent activity against 
Micrococcus luteus 
* No uses reported in Mbeya 
C. padoides, roots Good activities against 
Staphylococcus aureus and 
Enterobacter aerogenes. 
* No uses reported in Mbeya 
C. padoides, stem bark Good activities against 
Staphylococcus aureus and 
Enterobacter aerogenes. 
* No uses reported in Mbeya 
C. molle, leaves Excellent effects against 
Micrococcus luteus and 
Enterobacter aerogenes 
* To treat gonorrhea, syphilis, 
influenza, oedema, skin 
diseases, diarrhea and 
wounds 
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5.4. Antifungal effects of extracts and fractions of Combretum, 
Terminalia and Pteleopsis spp. (II) 
 
The incidence of opportunistic fungal infections in patients treated with immunosuppressive 
drugs, intensive chemotherapy, suffering from AIDS and neonates is increasing at an alarming 
rate (Denning et al., 1997). Mycotic infections are very difficult to eradicate and they constitute 
an enormous challenge for health care providers. The fungi, like their hosts, are eukaryotic 
organisms, making it difficult to choose intracellular targets whose inhibition would not also be 
deleterious to the host cells (Di Domenico, 1999). Although an array of different treatments are 
used for fungal infections, none of them are ideal in terms of efficacy, safety or antifungal 
spectrum (Di Domenico, 1998; Ablordeppey at al., 1999). Many of the current drugs are very 
toxic (Amphotericin B), lead to the development of resistance (fluconazole and 5-flucytosine) or 
exhibit drug-drug interactions (azoles) (White et al., 1998). Potent antifungal drugs might be 
found from the plant kingdom. Some research projects have been going on to find plant derived 
antifungal compounds: In a screening of African and Panamian plants, Hostettman & Marston 
(1994) found antifungal activity in 15 % of the investigated plants of which the most promising 
species were used in traditional medicine. In the search of the underlying active principles of 
Pelargonium species, used for treatment of respiratory infections, antifungal hydrolysable tannins 
were identified (Kayser & Kolodziej, 1997; Latté & Kolodziej, 2000). Several methods have 
been used for the screenings of antifungal compounds in plants, the most common ones being 
agar diffusion, broth microdilution techniques and bioautography. Bioautography allows the 
combination of a bioassay and localization of the active compounds on the TLC plate employed 
for the assay (Hostettman & Marston, 1994). 
We have investigated the antifungal effects of thirty-five extracts of five species of Terminalia, 
ten species of Combretum and Pteleopsis myrtifolia (II, Table 2) with the aid of a filter paper 
agar diffusion method, and the results in relation to the traditional medicinal uses of the plants in 
Mbeya are summarized in Table 10. Some of the plant species included in our investigation are 
used for the treatment of topical fungal infections and diarrhea as well as for other infectious 
diseases in African traditional medicine (II, Table 1; Table 7). Some of the plants in this 
screening have to our knowledge not been investigated for their antifungal effects before. 
Five species of yeasts (Candida) and the yeastlike basidiomycet, Cryptococcus neoformans, most 
of them common opportunistic pathogens, were used as test organisms (II, Table 2). All the 
fungal species used in our screenings are usually harmless to healthy persons, but have the ability 
to cause opportunistic systemic infections in immunocompromized hosts, although also healthy 
persons can get topical infections on the skin and mucosal surfaces. Candida species are also 
known to cause subcutaneous infections in tropical parts of the world, usually introduced through 
wounds. Candida albicans, also part of the normal flora in humans (in 30- 50 %), is the most 
frequently encountered human fungal pathogen causing systemic fungaemias, although 
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physicians report the increasing occurrence of non-albicans (NAC) Candida species, such as 
Candida parapsilosis, C. tropicalis, C. krusei and C. glabrata, during the last two decades, some 
of them exhibiting natural resistance to antifungal drugs (Sobel, 1998; Viscoli et al., 1999; 
Krcmery & Barnes, 2002). Reports within the last years have indicated the rapid development of 
fluconazole and amphotericin B resistance in Candida tropicalis (Krcmery & Barnes, 2002). 
Cryptococcus neoformans is the only significant human pathogen amongst the basidiomycetous 
fungi and causes life-threatening meningoencephalitis in immunosuppressed patients, especially 
in those with HIV infection (Harrison, 2000). In Africa and South-East Asia, in particular, AIDS 
related cryptococcosis appears to be more common than it was in Europe and North America 
prior to combination antiretroviral therapy (Kayembe et al., 1994). Despite conventional 
treatment, infections with Cryptococcus neoformans var. gattii strain are associated with 
significant mortality (Seaton et al., 1996), and not infrequently leads to blindness in survivors 
(Harrison, 2000). 
 
5.4.1. Antifungal effects of the species of Terminalia collected from 
Tanzania 
 
We found that the species of Terminalia in general gave stronger antifungal effects than the 
Combretum species and Pteleopsis myrtifolia used in this study, although also some of the 
species of Combretum gave good antifungal effects (II, Table 2). There was a large variation in 
activity between different species of Terminalia and Combretum, as well as between different 
extracts made from different plant parts (roots, leaves, stem bark and fruits). Some 
species/extracts did not show any antifungal activities compared to others with strong activity. 
The strongest antifungal effects of all the species used in our screenings were shown by T. 
sambesiaca, T. sericea and T. kaiserana (II, Table 2; Table 10) which also gave the best 
antibacterial effects (See previous chapter, Table 9; I, Table 2). In the following the species with 
the strongest antifungal activities are presented. 
 
Terminalia sambesiaca 
A root extract of T. sambesiaca (50 mg/ml) gave the strongest antifungal effects of all the 
investigated extracts and species of Terminalia and was especially active against Candida 
glabrata (MIC = 3.13 mg/ml) and Cryptococcus neoformans (MIC = 1.56 mg/ml) (II, Table 3). 
The root extract gave an antifungal activity comparable to the positive controls, itraconazol and 
amphotericin B used in our screening. Another research group has recently screened T. 
sambesiaca for antifungal effects (Masoko et al., 2005; Masoko & Eloff, 2005), and in agreement 
with our results they found that this species possesses potent antifungal activity against Candida 
albicans and Cryptococcus neoformans, with average MIC values ranging from 0.232 – 0.64 
mg/ml, although they used leaf material and not roots and stem bark. We did not detect any 
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antifungal activity of a leaf extract of T. sambesiaca against Cryptococcus neoformans (II, Table 
2) but this might be due to the use of different methods, Masoko et al. (2005) using a 
microdilution assay. Masoko & Eloff (2005) found that the antifungal activity of the leaves of T. 
sambesiaca was concentrated to nonpolar fractions, such as hexane and dichloromethane, 
whereas we found that the most polar fractions (RF 1 and RF 2) isolated from a methanolic root 
extract of T. sambesiaca with column chromatography were the antifungally most active ones (II, 
Table 2). It seems that the roots and leaves of T. sambesiaca contain different kinds of antifungal 
compounds, and that this species contains a large spectrum of antifungal compounds differing 
from each other in their polarities. Carpano et al. (2003) studied the antifungal effects of the 
aerial parts of the South-American species Terminalia australis and found, similarly to us, that 
the methanol and aqueous extracts gave the strongest antifungal activities against Candida 
albicans and C. krusei, whereas a nonpolar dichloromethane extract was inactive. Hydrolysable 
tannins might be present in higher concentrations in more polar extracts. Hydrolysable tannins 
have been isolated from both Asian and African species of Terminalia (Burapadaja & Bunchoo, 
1995; Silva et al., 1997; Silva et al., 2000; Lin et al., 2001), and have been found to be especially 
potent against Cryptococcus neoformans, showing MIC values between 0.02 and 0.1 μM, 
corresponding to 16-125 μg/ml (Latté & Kolodziej, 2000). Corilagin, also known from some 
Terminalia species (Burapadaja & Bunchoo, 1995), was found to be more active than the 
antibiotics sertaconazol and amphotericin B against C. glabrata, and some hydrolysable tannins 
were more potent against non-albicans species of Candida than against C. albicans (Latté & 
Kolodziej, 2000). 
The strong antifungal activity shown by Terminalia sambesiaca in our investigation shows that 
this plant has antimicrobial potential and this is in agreement with the traditional use of this plant 
in Africa where the root bark is mixed with porridge for the treatment of bloody diarrhea 
(Chhabra et al., 1989). The way of preparing this plant into water decoctions for traditional 
medicine (Chhabra et al., 1989) might lead to the extraction of antifungally active water soluble 
compounds, since we detected strong antifungal activity for polar fractions obtained from a 
methanolic extract of the roots of T. sambesiaca. Our results indicate that this species can be used 
for antifungal therapy in remotely situated villages in Africa, where conventional antibiotics are 
not available. The strong activity of this plant against Cryptococcus neoformans makes it a 
valuable medicinal plant in Africa, where a high proportion of AIDS-related cryptococcal 
infections occur (Kayembe et al., 1994). 
 
Terminalia kaiserana 
A root extract of Terminalia kaiserana gave the second best antifungal effects of the four species 
of Terminalia used in our screening (II, Table 2), and was the most effective extract to inhibit the 
growth of Candida krusei and was also effective against C. glabrata (MIC = 1.56 mg/ml) (II, 
Table 3). In addition the root extract of T. kaiserana was as effective as the root extract of T. 
sambesiaca against Cryptococcus neoformans (MIC = 1.56 mg/ml) (II, Table 3 and Table 2). A 
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leaf extract of T. kaiserana did, interestingly, not show any antifungal activity, at least against the 
species of yeast we used in this screening, although in a previous screening (I, Table 2) we found 
some activity against C. albicans. This might be explained by the fact that two different strains of 
C. albicans were used which might differ from each other in their sensitivity. Differences 
between different plant parts in antifungal and biological activity in general is well known and for 
example Julkunen-Tiitto (1989), who studied the differences in phenolic composition between 
plant organs of Finnish Salix species, found that different plant organs can differ significantly 
from each other in terms of phenolic compound composition and quantity. The same trend of the 
leaf extracts being less active than the extracts of the roots could be seen in Terminalia 
sambesiaca and T. sericea as well, but not in T. stenostachya in which the leaf extract gave good 
effects against most of the yeasts and was more effective than an extract of the stem bark (II, 
Table 2). The chemical composition of T. kaiserana is unknown, but probably also this species of 
Terminalia contains hydrolysable tannins, as well as flavonoids and saponins, which have been 
found from many species of Terminalia (Baba- Moussa et al., 1999; Silva et al., 2002). The 
antifungal potential of root extracts of T. kaiserana is so great that it would be worth to elucidate 
which compounds are responsible for these effects. 
T. kaiserana is a well known plant among traditional healers in Africa (I, Table 1; II, Table 1; 
Chhabra et al., 1989; Kokwaro, 1976; Haerdi, 1964). The roots are the most used part of this 
species, and this is in accordance with our findings that root extracts are more effective than the 
leaves in inhibiting fungal growth (Table 10). Kokwaro (1976) and Haerdi (1964) report that the 
roots of T. kaiserana are used for treatment of gonorrhea and bilharzia and the leaf sap for cough, 
and traditional healers in Mbeya use both leaves, roots and stem bark as hot water decoctions or 
mixed in porridge to treat diarrhea, gonorrhea and vomiting (I, Table 1, Table 7). These uses in 
traditional medicine agree with our results on the antifungal potential of T. kaiserana since 
diarrhea can be a symptom of Candida infection. The excellent antifungal activity shown by T. 
kaiserana indicates that this species could have an additional use specifically for the treatment of 
fungal infections in African traditional medicine. To our knowledge we are the first to report on 
the excellent antifungal activity of this species of Terminalia and so far no other research group 
have included this species in biological screenings, although Eloff (1999) have screened the 
antibacterial effects of 27 species of South African members of Combretaceae. 
 
Terminalia sericea 
Terminalia sericea was the third species of Terminalia in our investigation to give excellent 
antifungal effects (II, Table 2). Methanolic root extracts of this species were especially active 
against Candida glabrata and gave the lowest MIC value of all the extracts used in this 
investigation against this species of yeast (0.78 mg/ml) (II, Table 3). When different kinds of 
extracts of the roots were compared for their antifungal effects we found, interestingly, that a hot 
water decoction gave the best results against C. albicans, the acetone extract being second most 
effective and ethanolic and methanolic extracts being less effective. The roots of T. sericea are 
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generally reported to be prepared into hot water decoctions for the treatment of stomach problems 
in East Africa (Drummond & Coates-Palgrave, 1973; Fyhrquist et al., 2002), and thus we have 
shown that this way of preparing the plant for medicine seems to extract many antifungal 
compounds. Acetone seems also to be a good solvent for extracting antifungal compounds from 
T. sericea, since this extract gave good effects against C. albicans. Also Eloff (1999) and Martini 
and Eloff (1997) have reported that acetone is a good extractant for antimicrobial compounds in 
Terminalia spp. and Combretum spp. The differences we found in the antifungal activity of 
methanol, ethanol and acetone extracts were, however, very small and the extracts gave nearly 
equal antifungal effects against Candida glabrata and Cryptococcus neoformans. Only a few 
other investigations have been performed on the antifungal effects of T. sericea; In their 
screening of the antifungal effects of six species of Terminalia, Masoko et al. (2005) and Masoko 
& Eloff (2005) found that T. sericea was the antifungally most effective species, and that the best 
effects were obtained with dichloromethane and hexane extracts of the leaves, although good 
effects were also obtained with acetone and methanol extracts against Candida albicans and 
Cryptococcus neoformans. When the MIC values of the six Terminalia species were compared, 
they were nearly similar, but T. sericea contained more extractable antifungal compounds/g plant 
material. It would, as Masoko et al. (2005) also point out, be interesting to know if it is the same 
compound which is active against different fungal species, and also to know whether the same 
antifungal compound is present in different species of Terminalia. Moshi & Mbwambo (2005) 
detected good antifungal activities in both methanol and butanol extracts of the roots of T. sericea 
but found less activity of an aqueous root extract against Candida albicans. Since both Masoko & 
Eloff (2005) and Moshi & Mbwambo (2005) have found that relatively non-polar extracts of T. 
sericea give good antifungal effects and we have found good activity of hot water decoctions as 
well as acetone extracts, the antifungal activity of this species might due to both tannins as well 
as less polar compounds. Resveratrol-3-O-β-D-rutinoside (Bombardelli et al., 1975) and the 
triterpenoids sericoside, arjunglucoside as well as the aglycone of sericoside have been isolated 
from the roots and stem of T. sericea (Bombardelli et al., 1974; Bombardelli et al., 1986; Rode et 
al., 2003). Resveratrol (Chan, 2002; Leiro et al., 2004) as well as triterpenoids (Abad et al., 2007) 
are known to possess antifungal potential, and thus some of the compounds mentioned above 
might be responsible for the excellent antifungal effects we have observed for T. sericea. 
Our results on the antifungal effects of Terminalia sericea agree with the use of hot water 
decoctions of this plant as well as in tea and porridge for the treatment of diarrhea and stomach 
problems in African traditional medicine since these ailments might be due to fungal infections 
(Watt & Breyer-Brandwijk, 1962; II, Table 1; Table 7; Table 10). 
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5.4.2. Antifungal effects of species of Combretum collected from Tanzania 
 
Ten species of Combretum were screened for their antifungal effects (II, Table 2). Some of the 
species, such as C. constrictum and C. psidiodes, have not been investigated for their antifungal 
effects before. Since some of the species of Combretum we screened are known to be used for the 
treatment of diseases and ailments related to fungal (microbial) infections in African traditional 
medicine (II, Table 1; Table 7) we expected to find at least some antifungally active species 
among the ten screened ones. Root extracts of Combretum padoides and of C. molle gave the 
most outstanding antifungal effects of all the investigated extracts, whereas some other extracts, 
such as a leaf extracts of C. fragrans and C. molle showed only slight or not any activity against 
the fungal species used in our investigation. The antifungal activity was not related to/restricted 
to any particular plant organ in Combretum spp. Rather, it seemed to be species specific whether 
to which organ would show the highest activity. In some cases extracts showed species specifity 
in their antifungal effects, such as a leaf extract of C. apiculatum which gave slight antifungal 
effects against Cryptococcus neoformans but no activity against the Candida species. This 
arouses a question to whether this extract acts with a more specific inhibitory mechanism against 
C. neoformans. The extracts of the fruits were generally relatively inactive compared to the other 
plant parts of the Combretum species, with an exception of a fruit extract of C. psidiodes which 
inhibited the growth of Candida krusei, but none of the other species of Candida. Candida 
glabrata and C. krusei were the most sensitive fungal species whereas Cryptococcus neoformans 
was more resistant to the extracts of Combretum. Although some of the extracts gave high 
inhibitory values against C. glabrata, there were altogether more extracts showing activity 
against C. krusei, but giving smaller inhibition zones against this fungal species. Candida 
albicans seemed to be the most resistant species of all the fungal species used in our study. 
 
The Combretum species showing the most potential antifungal effects in our screenings are 
presented below. 
 
Combretum padoides 
The most outstanding antifungal effects were observed with a root extract of C. padoides which 
gave fungicidal inhibition zones against Candida glabrata (MIC 6.25 mg/ml) and excellent 
inhibitory effects also against C. parapsilosis and Cryptococcus neoformans (MIC 6.25 mg/ml) 
(II, Table 2 and Table 3). This species of Combretum is used for treatment of snakebites and 
hookworms (Neuwinger, 2000), but not for ailments caused by microbial infections, and thus it 
was surprising that it gave the best antifungal results of all the investigated species of 
Combretum. On the other hand, both saponins (Carr & Rogers, 1987) as well as five triterpenoid 
desmosides (Rogers, 1989) have been isolated from leaf extracts of C. padoides, and both groups 
of compounds are known to possess antifungal potency. The chemical composition of the root 
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extract of C. padoides is however unknown, and the compounds responsible for the antifungal 
effects of the roots of this plant might be very different from them found in the leaves. Our 
results on the excellent antifungal effects of C. padoides root extracts indicate that this species 
might be used in a new way in African traditional medicine for treatment of fungal infections. 
 
Combretum molle 
C. molle root extracts gave excellent antifungal effects against all the species of Candida and 
Cryptococcus neoformans, and gave outstanding inhibitory effects against Candida glabrata 
(MIC 6.25 mg/ml) (II, Table 2 and Table 3). Extracts of the leaves were not as antifungal as the 
root extracts and were inhibitory only against the growth of Candida krusei, whereas none of the 
other fungal species were affected by this extract. This shows clearly that the leaves and roots 
contain active compounds in different amounts and might even contain different kinds of 
compounds. Some other authors have investigated the antifungal effects of C. molle: Khan et al., 
(2000) found that the stem bark of C. molle inhibited the growth of C. albicans with a MIC value 
of 5 mg/ml and Runyoro et al., (2006) observed that a root extract of C. molle gave fairly large 
inhibition zones against C. albicans. Baba-Moussa et al. (1999) found that a leaf extract of C. 
molle gave excellent antifungal effects against some dermatophytes, such as Microsporum 
gypseum (MIC = 0.25 mg/ml) and Trichophyton mentagrophytes (0.25 mg/ml). In many African 
countries, peeled twigs of C. molle, among many other plant species, are used as chewing sticks, 
“Miswaki” (Runyoro et al., 2006) and this kind of use of C. molle might be beneficial in treating 
Candida infections in the mouth often occurring in immuno-compromised patients such as those 
suffering from AIDS. C. molle is also used both internally as water decoctions for the treatment 
of diarrhea and stomach problems as well as topically, as an ointment for fungal infections on the 
skin (I, Table 1; Table 2, Table 7), and all these traditional uses are now justified by the results of 
us and other authors on the good antifungal potential of this species of Combretum. The excellent 
antifungal effects of C. molle might be due to hydrolysable tannins, since punicalagin and another 
tannin designated CM-A, have been isolated from the stem bark of C. molle (Asres et al., 2001a, 
Asres et al., 2001b). Punicalagin is an ellagitannin containing a galloyl moiety. It was originally 
isolated from Punica granatum, and is reported to possess antimicrobial activity against Candida 
albicans (Burapadaja & Bunchoo, 1995). As mentioned before, many hydrolysable tannins are 
known to possess good anti-Candidal and anti-Cryptococcal effects and the pyrogalloyl element 
in the tannin molecule seems to be crucial for the antifungal response (Latté & Kolodziej, 2000). 
Interestingly, when Asres et al. (2001b) investigated the antimalarial effects of punicalagin and 
CM-A they found that they were less effective than the crude extract of C. molle and speculated 
that the different tannins in the extract act synergistically with each other or with other 
compounds in the extract, or that some very active compounds were lost during the purification 
of the extract. In addition to tannins, C. molle has been found to contain many other compounds 
with potential antifungal activity: Letcher et al. (1972) have isolated a bibenzyl from the 
heartwood of C. molle; acid saponins like mollic acid-3-β-D-glucoside have been isolated from 
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the leaves of C. molle, and was found to give antifungal effects against Penicillium sp. (Pegel & 
Rogers, 1985). Thus, our results and the results of other authors indicate that C. molle is a rich 
source of antifungal compounds and this explains why the plant frequently is used for the 
treatment of fungal infections in African traditional medicine. 
 
Combretum psidioides and Combretum fragrans 
An extract of the stem bark of Combretum psidioides and a root extract of C. fragrans both gave 
excellent antifungal effects against Candida glabrata (II, Table 2). To our knowledge there are 
no previous reports on the antifungal effects of C. psidioides. Some phenanthrene compounds 
have been isolated from C. psidioides but the antimicrobial effects of these compounds were not 
investigated (Pettit et al. 1987). This species shows good antifungal potential also against 
Cryptococcus neoformans and Candida parapsilosis. Interestingly, extracts made from the fruits, 
leaves and stem bark of C. psidioides all showed activity against C. krusei. The use of C. 
psidioides for the treatment of diarrhea in African traditional medicine (Haerdi, 1964; I, Table 1; 
II, Table 1; Table 7) is now justified by the promising antifungal profile shown by this species 
(Table 10). A root extract of C. fragrans gave good antifungal activities against all the Candida 
species except C. tropicalis and was inactive against Cryptococcus neoformans. In addition to 
our investigation C. fragrans has been studied by Batawila et al. (2005) who found that a leaf 
extract of this species possessed good antifungal effects against Candida zeylanoides, C. 
tropicalis, C. albicans and C. glabrata and C. guillermondii with MIC values ranging between 
0.25 – 2 mg/ml. We did, however, not detect any antifungal effects of the leaf extract of this 
species. The discrepancies in the results of the antifungal effects of leaf extracts of this species 
between Batawila et al. (2005) and our group might be due to the use of different screening 
methods, Batawila et al. (2005) using an aqueous medium dilution method, whereas we used an 
agar filter paper diffusion method. Batawila et al. (2005) found that the leaves of C. fragrans 
contain large amounts of tannins, flavonoids and a few saponins, which indicates that these 
compounds might be responsible for the good antifungal activities shown by this species. 
 
5.4.3. Antifungal effects of Pteleopsis myrtifolia 
 
Pteleopsis myrtifolia was the only representant of the genus Pteleopsis included in our 
investigation. Since it is used for the treatment of wounds in African traditional medicine 
(Hedberg et al., 1982) it was not surprising that a root extract of P. myrtifolia gave good 
antifungal effects against Candida glabrata and C. krusei and some antifungal activity against the 
rest of the Candida species as well as against Cryptococcus neoformans (II, Table 2). As far as 
we know we are the first to report good antifungal activity for this species. Another species of 
Pteleopsis, P. suberosa, has been found to possess powerful antifungal effects against both 
dermatophytes and Candida albicans (Baba-Moussa et al., 1999) and this species was found to be 
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more active than the species of Combretum and Terminalia used in the investigation. Saponins 
and tannins were found in P. suberosa, why the same kind of compounds might be found from P. 
myrtifolia as well and be responsible for the good antifungal profile of this species. 
 
Table 10. Summary of the antifungal effects of the most effective extracts of Terminalia, Combretum and 
Pteleopsis in our screening and correlation to ethnomedical use in Mbeya. * not investigated. 
 
Species and extract Results in screening  MIC values Traditional use in 
Mbeya 
Terminalia sambesiaca, 
roots  
Antifungal against all Candida 
species and Cryptococcus 
neoformans. Produced the largest 
zones of inhibition of all the 
extracts. 
Cryptococcus neoformans, 
1.56 mg/ml 
 
Candida glabrata, 3.13 
mg/ml 
No use reported 
T. kaiserana, roots The second best extract to inhibit 
fungal growth. Most effective of 
all the extracts to inhibit the 
growth of C. krusei.  
Candida glabrata, 1.56 
mg/ml 
 
Cryptococcus neoformans, 
1.56 mg/ml 
To treat gonorrhea, 
diarrhea and vomiting; 
together with C. molle for 
diabetes  
T. sericea, roots Hot water decoction stronger 
inhibitor than a MeOH extract of 
the growth of C. albicans. 
Acetone, EtOH and MeOH 
extracts gave good antifungal 
profiles against all Candida 
species. 
Candida glabrata, 0.78 
mg/ml 
 
Cryptococcus neoformans, 
6.25 mg/ml 
To treat diarrhea, fever, 
hypertension and bacterial 
infections 
T. stenostachya, leaves Good antifungal profile against all 
Candida species except C. 
tropicalis. Active against 
Cryptococcus neoformans. 
* * 
Combretum padoides, 
roots 
Most antifungal of the Combretum 
species screened. Good antifungal 
profile against all Candida species 
and C. neoformans. Fungicidal 
against C. glabrata. 
Candida glabrata, 6.25 
mg/ml 
 
Cryptococcus neoformans, 
6.25 mg/ml 
* 
C. molle, roots Good antifungal profile against all 
Candida species and C. 
neoformans 
Candida glabrata, 6.25 
mg/ml 
 
Cryptococcus neoformans, 
12.50 mg/ml 
To treat gonorrhea, 
syphilis, influenza, 
oedema, skin diseases and 
wounds 
C. fragrans, roots Good antifungal activity against all 
species of Candida except C. 
tropicalis. Not active against C. 
neoformans. 
* To treat diarrhea 
C. psidioides, stem bark Antifungal against C. krusei, C. 
glabrata, C. parapsilosis and 
Cryptococcus neoformans. 
* To treat diarrhea, muscle 
pain and oedema 
Pteleopsis myrtifolia, 
roots 
Antifungal against all Candida 
species, but especially active 
against C. glabrata and C. krusei, 
as well as C. neoformans 
* * 
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5.5. Antiproliferative and cytotoxic effects of extracts of Combretum, 
Terminalia and Pteleopsis against some human cancer cell lines and 
BBCE endothelial cells (III) 
 
Seven species of Terminalia have a long history in African and Asian traditional medicine for the 
treatment of cancer (Hartwell, 1982). Of the species of Combretum, only C. latifolium appears to 
have been recorded as a folk medical treatment of cancer (Hartwell, 1982). Based on my results 
the roots and leaves of C. zeyheri are used for the treatment of cancer (tumors) in some villages in 
Mbeya region (I, Table 1; Table 7). The genus Pteleopsis does not include species used for 
treatment of cancer in African traditional medicine, but was included in this study because of its 
relationship to Combretum and Terminalia. 
The genus Combretum seems to be particularly interesting in terms of anticancer compounds, and 
the South-African species C. caffrum, along with some other species of Combretum, are known 
to contain a series of rare small molecular bibenzyles, the combretastatins, which have a high 
affinity for the colchisin binding site of tubulin (situated between α- and β-tubulin in the tubulin-
heterodimer), inhibiting tubulin polymerization and microtubule assembly (Pettit et al., 1988; 
Pettit et al., 1989; Zhou & Giannakou, 2005). Combretastatin A-4 has been found to inhibit the 
proliferation of a variety of cancer cell lines, including multidrug resistant (MDR) cancer cell 
lines (McGown & Fox, 1990; El Zayat et al., 1993) and to trigger apoptosis (Cirla & Mann, 
2003). In addition combretastatins have been shown to exhibit both antivascular and anti-
angiogenic effects (Dark et al., 1997). 
Because of this background of traditional use as well as some species of Combretum containing 
powerful anticancer compounds, we decided to elucidate the in vitro anticancer effects of 
selected species of Combretum and Terminalia as well as Pteleopsis myrtifolia, some of them not 
studied before for their anticancer effects. A summary of our results on the cytotoxic effects of 
the species of Combretum, Terminalia and Pteleopsis is presented in Table 12 and III, Table 2. 
 
5.5.1. Antiproliferative effects of Combretum spp. 
 
At a concentration of 25 μg/ml six extracts of Combretum showed pronounced antiproliferative 
effects (> 70 % inhibition of proliferation) against the T 24 bladder cancer cells, three against the 
HeLa cervical cancer cells and three against the MCF 7 breast cancer cells (III, Table 2; Table 
11) and one extract, a leaf extract of C. fragrans gave excellent antiproliferative activity against 
an endothelial cell line (Table 11). The cytotoxically most active Combretum species were in 
general more active than the Terminalia species showing the best activities. At 250 μg/ml all the 
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extracts of Combretum spp. were lethal to the cancer cell lines, and resulted in empty wells 
compared to control cells. 
 
Below those species of Combretum giving the most outstanding results in the screenings are 
presented. 
 
Combretum fragrans 
Of all the investigated fourteen species of Combretum, Terminalia and Pteleopsis myrtifolia, a 
methanolic leaf extract of Combretum fragrans gave the most outstanding antiproliferative 
effects against the human cancer cell lines (III, Table 2) as well as the BBCE endothelial cells 
(Table 11). At 25 μg/ml this extract reduced the growth of all the cancer cell lines as well as the 
BBCE endothelial cells (Table 11; III, Table 2) to 6.8 – 13.3 % growth of control, and the growth 
inhibitory effect was dose and cell line dependent (III, Figure 1), the MCF 7 breast cancer cells 
being more resistant than the bladder and cervical cancer cell lines. Still at 4.3 μg/ml this extract 
inhibited the proliferation of 60 % of the HeLa cervical cancer cells compared to the control cells 
(III, Figure 1). All the cancer cell lines exposed to this extract appeared to round up and failed to 
thrive, while the non-treated cancer cells were adherent. Sublethal concentrations of the leaf 
extract of Combretum fragrans (4.3 μg/ml) might induce apoptosis at least in some cancer cell 
lines, since some fragmentation of the nucleus as well as formation of apoptotic bodies could be 
observed in HeLa cervical cancer cells stained with Hoechst. Further investigations on the effects 
of this extract on expressions of marker enzymes for apoptosis (p53, caspases etc.) are needed to 
verify this observation. Notably, the leaf extract of C. fragrans might act by specific cytotoxicity 
against cancer cell lines, not attacking normal cells, since we found that it only to a minor extent 
affected the division of COS-7 green monkey fibroblasts. 
 
The good antiproliferative effects of the leaf extract of C. fragrans on BBCE endothelial cells we 
have observed is interesting (Table 11), since tumorigenesis is dependent on the formation of 
new blood vessels (angiogenesis). Indeed, the cis-stilbene combretastatin A-4, originally isolated 
from the stem bark of C. caffrum (Pettit et al., 1989), has been found to possess both in vivo and 
in vitro anti-angiogenic and antivascular effects (Dark et al., 1997), and it is possible that this 
kind of compounds would be responsible for the good antiproliferative effects on BBCE cells we 
observed by the leaf extract of C. fragrans. 
 
Compared to the leaf extract the root extract of Combretum fragrans showed only slight or no 
cytotoxic effects on the cell lines investigated (III, Table 2). This is particularly interesting and is 
an example of that screenings of medicinal plants should always include different parts of the 
plants, since the variation in secondary compounds between different plant organs can be 
enormous. 
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To our knowledge we are the first to report on the excellent cytotoxic effects of C. fragrans. 
Batawila et al. (2005) have isolated tannins and flavonoids from a leaf extract of this species and 
found that it possesses good antifungal effects, but they did not study its cytotoxic effects. The 
excellent cytotoxic effects of the leaf extract of C. fragrans might thus be due to tannins and 
flavonoids, since these classes of compounds have been reported to possess anticancer effects 
(Ko et al., 2000; Saleem et al., 2002). The leaves of several species of Combretum have been 
found to contain powerful cytotoxic compounds: Pentacyclic triterpenes have at least partly been 
found to be responsible for the cytotoxic effects of a leaf extract of C. nigricans, and gave good 
activities against glioblastoma (U-373 MG), colon (HCT-15), non-small lung (A549) and bladder 
cancer (J82) cell lines (Simon et al., 2003a). Combretum woodii (Eloff et al., 2005) and C. 
erythrophyllum (Schwikkard et al, 2000) have been found to contain combretastatins in their 
leaves, and thus it may be possible that leaf extracts of C. fragrans also contain these kinds of 
compounds, which might be responsible for the remarkable antiproliferative effects we have 
observed for this extract against all the investigated cancer cell lines and the BBCE endothelial 
cells. 
 
Since C. fragrans is frequently used in African traditional medicine, although not for treatment of 
cancer, the excellent cytotoxic effects we observed for this species could add an important new 
aspect of the use of this plant for the treatment of cancer in rural parts of Africa. On the other 
hand, careful studies on the toxicity of leaf extracts of this species must be performed to assess 
the proper and safe way to use it. The fact that mainly the leaves of this plant seem to contain 
cytotoxic compounds is beneficial since leaves are the easiest part to collect, and also makes non-
destructive collection possible (compared to collections of roots). 
 
Combretum zeyheri 
A methanolic fruit extract of C. zeyheri gave antiproliferative effects comparable to those of the 
leaf extract of C. fragrans, showing excellent effects against all the human cancer cell lines (III, 
Table 2). Fruits of Combretum species are, however, considered poisonous in African traditional 
medicine (Rogers & Verotta, 1996). An extract of the roots of C. zeyheri was less cytotoxic than 
the fruit extract, and exhibited only moderate cytotoxicity against the T 24 bladder cancer cells 
and nearly no toxicity against the HeLa cervical cancer and MCF 7 breast cancer cells (III, Table 
2). An extract of the stem bark of C. zeyheri gave moderate antiproliferative effects against the 
BBCE endothelial cell line (Table 11), showing that this species of Combretum might contain 
antiangiogenic and –vascular compounds. The stem bark extract gave only moderate 
antiproliferative effects against the T 24 bladder cancer cell line, weak effects against the MCF 7 
breast cancer cell line, and was growth stimulatory of the HeLa cervical cancer cells. Previously, 
triterpenoids and saponins have been isolated from the leaves of C. zeyheri (Carr & Rogers, 
1987) and these compounds might also be responsible for the cytotoxic effects of the fruit extract 
we observed. 
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In some villages of Mbeya region hot water decoctions of the stem bark and roots of C. zeyheri 
are used for the treatment of cancer (I, Table 1; Table 7). However, we have now found that 
extracts of the roots and stem bark of this species only possess minor antiproliferative effects 
compared to the fruits against the cancer cell lines in our study. On the other hand, the extract of 
the stem bark gave antiproliferative effects against the BBCE endothelial cell line, and this might 
justify the use of extracts of stem bark of C. zeyheri for the treatment of tumors in Mbeya region. 
 
Combretum padoides 
Good antiproliferative activities were also shown by an extract of the stem bark of C. padoides, 
which gave strong cytotoxic effects against HeLa cervical cancer cells (17.4 % growth of control) 
and good effects against T 24 bladder cancer cells (31.4 % growth of control) (III, Table 2). An 
extract of the roots was not as cytotoxic as the stem bark. No reports exist on the secondary 
compounds in the stem bark of C. padoides, but the leaves are known to contain mono- and bi-
desmosidic triterpenoids (Rogers, 1989). 
 
Combretum molle 
Methanolic extracts of the roots and leaves of C. molle gave almost similar results against the T 
24 bladder cancer cells, and both extracts were good inhibitors of the growth of this cell line 
reducing the growth to 26.3 – 27.7 % of the control (III, Table 2). Since this species is so 
frequently used in Tanzanian traditional medicine (Table 7; I, table 1), and showed mildly 
cytotoxic effects, we speculate the possibility of using it for the long term treatment of cancer in 
rural regions of Africa. Substituted phenanthrenes and a substituted bibenzyl have been isolated 
from the heartwood of Combretum molle (Letcher et al., 1972). C. molle has been found to be 
cytotoxic against a murine P-388 lymphocytic leukemial cell line, but the compound/-s 
responsible for this action was/were not identified (Pettit et al., 1987). The triterpenoid mollic 
acid 3β-D-glucoside, a well known anti-molluscicide, has been isolated from acetone extracts of 
the leaves of C. molle (Pegel & Rogers, 1985), but no investigations on the cytotoxic effects of 
this compound have been performed. 
 
5.5.2. Antiproliferative effects of Terminalia spp. 
 
The most cytotoxic species of Terminalia were not at all as antiproliferative as the most potent 
species of Combretum, although some of the species gave good antiproliferative effects (> 70 % 
inhibition of proliferation) at 25 µg/ml against both the cancer cell lines (III, Table 2) and the 
BBCE endothelial cell line (Table 11). Similarly to the species of Combretum, most of the 
species of Terminalia gave strong cytotoxic effects at 250 µg/ml killing nearly all the cells in the 
wells when observed in light microscope. Methanolic extracts of the roots of T. sambesiaca and 
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T. sericea gave the strongest cytotoxic effects of all the Terminalia species studied. Root extracts 
of T. sambesiaca and T. kaiserana were potent inhibitors of the growth of the BBCE endothelial 
cell line (Table 11). 
 
Terminalia sambesiaca 
A root extract of T. sambesiaca gave the strongest antiproliferative effects of all the Terminalia 
species against the HeLa cervical cancer cells (18 % growth of control), and gave also good 
effects against the T 24 bladder cancer cells (29.5 % growth of control) (III, Table 2). To the best 
of our knowledge we are the first to report that this species possesses excellent-good cytotoxic 
activity. The extract of the stem bark of T. sambesiaca was not at all as active as the root extract, 
and interestingly showed only weak antiproliferative effects against the HeLa cervical cancer 
cells (81 % growth of control), but exhibited modest activity against the T 24 bladder cancer cells 
(58.5 % growth of control) (III, Table 2). The ethnomedical use of T. sambesiaca in Tanzania for 
treatment of cancer (Chhabra et al., 1989), correlates well with the good antiproliferative effects 
we found for this species, although in Tanzania extracts of leaves and stem bark are used for this 
purpose, but not the roots. We did not include leaves in our investigation due to lack of plant 
material, but it would be interesting to explore also the cytotoxic potential of this organ of T. 
sambesiaca in comparison to roots and stem bark. 
 
Interestingly, root extracts of T. sambesiaca gave very good antiproliferative effects against the 
BBCE endothelial cell line (Table 11), and thus this species seems also to contain anti-angiogenic 
compounds. Flavonoids, such as luteolin and genistein, of which luteolin has been isolated from 
the leaves, bark and stem of Terminalia arjuna (Pettit et al., 1996), have been found to possess 
anti-angiogenetic effects against HUVEC umbilicalial vein endothelial cells (Bagli et al., 2004). 
It is therefore possible that the root extract of T. sambesiaca might contain flavonoids responsible 
for its good antiproliferative effects against the BBCE endothelial cells. 
 
A part of the good cytotoxic effects shown by T. sambesiaca might be due to hydrolysable 
tannins and their monomers, since several authors have found this group of molecules from 
Terminalia spp. (Baba-Moussa et al., 1999; Chen et al., 2000; Saleem et al., 2002) and have 
found that some of these compounds, such as chebulinic acid, tannic acid and ellagic acid possess 
antiproliferative effects (Saleem et al., 2002). To the best of our knowledge the tannin 
constituents of T. sambesiaca are unknown. Our investigation indicates that it would be worth to 
perform an activity guided isolation of the compounds responsible for the good cytotoxic activity 
of the root extract of T. sambesiaca. Perhaps, the scarce occurrence of T. sambesiaca in nature 
and thus the difficulty of getting plant material for performing biological assays might be one 
reason why this species has been studied for its biological (antimicrobial) effects only for a few 
times, both investigators being Africans (Chhabra et al., 1989; Masoko et al., 2005). 
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Terminalia sericea 
A root extract of Terminalia sericea gave as good cytotoxic effects as the root extract of T. 
sambesiaca against the T 24 bladder cancer cells and was slightly less effective than T. 
sambesiaca against the HeLa cervical cancer cell line, but showed better effects against the MCF 
7 breast cancer cell line (III, Table 2). The root extract of T. sericea did, however, not give so 
good effects against the BBCE endothelial cell line (Table 11). An extract of the leaves was not 
as antiproliferatively potent as the root extract. The good antiproliferative effects of T. sericea on 
the cancer cell lines indicates that hot water decoctions of the roots might be used for the 
treatment of cancer in African traditional medicine. T. sericea is a popular medicinal plant in 
many African countries, and is used for the treatment of various ailments and diseases but not for 
cancer (Hedberg et al., 1982; Arnold & Gulimian, 1984). Ethyl acetate extracts of T. sericea have 
been found to inhibit topoisomerase I, an enzyme responsible for the uncoiling of DNA and thus 
these extracts seem to inhibit replication of DNA (Wall et al., 1996). The compound responsible 
for this action is, however, unknown. Anolignan B, which has been isolated from the roots of T. 
sericea and Anogeissus acuminata has been found to possess cytotoxic effects against a 
fibrosarcoma cell line (Rimando et al., 1994). Some triterpenoids such as sericoside, 
arjunglucoside and an aglycon of sericoside have been isolated from the roots and stem bark of T. 
sericea (Bombardelli et al., 1974; Bombardelli et al., 1986) but none of them have been explored 
for their cytotoxic effects. Triterpenoids are known to exert cytotoxic effects (Simon et al., 
2003a), and thus the triterpenoids isolated from T. sericea may in part be responsible for the good 
cytotoxic effects shown by the root extract of this species. 
 
5.5.3. Antiproliferative effects of Pteleopsis myrtifolia 
 
A root extract of the only species of Pteleopsis in this investigation, P. myrtifolia gave strong 
antiproliferative effects against the T24 bladder cancer cells, but was less effective against the 
HeLa cervical cancer and MCF7 breast cancer cell lines (III, Table 2). We are the first to report 
about the cytotoxic potential of this species. Saponins and triterpenoids have been isolated from 
the stem bark of Pteleopsis hylodendron (Ngounou et al., 1999) and P. suberosa contains 
saponins and tannins (Baba-Moussa et al., 1999), and similar compounds might therefore be 
present also in P. myrtifolia. P. myrtifolia is frequently used in African traditional medicine 
(Chhabra et al., 1989) but there are no reports that it would be used for the treatment of cancer. 
Thus our results indicate that this species might be used for the treatment of schistosomiasis 
induced bladder cancer, which is a common form of cancer among the male population in 
African countries (el-Mawla et al., 2001). 
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Table 11. Antiproliferative effects of extracts of Combretum and Terminalia against BBCE endothelial 
cells. Results are shown as the % of growth of control and obtained with Coulter count. The most 
antiproliferative extracts indicated in bold. Results are presented as means ± S.E.M % of triplicates in two 
experiments. 
 
Cell line 
Extracts, 25 μg/ml 
BBCE endothelial cell lines 
% growth 
Combretum spp.  
C. fragrans L 14.08 ± 3.02 
C. fragrans R 62.23 ± 2.97 
C. molle L 74.76 ± 1.62 
C. zeyheri S 56.48 ± 0.15 
Terminalia spp.  
T. kaiserana R 20.94 ± 1.49 
T. sambesiaca R 17.54 ± 1.18 
T. sambesiaca S 34.34 ± 2.87 
T. sericea R 68.97 ± 4.67 
T. stenostachya S 40.46 ± 1.03 
 
L, leaves; R, roots; S, stem bark. 
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Table 12. Summary of the antiproliferative effects of the most effective extracts of Combretum, Terminalia and Pteleopsis myrtifolia in our 
screening and correlation to ethnomedical use in Mbeya. * not investigated. 
 
Species Cytotoxicity Ethnomedical use in Mbeya Secondary compounds  
Combretum spp. Our results/results from literature   
C. fragrans Extracts of the leaves gave the strongest inhibitory 
effects of all the extracts used in this study. At 4.3 
μg/ml this extract inhibited the proliferation of 60 % 
of the HeLa cervical cancer cells. Root extracts are 
only slightly cytotoxic.  
 
Leaf extract not toxic against COS-7 green monkey 
fibroblasts. 
 
Leaf extract may cause apoptosis in the HeLa cell line 
at concentrations of 4.3 μg/ml.  
 
No other author has investigated this plant for 
cytotoxic effects.  
Roots for treatment of diarrhea. Leaf extracts contain tannins, 
flavonoids and saponins (Batawila 
et al., 2005). 
C. molle Extracts of roots and leaves good inhibitors of the 
proliferation of T 24 bladder cancer cells.  
 
Cytotoxic against a murine P-388 lymphocytic 
leukemial cell line (Pettit et al., 1987).  
Leaves, roots and stem bark to treat 
gonorrhea, syphilis, oedema, skin 
diseases and wounds. 
Mollic acid β-3-D-glucoside from 
the leaves (Pegel & Rogers, 1985); 
Substituted phenanthrenes and a 
substituted bibenzyl from the 
heartwood (Letcher et al., 1972). 
C. padoides An extract of the stem bark showed good cytotoxic 
activity against HeLa cervical cancer cells and T 24 
bladder cancer cells. 
 
No previous reports on cytotoxic activity of this plant. 
* Mono- and bidesmosidic 
triterpenoids from leaves (Rogers, 
1989); Saponins in leaves (Carr & 
Rogers, 1987). 
C. zeyheri  A fruit extract as cytotoxic as the leaf extract of C. 
fragrans, effective against all the cancer cell lines. An 
extract of the roots only mildly cytotoxic and stem 
bark had growth stimulatory effects on HeLa cervical 
cancer cells.  
 
No previous reports on cytotoxic activity of this plant. 
Roots and leaves to treat diarrhea 
and cancer. 
Triterpenoids and saponins from 
leaves (Carr & Rogers, 1987). 
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Table 12. Continued. 
 
Pteleopsis spp.    
P. myrtifolia A root extract gave strong antiproliferative effects 
against T 24 bladder cancer cells; less effective 
against HeLa cervical cancer and MCF 7 breast cancer 
cells. 
 
No previous reports on cytotoxic activity of this plant. 
* A related species, P. suberosa is 
known to contain saponins and 
tannins (Baba-Moussa et al., 
1999); P. hyladendron contains 
triterpenoids and saponins in stem 
bark (Ngounon et al., 1999). 
Terminalia spp.     
T. sambesiaca  A root extract was strongly active against HeLa 
cervical cancer cells. 
 
No previous reports on cytotoxic activity of this plant.  
No use reported. May contain saponin-like 
compounds in leaves (Masoko et 
al., 2005).  
T. sericea  As effective as T. sambesiaca against T 24 cells and 
slightly less effective against HeLa cells. Good 
cytotoxic effects against the MCF 7 breast cancer cell 
line. 
 
Anolignan B from roots of T. sericea cytotoxic against 
a fibrosarcoma cell line (Rimando et al., 1994); Ethyl 
acetate extract inhibits topoisomerase I (Wall et al., 
1996).  
Leaves, roots and stem bark to treat 
diarrhea, fever, hypertension and 
bacterial infections. 
The triterpenoids sericoside, 
arjunglucoside and an aglycon of 
sericoside have been isolated from 
roots and stem bark (Bombardelli 
et al., 1974; Bombardelli, 1986; 
Rode et al., 2003); the lignan 
Anolignan B from the roots 
(Rimando et al., 1994). 
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6. Conclusions and Summary 
 
The results indicate that finding medicinal plants with good biological activities is enhanced 
when plants are chosen on the basis of ethnomedical use and when a group of related plants are 
screened. The chemotaxonomic approach on choosing a group of taxonomically related species, 
in our case species of Combretaceae, seems to be successful when trying to find plant species 
with new/improved biological activities. Although, some of the species of Combretum, 
Terminalia and Pteleopsis, included in this study, have been investigated for their traditional 
medicinal uses before by various authors, we have, in some cases reported on different or 
additional ethnomedical uses of certain species. This work has also elucidated the ways in which 
Combretum and Terminalia species are prepared for traditional medicines in Mbeya region, 
Tanzania, different countries and regions of Africa differing from each other in terms of methods 
for preparing herbal medicines from this plant group. Since ethnopharmacological knowledge is 
often handed down orally from generation to generation and usually no written documents are 
available, it is important to documentate this valuable information. Also, in many countries in 
Africa over 80 % of the population is entirely dependent on traditional medicine for their health 
care, and thus written information might aid and improve the health care of the local people, as 
well as help to preserve the information. 
 
Ethnomedical uses of Combretaceae in Mbeya, Tanzania. Of ten species of Combretum and 
Terminalia six were commonly used as medicinal plants by the traditional healers in the villages 
we visited. These were Combretum molle, C. fragrans, C. psidioides, C. zeyheri, Terminalia 
sericea and T. kaiserana. The ethnomedical uses reported by the healers in Mbeya region 
correlated well with traditional uses of this plant group practiced by healers in other African 
countries as well as in Tanzania, reported by other authors. Common medicinal uses of 
Combretum and Terminalia species in Mbeya region was for the treatment of infectious diseases 
(gonorrhea, syphilis, “stomach problems”, diarrhea, influenza), fever, wounds, pains in the 
muscles (general body pain), oedema and hypertension. One species of Combretum, C. zeyheri 
was also reported to be used for the treatment of stomach tumors. In Mbeya region all plant parts 
of Combretum and Terminalia species were reported to have medicinal uses except from the 
fruits and flowers, the fruits of Combretum spp. being considered poisonous by many of the 
healers we interviewed. The traditional healers in Mbeya reported that most of the species of 
Combretum and Terminalia we showed them are abundant and easy to find. The most common 
way of preparing these plants for medicine is to use dried plant material and make hot water 
decoctions of it, although it was also common to mix either hot water extracts or the dried plant 
material itself in maize porridge. Leaves are sometimes prepared as teas (infusions). Fresh plant 
material was also used sometimes, although it was more common to use dried material. In some 
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cases the plants are used topically, mainly to treat wounds and infections on the skin, and for 
these purposes the dried plant material is mixed with sheep fat for ointments. 
 
Correlation between ethnomedical use and biological effects. In many cases we found that the 
ethnomedical use of Combretum and Terminalia species correlated well with the antimicrobial 
effects of extracts made of them, and in some cases even with the cytotoxic properties of the 
plants. For example, species which gave the most outstanding/strong antibacterial and antifungal 
effects, such as T. kaiserana, T. sambesiaca and T. sericea, are used for the treatment of 
infectious diseases and diarrhea in Tanzania. Interestingly, two of the Combretum species, C. 
fragrans and C. molle, which both are used for diarrhea, “stomach problems” and wounds, gave 
excellent antibacterial and antifungal effects. The cytotoxic activity of the extracts of 
Combretaceae was in some cases related to their uses in traditional medicine: a fruit extract of C. 
zeyheri, the only species of Combretum used for treatment of tumors in Tanzania, Mbeya, 
showed excellent antiproliferative effects against the human T 24 bladder cancer, HeLa cervical 
cancer and MCF 7 breast cancer adenocarcinoma cell lines, and a root extract of T. sambesiaca, 
also used for cancer in Tanzanian traditional medicine, effectively inhibited the growth of the 
HeLa cells. Very good cytotoxic effects were however also observed for a leaf extract of C. 
fragrans, which is not reported to be used for cancer in traditional medicine, either in Mbeya, 
Tanzania or in other countries in Africa. 
 
Antibacterial effects. The species of Terminalia were in general more antibacterial than the 
species of Combretum, although good antibacterial effects were also obtained with some of the 
Combretum species. Of the Terminalia species screened, T. sambesiaca, T. sericea and T. 
kaiserana gave the best effects, and for the first two the root extracts were more effective than 
extracts of the leaves or stem bark. A leaf extract of T. kaiserana was the only extract to inhibit 
the growth of the gram-negative E. coli. In a root extract of T. sambesiaca the antibacterial 
effects were highest in the more polar fractions. A hot water decoction of the roots of T. sericea 
was as effective as EtOH, acetone and MeOH extracts against all the bacterial species. Thus, it 
seems, that antibacterial compounds are extracted in hot water decoctions, the traditional way of 
preparing T. sericea for medicine. Our results on the good antibacterial effects of Terminalia 
species correlate well with the results published by Eloff (1999). Similarly to us, many authors 
report that especially polar extracts of Terminalia show a broad activity spectrum against both 
gram-positive and gram-negative bacteria (Ahmad et al., 1998; Malekzadeh et al., 2001; Gupta et 
al., 2002; Steenkamp et al., 2004; Moshi & Mbwambo, 2005). Antimicrobial ellagitannins 
(Burapadaja & Bunchoo, 1995; Conrad et al., 2001; Lin et al, 2001), lignans (Valsaraj et al., 
1997; Eldeen et al., 2005), flavonoids (Valsaraj et al., 1997; Srivastava et al., 2001) and 
triterpenoids (Conrad et al., 1998; Atta-ur-Rahman et al., 2002) have been found from different 
species of Terminalia, which shows that this genus contains a broad range of different 
antimicrobial compounds. 
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Three species of Combretum, C. fragrans, C. padoides and C. molle gave excellent antibacterial 
effects. In summary, many Combretum species are known to possess powerful antibacterial 
effects against both gram-negative and gram-positive bacteria (Martini & Eloff, 1998; Eloff, 
1999; Elegami et al., 2002; Katerere et al., 2003; Eloff et al., 2005; Eloff & Katerere, 2005; 
Karou et al., 2005). Tannins, flavonoids, saponins, coumarins, phenanthrene derivatives, 
anthracene glycosides and triterpenoids, some of them with antibacterial effects, have been 
isolated from species of Combretum (Bombardelli et al., 1974; Carr & Rogers, 1987; Malan & 
Swinny, 1993; Jossang et al., 1994; Udem et al., 1996; Martini & Eloff, 1998; Martini, 2001; 
Martini & Eloff, 2004). 
 
Antifungal effects. We found that the species of Terminalia in general gave stronger antifungal 
effects against the species of yeast and Cryptococcus neoformans than the species of Combretum. 
Three species of Terminalia, T. sambesiaca, T. sericea and T. kaiserana gave excellent 
anticandidal and anticryptococcal activities, and the effects were in some cases comparable to the 
standard antibiotics, itraconazol and amphotericin used in our investigation. A hot water 
decoction of the roots of T. sericea was more effective than MeOH, EtOH and acetone extracts in 
inhibiting the growth of C. albicans. This indicates that many antifungal compounds are 
extracted especially in hot water extracts of this species and justifies this kind of preparation of 
medicine from T. sericea in African traditional medicine. Amphotericin B gave very poor 
inhibition against Candida glabrata compared to the extracts of the most effective species of 
Terminalia. Candida albicans, C. tropicalis and C. parapsilosis seemed to be the most resistant 
species, while C. krusei, C. glabrata and Cryptococcus neoformans were more sensitive to the 
extracts of Terminalia spp. Extracts of the roots seemed to be much more antifungal than extracts 
of the leaves, and in some cases extracts of the leaves were inactive against all the species of 
yeasts, although a leaf extract of T. stenostachya showed good antifungal activity. Thus, 
antifungal compounds, at least in the African species of Terminalia we have screened, seem 
mostly to be concentrated to the roots. Interestingly, we found that all fractions of a root extract 
of T. sambesiaca gave antifungal effects, although the more polar ones were more active. This 
result and studies of other authors on Terminalia species indicate that they contain a diverse array 
of antimicrobial compounds of different polarity. Hydrolysable tannins are known from many 
species of Terminalia and might be an attractive group of antifungals due to their high anti-
cryptococcal and anti-Candida (non-albicans) inhibitory activity, as well as most of them 
showing low toxicity in the mammalian body and being water soluble, thus easily extracted from 
plant material into water decoctions (such as in traditional medicine). The excellent antifungal 
effects we found for some extracts of Terminalia indicate that this genus in general might be used 
for treatment of fungal infections in remote areas in Africa where conventional antifungals are 
not available. 
The species of Combretum gave in general less prominent antifungal effects than those of 
Terminalia, although some species and extracts, such as the root extracts of C. padoides and C. 
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molle gave excellent antifungal effects and were active against all the fungal species investigated. 
In contrast to the genus Terminalia, relatively few African species of Combretum have been 
subjected to antifungal studies (Batawila et al., 2005; Katerere et al., 2003; Masika & Afolayan, 
2002; Pegel & Rogers, 1985; Malan & Swinny, 1993; Baba-Moussa et al, 1999). 
 
Cytotoxic effects. The antiproliferative effects of the Combretum species and extracts made from 
different plant organs of the same species, differed markedly from each other. There was no clear 
trend to which plant organ would be the cytotoxically most active among the species of 
Combretum, since the species differed from each other in terms of which organ was the most 
cytotoxic. To my knowledge we are the first to report on the outstanding cytotoxic effects of a 
leaf extract of C. fragrans. This extract effectively inhibited the proliferation of all the cancer cell 
lines as well as a BBCE endothelial cell line. This extract might induce apoptosis in HeLa 
cervical cancer cells at a concentration of 4.3 μg/ml since some fragmentation of the nucleus of 
the cells could be observed. Cytotoxic compounds identified from some African species of 
Combretum include the combretastatins (Pettit et al., 1987, 1988, 1989, 1995), pentacyclic 
triterpenoids (Simmons et al., 2003), flavonoids (Martini et al., 2004), an ellagic acid derivative 
(Asami et al., 2001) and hydrolysable ellagitannins (Jossang et al., 1994). Hydrolysable tannins 
have been found to show potent host-mediated anti-tumor effects in mice (Okuda, 2005). 
Punicalagin has been found to inhibit cell growth and anchorage-independent growth in H-ras 
transformed NIH3T3 fibroblasts, and possibly the effect is mediated through modulation of the 
redox status of the cells (Chen et al., 2005). Thus, tannins might in part be responsible for the 
good cytotoxic effects we have found in some of our extracts of Combretum since these kinds of 
molecules are found from species of Combretum. 
Of the five investigated species of Terminalia, T. sambesiaca and T. sericea showed the most 
promising cytotoxic potential and the root extracts of both species gave strong effects against the 
HeLa cervical cancer and T24 bladder cancer cell lines. T. sambesiaca has not been investigated 
for its in vitro antiproliferative effects before. Our results are in agreement with those of other 
authors who have found several, mainly Asian species of Terminalia with good cytotoxic 
potential. The Asian species T. catappa, T. chebula, T. bellerica and T. arjuna, to mention a few, 
have been reported to possess cytotoxic (Lee et al., 1995; Saleem et al., 2002) chemopreventive 
(Chen et al., 2005) and antimutagenic (Liu et al., 1996; Chen et al., 2000; Kaur et al., 2000) 
properties. African species of Terminalia have mainly been studied for their antimicrobial effects, 
while studies on their cytotoxic effects on cancer cell lines are rare, an exception being the study 
on T. sericea crude extracts which were found to inhibit topoisomerase I activity (Wall et al., 
1996). Hydrolysable ellagi- and gallotannins are thought to be responsible for much of the 
chemopreventive (Chen et al., 2000) and cytotoxic activity shown by species of Terminalia 
(Saleem et al., 2002; Pettit et al., 1989; Lee et al., 1995), which may explain the good cytotoxic 
effects for T. sambesiaca and T. sericea in my study. 
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My study demonstrated for the first time that root extracts of Pteleopsis myrtifolia possess 
excellent antiproliferative effects against T 24 bladder cancer cells. Decoctions of this species 
might thus be used for the treatment of schistosomiasis caused bladder cancer which is very 
common in African countries. 
 
The Combretaceae plant family seems to include many medicinally interesting genera and 
species and there is still much to elucidate of biological activity of crude extracts and active 
compounds from these plants. New techniques for bioactivity guided isolation of active 
compounds, such as microfractionation, may enhance the finding of new compounds/known 
compounds with new biological activities from this plant group. The investigation of the 
biological effects of Combretaceae seems to be just in its beginning, but has expanded during the 
beginning of the new millennium with many new investigations. 
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Table 13. Summary of our results on the antibacterial, antifungal and cytotoxic effects of Combretum, Terminalia and Pteleopsis, ethnomedical use as well as 
compounds isolated from the species. * not investigated. 
 
Species Antibacterial effects 
(I) 
Antifungal effects 
(II) 
Cytotoxic effects (III) Ethnomedical use; other 
authors/our results (I) 
Major 
compounds 
 
Combretum species      
1. C. apiculatum Sond. 
 
* Leaf extract inactive 
against all Candida spp., 
slightly active against 
Cryptococcus 
neoformans. 
 
Root extract showed 
slight activity against 
Candida krusei and C. 
tropicalis. 
Cytotoxic against MCF 7 
breast cancer cells (ca. 40 
% growth of control). 
Abdominal disorders, conjunctivitis 
(Watt & Breyer-Brandwijk, 1962); 
leprosy, bloody diarrhea, snake bite, 
scorpion sting (Kokwaro, 1976); body 
exhaustion in women (Gelfland et al., 
1985); mental illness (Chhabra et al., 
1989). 
 
Not investigated in Mbeya 
(Fyhrquist et al., 2002). 
phenanthrenes, di-
hydrophenanthrenes, 
bibenzyls (Letcher & 
Nhamo, 1971). 
2. C. collinum Fresen. 
 
* Root extract inactive 
against all fungal species 
in our screening. 
 
Leaf extract inactive 
against all other fungi 
except Candida krusei. 
A leaf extract very active 
against MCF 7 breast 
cancer cells. 
Malaria (Haerdi, 1964); Diarrhea, 
excessive menstrual bleeding, rectal 
prolapse (Hedberg et al., 1982); 
dysentery, snake bites (Kokwaro, 1976); 
“madi”, a blood disease (Watt & Breyer-
Brandwijk, 1962); gastroenteritis 
(Adjanouhoun et al., 1993). 
 
No use reported in Mbeya (Fyhrquist et 
al., 2002) 
triterpenoids in leaf 
trichomes (Rogers & 
Coombes, 1999). 
3. C. constrictum Laws. 
 
* Leaf extract slightly 
active against Candida 
krusei and extract of stem 
bark slightly active 
against Cryptococcus 
neoformans. 
* Snakebites, aphrodisiac (Kokwaro, 
1976). 
 
Not investigated in Mbeya. 
(Fyhrquist et al., 2002) 
* 
4. C. fragrans F. Hoffm. 
 
Root extracts gave 
excellent activity 
against Micrococcus 
luteus and Enterobacter 
aerogenes, stem bark 
extract against M. 
luteus. 
 
MIC against Sarcina 
sp.: 7.3 mg/ml 
Root extract gave good 
antifungal activity 
against all species of 
Candida except C. 
tropicalis. No activity 
against C. neoformans. 
 
Leaf extract inactive 
against all the fungal 
species in our screening. 
A leaf extract gave the 
most outstanding cytotoxic 
effects of all the extracts 
used in our screening. At 
4.3 μg/ml it inhibited 60 % 
of the proliferation of 
HeLa cervical cancer cells. 
Also very good 
antiproliferative activity 
against BBCE endothelial 
cells. 
 
Root extract inactive or 
just slightly active against 
the cancer cell lines. 
Coughs, syphilis (Kokwaro, 1976); 
aphrodisiac (Gelfland et al., 1985); 
chronic wounds (Adjanouhoun et al., 
1986); leprosy (Chhabra et al., 1989); 
snakebites (Neuwinger, 2000) 
 
Diarrhea (Fyhrquist et al., 2002) 
leaf extracts contain 
tannins, flavonoids 
and a few saponins 
(Batawila et al., 
2005). 
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Table 13. continued. 
 
5. C. hereroense Schinz. 
 
Extracts of stem bark 
gave good activity 
against most of the 
bacterial species, 
especially Enterobacter 
aerogenes and Sarcina 
sp. 
Extracts of stem bark 
gave moderate antifungal 
activity against most of 
the Candida species, but 
was inactive against C. 
neoformans. 
Stem bark: some 
cytotoxicity against T 24 
cells. 
Cardiac problems, heartburn, venereal 
diseases, body pain, chest problems, 
coughs, stomach problems, headache, 
schistosomiasis (Watt & Breyer-
Brandwijk, 1962; Gelfland et al., 1985); 
Schistosomiasis (Kokwaro, 1976). 
Not investigated in Mbeya 
(Fyhrquist et al., 2002). 
Phenanthrene 
derivates in 
heartwood (Letcher 
& Nhamo, 1973); 
flavonoids in leaf 
extracts (Carr & 
Rogers, 1987). 
6. C. molle G. Don. Good antibacterial 
activity of leaf extract 
against Enterobacter 
aerogenes and M. 
luteus. 
Good antifungal profile 
of root extract against 
most of the Candida 
species and C. 
neoformans MIC 12.5 
mg/ml, C. glabrata MIC 
6.25 mg/ml. 
Extracts of roots and stem 
bark showed good activity 
against T 24 bladder 
cancer cells. 
Wound dressing, stomach problems, 
snake bites, aid in child birth (Watt & 
Breyer-Brandwijk, 1962); abortions, 
antidiarreic (Haerdi, 1964); wounds from 
poisoned arrows (Haerdi, 1964); wounds 
(Drummond & Coates-Palgrave, 1973); 
hookworms, stomach pains, snake bite, 
leprosy, fever, dysentery, general body 
swellings, chest complaints, 
abortifacient, wounds (Kokwaro, 1976); 
angina, dropsy (Kerharo, 1974); 
expectorant, syphilis, snakebites 
(Hedberg et al., 1982); swelling of 
abdomen, abortion, constipation, sterility 
(Chhabra et al., 1989); stomach 
problems, snake bites, wounds, 
dysentery, galactogogue (Neuwinger, 
2000). 
 
Gonorrhea, syphilis, influenza, oedema, 
skin diseases, wounds (Fyhrquist et al., 
2002). 
Substituted 
phenanthrenes and a 
substituted bibenzyl 
from the heartwood 
of Combretum molle 
(Letcher et al., 1972); 
Mollic acid 3β-D-
glucoside from an 
acetone extract of the 
leaves (Pegel & 
Rogers, 1976; 
Valsaraj et al., 1997). 
7. C. obovatum F. Hoffm. 
 
* Stem bark extract did not 
show any antifungal 
activity against C. 
albicans and C. krusei. 
Not investigated against 
the rest of the fungal 
species. 
* No reports in literature. 
 
Not investigated in Mbeya 
(Fyhrquist et al., 2002). 
* 
8. C. padoides Engl. & Diels  Both stem bark and root 
extracts gave good 
antibacterial activity 
against S. aureus and E. 
aerogenes. 
Most antifungal of all the 
species of Combretum in 
our screening. A root 
extract gave good 
activity against all the 
fungal species in our 
screening. Fungicidal 
against C. glabrata, MIC 
6.25 mg/ml, C. 
neoformans, MIC 6.25 
mg/ml. 
An extract of the stem bark 
gave good activity against 
the HeLa cervical cancer 
cell line (17.4 % growth of 
control) 
Snake bites and hookworms (Kokwaro, 
1976). 
 
Not investigated in Mbeya 
(Fyhrquist et al., 2002). 
Mono- and bi-
desmosidic 
triterpenoids from the 
leaves (Rogers, 
1989); saponins in 
leaves (Carr & 
Rogers, 1987). 
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Table 13. continued. 
 
9. C. psidioides Welw.  Leaf extract good 
antibacterial effects 
against E. aerogenes 
and M. luteus 
Extracts of stem bark 
antifungal against C. 
krusei, C. glabrata and 
C. neoformans. 
Not cytotoxic. Aphrodisiac, diarrhea, malaria, 
rheumatic back pain (Haerdi, 1964); 
galactogogue (Gilges, 1985). 
 
Diarrhea, muscle pain, oedema 
(Fyhrquist et al., 2002). 
Phenanthrenes (Pettit 
et al., 1987). 
10. C. zeyheri Sond. Extracts of fruits, stem 
bark and roots gave 
good antibacterial 
effects. 
Slight or no antifungal 
effects of stem bark, 
fruits and roots. 
The fruits are very 
cytotoxic against all the 
investigated cancer cell 
lines. 
 
Extracts of roots and stem 
bark just slightly cytotoxic 
or not active at all. 
Scorpion bites (Watt & Breyer-
Brandwijk, 1962); coughs, colic, 
smallpox (Drummond & Coates-
Palgrave, 1973); Schistosomiasis, dry 
wounds, rheumatism, back pain, bloody 
diarrhea, coughs (Kokwaro, 1976); 
diarrhea, vomiting (Hedberg et al., 
1982); bloody diarrhea (Gelfland et al., 
1985); rheumatism, joint pains, eye 
inflammation, conjunctivitis (Kremnitz 
et al., 1988); treatment of back pain, 
malaria (Van Koenen, 1996); 
schistosomiasis (Neuwinger, 2000); 
 
Diarrhea, cancer (tumours) (Fyhrquist et 
al. 2002). 
Triterpenoids and 
saponins from leaves 
(Carr & Rogers, 
1987). 
Pteleopsis spp.      
1. P. myrtifolia Engl. & 
Diels 
* A root extract antifungal 
against all the species of 
Candida and C. 
neoformans 
Cytotoxic against T 24 
bladder cancer cells. 
Dysentery (Haerdi, 1964); venereal 
diseases (Kokwaro, 1976); dysentery, 
menorrhagia, swellings of the stomach, 
wounds, sterility, infertility 
(Hedberg et al., 1982). 
 
A related species of Pteleopsis, P. 
suberosa is used for treatment of gastric 
ulcers (Baba-Moussa et al., 1999) 
 
Not investigated in Mbeya (Fyhrquist et 
al. 2002). 
No reports for P. 
myrtifolia, but related 
species such as P. 
suberosa contains 
saponins and tannins 
(Baba-Moussa et al., 
1999) and Pteleopsis 
hylodendron 
triterpenoids and 
saponins in stem bark 
(Ngounou et al., 
1999) 
Terminalia spp.      
1. T. glaucescens Benth. * * * Burns, headache, stomach problems 
(Bouquet & Debray, 1974); AIDS related 
fungal infections (Koudou et al., 1995); 
fungal infections of skin (Batawila et al., 
2005); coughs, wounds, dental care 
(Neuwinger, 2002). 
 
No use reported in Mbeya (Fyhrquist et 
al., 2002) 
* 
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Table 13. continued. 
 
2. T. kaiserana F. Hoffm. A leaf extract the only 
extract in our screening 
which showed activity 
against E. coli. Both leaf 
and root extracts 
showed good 
antibacterial activity. S. 
aureus, MIC 4.7 mg/ml, 
Sarcina sp., MIC 4.3 
mg/ml. 
Powerful inhibitor of 
fungal growth. Most 
effective of all extracts 
on inhibiting C. krusei. 
Candida glabrata, MIC 
1.56 mg/ml, C. 
neoformans, MIC 1.56 
mg/ml. 
Root extract cytotoxic 
against HeLa cervical 
cancer cells and BBCE 
endothelial cells. 
Gonorrhea, bilharzia schistosomiasis, 
diuretics, aphrodisiac, headache, back 
and kidney pain, scabies, cardiac 
problems, cough (Haerdi, 1964; Chhabra 
et al., 1989) 
 
Gonorrhea, diarrhea 
(Fyhrquist et al., 2002). 
* 
3. T. sambesiaca Engl. & 
Diels 
 
A root extract gave the 
best antibacterial effects 
of all extracts of 
Combretum and 
Terminalia. 
Enterobacter aerogenes 
MIC 0.9 mg/ml, M. 
luteus MIC 1.0 mg/ml, 
Sarcina sp. 1.2 mg/ml, 
S. epidermidis 1.5 
mg/ml, S. aureus, 1.8 
mg/ml. Also stem bark 
extracts antibacterial. 
Together with T. sericea 
and T. kaiserana the 
most powerful antifungal 
extract of all screened 
species of Terminalia 
and Combretum. 
Cryptococcus 
neoformans MIC 1.56 
mg/ml, Candida glabrata 
MIC 3.13 mg/ml. 
 
Fractionated extract of 
the root: antifungal 
activity was found 
especially in polar 
fractions. Active 
compounds might be 
tannins? 
 
 
A root extract the most 
effective inhibitor of the 
growth of HeLa cervical 
cancer cells (18 % growth 
of control) of all the 
species/extracts of 
Terminalia we 
investigated. 
 
Root extract very active 
against BBCE endothelial 
cells. 
 
Extract of stem bark only 
slightly cytotoxic. 
Bloody diarrhea, cancer, gastric ulcers, 
appendicitis (Chhabra et al., 1989). 
 
No uses of this plant were reported in 
Mbeya 
(Fyhrquist et al., 2002) 
May contain saponin-
like compounds in 
the leaves (Masoko et 
al., 2005). 
4. T. sericea Burch ex. DC.  Extracts of roots 
especially active against 
Micrococcus luteus, 
Sarcina sp., S. aureus 
and E. aerogenes. When 
EtOH, MeOH, acetone 
extracts and a hot water 
decoction were 
compared, they were 
found to be equally 
active against all the 
bacterial species. 
 
Extracts of leaves active 
against M. luteus and E. 
aerogenes, although not 
at all as potent as the 
extracts of the roots. 
Acetone-, EtOH- and 
MeOH-extracts of roots 
gave excellent antifungal 
effects against all 
Candida species and 
Cryptococcus 
neoformans. A hot water 
decoction gave the best 
effects against C. 
albicans compared to a 
MeOH extract. 
Root extract gave strong 
antiproliferative effects 
against T 24 bladder 
cancer cells. 
Diarrhea, dysentery, colic, diabetes (Watt 
& Breyer-Brandwijk, 1962); diarrhea, 
colic, pneumonia, eyewash for certain 
diseases in the eyes (Drummond & 
Coates-Palgrave, 1973); bilharzia 
(Kokwaro, 1976); gonorrhea (Hedberg et 
al., 1982); diarrhea, skin diseases, cough, 
general body weakness, pneumonia, 
venereal diseases (Neuwinger, 2000) 
 
Diarrhea, fever, hypertension, bacterial 
infections (Fyhrquist et al., 2002). 
The triterpenoids 
sericoside, 
arjunglucoside, 
aglycone of 
sericoside in roots 
and stem 
(Bombardelli et al., 
1974; Bombardelli et 
al., 1986; Rode et al., 
2003). 
 
Resveratrol-3-O-β-D-
rutinoside 
(Bombardelli et al., 
1975). 
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Table 13. continued. 
 
5. T. spinosa Engl. * A leaf extract was 
slightly antifungal 
against Candida krusei 
and C. tropicalis 
A leaf extract was 
cytotoxic against T 24 
bladder cancer cells. 
Fresh leaves for treatment of malaria 
(Chhabra et al., 1989) 
 
Not investigated in Mbeya (Fyhrquist et 
al., 2002). 
Methanolic extracts 
contain coumarins 
and tannins (Okemo, 
1996). 
6. T. stenostachya Engl. & 
Diels 
Extracts of stem bark 
very active against S. 
aureus and E. 
aerogenes. 
Leaf extract gave good 
antifungal profile against 
all the Candida species in 
our investigation, except 
C. tropicalis. Active 
against C. neoformans. 
Stem bark also active 
against some of the 
species of yeast. 
Extract of stem bark active 
against T 24 bladder 
cancer cells and BBCE 
endothelial cells. 
Treatment of epilepsy and 
poisoning (Neuwinger, 2000) 
 
 
Not investigated in Mbeya (Fyhrquist et 
al., 2002). 
* 
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